
<html lang="en"     class="pb-page"  data-request-id="3a82f0a5-16d0-4eaa-b9cf-4571094b348e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-4;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm701164t;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors" /></meta><meta name="dc.Creator" content="Ester  Muraglia" /></meta><meta name="dc.Creator" content="Olaf  Kinzel" /></meta><meta name="dc.Creator" content="Cristina  Gardelli" /></meta><meta name="dc.Creator" content="Benedetta  Crescenzi" /></meta><meta name="dc.Creator" content="Monica  Donghi" /></meta><meta name="dc.Creator" content="Marco  Ferrara" /></meta><meta name="dc.Creator" content="Emanuela  Nizi" /></meta><meta name="dc.Creator" content="Federica  Orvieto" /></meta><meta name="dc.Creator" content="Giovanna  Pescatore" /></meta><meta name="dc.Creator" content="Ralph  Laufer" /></meta><meta name="dc.Creator" content="Odalys  Gonzalez-Paz" /></meta><meta name="dc.Creator" content="Annalise  Di Marco" /></meta><meta name="dc.Creator" content="Fabrizio  Fiore" /></meta><meta name="dc.Creator" content="Edith  Monteagudo" /></meta><meta name="dc.Creator" content="Massimiliano  Fonsi" /></meta><meta name="dc.Creator" content="Peter J.  Felock" /></meta><meta name="dc.Creator" content="Michael  Rowley" /></meta><meta name="dc.Creator" content="Vincenzo  Summa" /></meta><meta name="dc.Description" content="HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral replication, but integrase inhibitors as marketed drugs have just very recently started to emerge. In this..." /></meta><meta name="Description" content="HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral replication, but integrase inhibitors as marketed drugs have just very recently started to emerge. In this..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 25, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701164t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701164t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701164t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701164t" /></link>
        
    
    

<title>Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701164t" /></meta><meta property="og:title" content="Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0015.jpeg" /></meta><meta property="og:description" content=" HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral replication, but integrase inhibitors as marketed drugs have just very recently started to emerge. In this study, we show the evolution from the N-methylpyrimidinone structure to bicyclic pyrimidinones. Introduction of a suitably substituted amino moiety modulated the physical−chemical properties of the molecules and conferred nanomolar activity in the inhibition of spread of HIV-1 infection in cell culture. An extensive SAR study led to sulfamide (R)-22b, which inhibited the strand transfer with an IC50 of 7 nM and HIV infection in MT4 cells with a CIC95 of 44 nM, and ketoamide (S)-28c that inhibited strand transfer with an IC50 of 12 nM and the HIV infection in MT4 cells with a CIC95 of 13 nM and exhibited a good pharmacokinetic profile when dosed orally to preclinical species." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701164t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701164t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701164t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701164t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701164t&amp;href=/doi/10.1021/jm701164t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 861-874</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701170f" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701284j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ester++Muraglia">Ester Muraglia</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olaf++Kinzel">Olaf Kinzel</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Gardelli">Cristina Gardelli</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benedetta++Crescenzi">Benedetta Crescenzi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Donghi">Monica Donghi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Ferrara">Marco Ferrara</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emanuela++Nizi">Emanuela Nizi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Orvieto">Federica Orvieto</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Pescatore">Giovanna Pescatore</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralph++Laufer">Ralph Laufer</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Odalys++Gonzalez-Paz">Odalys Gonzalez-Paz</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annalise++Di+Marco">Annalise Di Marco</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Fiore">Fabrizio Fiore</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edith++Monteagudo">Edith Monteagudo</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimiliano++Fonsi">Massimiliano Fonsi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Felock">Peter J. Felock</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Summa">Vincenzo Summa</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +39 0691093276 . Fax: +39 06 91093654. E-mail: <a href="/cdn-cgi/l/email-protection#5237212637200d3f272033353e3b33123f372031397c313d3f"><span class="__cf_email__" data-cfemail="0e6b7d7a6b7c51637b7c6f6962676f4e636b7c6d65206d6163">[email protected]</span></a></div><div class="corresp-fn" id="aff1">†IRBM Merck Research Laboratories Rome.</div><div class="corresp-fn" id="aff2">‡Merck Research Laboratories.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701164t&amp;href=/doi/10.1021%2Fjm701164t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 861–874</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 25, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 September 2007</li><li><span class="item_label"><b>Published</b> online</span>25 January 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 February 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701164t" title="DOI URL">https://doi.org/10.1021/jm701164t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D861%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEster%2BMuraglia%252C%2BOlaf%2BKinzel%252C%2BCristina%2BGardelli%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D4%26contentID%3Djm701164t%26title%3DDesign%2Band%2BSynthesis%2Bof%2BBicyclic%2BPyrimidinones%2Bas%2BPotent%2Band%2BOrally%2BBioavailable%2BHIV-1%2BIntegrase%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D874%26publicationDate%3DFebruary%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701164t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1540</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701164t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ester&quot;,&quot;last_name&quot;:&quot;Muraglia&quot;},{&quot;first_name&quot;:&quot;Olaf&quot;,&quot;last_name&quot;:&quot;Kinzel&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Gardelli&quot;},{&quot;first_name&quot;:&quot;Benedetta&quot;,&quot;last_name&quot;:&quot;Crescenzi&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Donghi&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Ferrara&quot;},{&quot;first_name&quot;:&quot;Emanuela&quot;,&quot;last_name&quot;:&quot;Nizi&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Orvieto&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Pescatore&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Odalys&quot;,&quot;last_name&quot;:&quot;Gonzalez-Paz&quot;},{&quot;first_name&quot;:&quot;Annalise&quot;,&quot;last_name&quot;:&quot;Di Marco&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Fiore&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;Monteagudo&quot;},{&quot;first_name&quot;:&quot;Massimiliano&quot;,&quot;last_name&quot;:&quot;Fonsi&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Felock&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Summa&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;861-874&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701164t&quot;},&quot;abstract&quot;:&quot;HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral replication, but integrase inhibitors as marketed drugs have just very recently started to emerge. In this study, we show the evolution from the N-methylpyrimidinone structure to bicyclic pyrimidinones. Introduction of a suitably substituted amino moiety modulated the physical−chemical properties of the molecules and conferred nanomolar activity in the inhibition of spread of HIV-1 infection in cell culture. An extensive SAR study led to sulfamide (R)-22b, which inhibited the strand transfer with an IC50 of 7 nM and HIV infection in MT4 cells with a CIC95 of 44 nM, and ketoamide (S)-28c that inhibited strand transfer with an IC50 of 12 nM and the HIV infection in MT4 cells with a CIC95 of 13 nM and exhibited a good pharmacokinetic profile when dosed orally to preclinical species.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701164t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701164t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701164t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701164t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701164t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701164t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701164t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701164t&amp;href=/doi/10.1021/jm701164t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701164t" /></input><a href="/doi/pdf/10.1021/jm701164t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (375 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701164t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701164t%26sid%3Dliteratum%253Aachs%26pmid%3D18217703%26genre%3Darticle%26aulast%3DMuraglia%26date%3D2008%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BBicyclic%2BPyrimidinones%2Bas%2BPotent%2Band%2BOrally%2BBioavailable%2BHIV-1%2BIntegrase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D4%26spage%3D861%26epage%3D874%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0015.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral replication, but integrase inhibitors as marketed drugs have just very recently started to emerge. In this study, we show the evolution from the <i>N</i>-methylpyrimidinone structure to bicyclic pyrimidinones. Introduction of a suitably substituted amino moiety modulated the physical−chemical properties of the molecules and conferred nanomolar activity in the inhibition of spread of HIV-1 infection in cell culture. An extensive SAR study led to sulfamide (<i>R</i>)-<b>22b</b>, which inhibited the strand transfer with an IC<sub>50</sub> of 7 nM and HIV infection in MT4 cells with a CIC<sub>95</sub> of 44 nM, and ketoamide (<i>S</i>)-<b>28c</b> that inhibited strand transfer with an IC<sub>50</sub> of 12 nM and the HIV infection in MT4 cells with a CIC<sub>95</sub> of 13 nM and exhibited a good pharmacokinetic profile when dosed orally to preclinical species.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human immunodeficiency virus type 1 (HIV-1) is responsible for human acquired immunodeficiency syndrome (AIDS), one of the most urgent world health threats. Currently approved therapies<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> are based on inhibitors of HIV protease (PIs),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> reverse transcriptase (NRTIs and NNRTIs, nucleoside and non-nucleoside reverse transcriptase inhibitors),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and more recently, fusion inhibitors (enfuvirtide).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> During the past years, the combination of protease and reverse transcriptase inhibitors (HAART, highly active antiretroviral therapy)<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> has demonstrated efficacy in strongly reducing morbidity and mortality. Nevertheless, the rapid emergence of drug resistant viral strains and the toxicity derived from chronic treatment remain serious issues that highlight the need for the development of new therapeutic strategies.</div><div class="NLM_p">The HIV-1 genome, together with protease and reverse transcriptase, encodes a third enzyme, integrase, which is necessary for the viral life cycle and is an appealing target for drug discovery for its essential function in viral replication and the absence of a direct counterpart in the host cells.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> HIV-1 integrase catalyzes the incorporation of the viral DNA into the host cell’s genome through a multistep process. In the initial assembly step, integrase binds to specific sequences of the double-stranded viral DNA, newly formed by reverse transcription. An endonucleolytic cleavage of the last two nucleotides from the 3′ terminus of both strands of the viral DNA generates a processed DNA/integrase preintegration complex (PIC), which crosses the nuclear membrane to access the host genome. The cell DNA is then cleaved by integrase in a nonspecific way, and the shortened strands of viral DNA are integrated into the host DNA sequence.</div><div class="NLM_p">Selective inhibition of the HIV-1 integrase activity causes an interruption of the HIV-1 replication cycle and could represent an answer to the unmet medical need for new and improved treatments.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Just very recently the first integrase inhibitor (raltegravir) was approved in the U.S. for treatment of HIV infection.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">We recently reported<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> that dihydroxypyrimidine carboxamide <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a potent HIV integrase strand transfer<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> inhibitor (IC<sub>50</sub> = 0.06 µM), but despite the high intrinsic potency, it showed a much lower activity in the cell based assays (CIC<sub>95</sub> > 10 µM in inhibiting the spread of HIV-1 infection in MT4 cell culture in the presence of 10% fetal bovine serum (FBS) or 50% normal human serum (NHS) (spread assay).<a onclick="showRef(event, 'ref15 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref17">(15, 17)</a> An extensive SAR study on the substitution at the 2-position of the dihydroxypyrimidine scaffold<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> demonstrated that various substituents are tolerated, providing compounds equipotent to <b>1</b> in the enzymatic assay. This observation was interpreted as an indication that the 2-substituent is not directly interacting with the HIV integrase enzyme and that this position could be exploited to modify the physical−chemical properties of the molecule (lipophilicity, solubility, plasma protein binding) in order to modulate the pharmacological properties.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Evolution from dihydroxypyrimidine to <i>N</i>-methylpyrimidinones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Introduction of a basic amine proved to be beneficial for cellular activity, as in <b>2</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> which proved to be a potent inhibitor both in the strand transfer and in the spread assays.</div><div class="NLM_p">Cyclization of the tertiary amine of <b>2</b> as in <b>3</b> provided a further enhancement in the spread activity, and the introduction of a methyl on the 1-nitrogen of the pyrimidine led to 1-Me-pyrimidinone structure <b>4</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which was more than 2 orders of magnitude more potent than <b>1</b> in the spread assay in the presence of 50% normal human serum (NHS).</div><div class="NLM_p">Capitalizing on the above observations of the importance of installing a β-amino substituent in the 2-position of the pyrimidine scaffold and the beneficial effect of the 1N-methylation, we envisaged the possibility of constraining the 1<i>N</i>-Me of the 1<i>N</i>-methylpyrimidinone scaffold <b>5</b> into a saturated cycle as in <b>6</b> (<i>n</i> = 0, 1, 2) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Strategic approach from <i>N</i>-methylpyrimidinones to bicyclic pyrimidinones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to probe the hypothesis summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, our initial investigations focused on the evaluation of structure <b>6</b> where R<sup>1</sup> and R<sup>2</sup> are alkyls, which should provide the closest cyclized analogues of <b>3</b>–<b>4</b>. We were pleased to see that dimethylamino derivatives <b>7a</b>−<b>c</b>, the closest analogues of <b>2</b>, indeed displayed intrinsic activity (IC<sub>50</sub> = 0.007, 0.069, and 0.55 µM, respectively) comparable to that for <b>1</b>–<b>4</b> for <i>n</i> = 0–1 and lower activity than <b>1</b>−<b>4</b> for <i>n</i> = 2. Substitution of the dimethylamino moiety with the cyclic amine pyrrolidine (<b>8b</b>) provided a compound that displayed the same activity as <b>7b</b>, but the introduction of more bulky cyclic amines (piperidine as in <b>9b</b>, morpholine as in <b>10b</b>,<b>c</b>) and the more lypophilic benzylmethylamine as in <b>11b</b>,<b>c</b> gave a 1 order of magnitude increase of the potency in the enzymatic assay. The positive influence of the benzyl moiety on integrase inhibition has also been suggested by a pharmacophore model previously reported by the Chimirri research group.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Interestingly, the unsubstituted derivatives <b>12a</b>−<b>c</b> also showed very high enzymatic activity (IC<sub>50</sub> = 0.008, 0.005, 0.019 µM, respectively), comparable to that of <b>9</b> and <b>10</b>. The activities displayed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> seem to follow a trend according to the size of the saturated ring in the bicyclic system, the seven-membered cycle (<i>n</i> = 2) being less active than the six-membered (<i>n</i> = 1), which is equally (or less as in <b>7b</b>) potent as the corresponding five-membered (<i>n</i> = 0) one. Unfortunately, all the above compounds show lower inhibitory effect on the spread of HIV infection in cell culture (CIC<sub>95</sub> ≥ 1 µM in the presence of 50% NHS). Nevertheless, these observations confirmed the potential of the bicyclic pyrimidinone series as HIV-1 integrase inhibitors and prompted us to undertake a further investigation on the 2-β-nitrogen in <b>6</b>, aimed at modifying the physical−chemical properties of the cyclized structures, in order to gain activity in the cell based assays.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Amino Substituents on Activity of Bicyclic Pyrimidinones<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0003.gif" alt="" id="gr3" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0004.gif" alt="" id="gr4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Results are the mean of at least three independent experiments.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Assays were performed with recombinant HIV-1 integrase (0.1 µM) preassembled on immobilized oligonucleotides. Inhibitors were added after assembly and washings. For details, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div></div></div><div class="NLM_p">The initial efforts concentrated on the exploration of the amide SAR, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Changing one of the two nitrogen alkyls into an acetyl group as in <b>13a</b>−<b>c</b> proved to be well tolerated for <i>n</i> = 0–1 and very favorable for <i>n</i> = 2, providing equipotent low nanomolar inhibitors in the strand transfer assay. When <i>n</i> = 2 (<b>13c</b>), activity was also observed in the cell based assay. A large variety of acyl groups was accepted: small acyl groups as in <b>14b</b> and more elaborate residues as in <b>15b</b> and <b>16b</b>. We were very pleased to discover that the introduction of a sulfonamide (as in <b>17b</b>) or a sulfone (as in <b>18b</b>,<b>c</b>) moiety in the β position with respect to the amide carbonyl resulted in very active inhibitors of the viral spread. The low shift in activity displayed in the low serum conditions (10% fetal bovine serum) with respect to the intrinsic enzymatic activity (less than 2-fold for <b>17b</b> and 3- to 4-fold for <b>18b</b>,<b>c</b>) confirmed the ability of the compounds to cross the cellular membrane. Moreover, the very low shift between the low and high serum (50% normal human serum) assay conditions can be rationalized as the presence of a significant unbound fraction of compound in human plasma,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which was confirmed by a low value of human plasma protein binding (81% and 70% bound to human plasma proteins, respectively, for <b>17b</b> and <b>18b</b>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Removal of one of the R<sup>2</sup> alkyl, as in <b>19b</b>, produced no change in the intrinsic potency but produced a marked drop of activity in the cell based assays.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Amide Substitution<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0005.gif" alt="" id="gr5" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0006.gif" alt="" id="gr6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Results are the mean of at least three independent experiments.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Assays were performed with recombinant HIV-1 integrase (0.1 µM) preassembled on immobilized oligonucleotides. Inhibitors were added after assembly and washings. For details, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Cell culture inhibitory concentrations (CIC<sub>95</sub>) are defined as those that inhibited by ≥95% the spread of HIV-1 infection in susceptible cell culture MT-4 human T-lymphoid cells. For details see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div></div></div><div class="NLM_p">The two enantiomers of <b>17b</b>, (<i>R</i>)-<b>17b</b> and (<i>S</i>)-<b>17b</b>, were prepared and further profiled in vitro and in vivo. Although showing the same in vitro enzymatic activity, enantiomer (<i>S</i>)-<b>17b</b> was 2-fold more potent in the spread assays (CIC<sub>95</sub>: 10% FBS, 0.016 µM; 50% NHS, 0.031 µM) than (<i>R</i>)-<b>17b</b>. The pharmacokinetic profile in rat of (<i>S</i>)-<b>17b</b>, as reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, was characterized by high plasma clearance (Clp = 55 (mL/min)/kg) and modest oral bioavailability (<i>F</i> = 17%). The metabolic stability in liver microsomes was studied in the presence of NADPH and UDPGA to evaluate the metabolism rate by oxidation and glucuronidation. (<i>S</i>)-<b>17b</b> displayed moderate stability in the presence of NADPH (turnover; rat 51, dog 15, human 36 %/h) and UDPGA (turnover; rat 47, dog 24, human 46 %/h).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The same pharmacokinetic profile was observed also for the enantiomer (<i>R</i>)-<b>17b</b> (data not shown). This finding, together with the low values of plasma protein binding measured in all the species investigated ((<i>S</i>)-<b>17b</b> plasma protein binding; rat 74, dog 71, human 78% bound), were consistent with the high plasma clearance observed in vivo (rat). The same profile observed for (<i>R</i>)-<b>17b</b> and (<i>S</i>)-<b>17b</b> was also observed for the enantiomers of derivative <b>18b</b> (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Sulfonamides and Sulfamides<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0007.gif" alt="" id="gr7" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0008.gif" alt="" id="gr8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Results are the mean of at least three independent experiments.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Assays were performed with recombinant HIV-1 integrase (0.1 µM) preassembled on immobilized oligonucleotides. Inhibitors were added after assembly and washings. For details, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">Cell culture inhibitory concentrations (CIC<sub>95</sub>) are defined as those that inhibited by ≥ 95% the spread of HIV-1 infection in susceptible cell culture MT-4 human T-lymphoid cells. For details, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetics</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">compd</th><th class="rowsep1" align="center" valign="middle">species</th><th class="rowsep1" align="center" valign="middle" char="."><i>F</i> (%)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" valign="middle" char=".">Clp<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a> ((mL/min)/kg)</th></tr></thead><tbody><tr valign="top"><td align="left">(<i>S</i>)-<b>17b</b></td><td align="left">rat<a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a></td><td align="char" char=".">17</td><td align="char" char=".">55</td></tr><tr valign="top"><td align="left"><b>20b</b></td><td align="left">rat<a class="ref internalNav" href="#tbl4-fn4" aria-label="d">d</a></td><td align="char" char=".">47</td><td align="char" char=".">48</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>22b</b></td><td align="left">rat<a class="ref internalNav" href="#tbl4-fn4" aria-label="d">d</a></td><td align="char" char=".">49</td><td align="char" char=".">14</td></tr><tr valign="top"><td align="left"> </td><td align="left">dog<a class="ref internalNav" href="#tbl4-fn5" aria-label="e">e</a></td><td align="char" char=".">16</td><td align="char" char=".">3.8</td></tr><tr valign="top"><td align="left">(<i>R</i>)-<b>22b</b></td><td align="left">rat<a class="ref internalNav" href="#tbl4-fn4" aria-label="d">d</a></td><td align="char" char=".">63</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"> </td><td align="left">dog<a class="ref internalNav" href="#tbl4-fn5" aria-label="e">e</a></td><td align="char" char=".">42</td><td align="char" char=".">3.8</td></tr><tr valign="top"><td align="left"> </td><td align="left">rhesus<a class="ref internalNav" href="#tbl4-fn6" aria-label="f">f</a></td><td align="char" char=".">9</td><td align="char" char=".">27</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>27b</b></td><td align="left">rat<a class="ref internalNav" href="#tbl4-fn7" aria-label="g">g</a></td><td align="char" char=".">15</td><td align="char" char=".">98</td></tr><tr valign="top"><td align="left"> </td><td align="left">dog</td><td align="char" char="."> </td><td align="char" char=".">23</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Plasma clearance.</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last">Dose: iv = po, 3 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (60%−20%−20%); po, 1% methylcellulose.</p></div><div class="footnote" id="tbl4-fn4"><sup>d</sup><p class="last">Dose: iv = po, 3 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−40%−40%); po, 1% methylcellulose.</p></div><div class="footnote" id="tbl4-fn5"><sup>e</sup><p class="last">Dose: iv, 1 mg/kg; po, 2 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−40%−40%); po, 1% methylcellulose.</p></div><div class="footnote" id="tbl4-fn6"><sup>f</sup><p class="last">Dose: iv, 1 mg/kg; po, 6.5 mg/kg. Formulation: iv, DMSO; po, 0.5% methylcellulose.</p></div><div class="footnote" id="tbl4-fn7"><sup>g</sup><p class="last">Dose: iv = po, 3 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−60%−20%); po, 1% methylcellulose.</p></div></div></div><div class="NLM_p">We then turned our attention to sulfonamide derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Sulfonamides <b>20b</b>,<b>c</b> proved to be potent compounds both on the enzyme and in the cellular assays. Pharmacokinetic evaluation of <b>20b</b> in rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) showed that, though characterized by a good oral bioavailability (<i>F</i> = 47%), the compound presents similar relatively high plasma clearance (Clp 48 (mL/min)/kg) already observed in the amide series. Metabolic stability studies in liver microsomes in the presence of UDPGA, in agreement with the observed in vivo data, showed high turnover in all species and in particular in rat and human (turnover; rat 88, dog 29, human 74 %/h).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Structurally more complex sulfonamides, such as <b>21b</b>, displayed similar high potency both on the enzyme and in the cell based assays and even lower metabolic stability in liver microsomes (turnover; rat 94, dog 78, human 90 %/h, in the presence of UDPGA).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">A significant improvement was obtained by modification of the sulfonamide moiety into a tetrasubstituted sulfamide as in <b>22a</b>−<b>c</b>. Compound <b>22b</b> was a low nanomolar inhibitor of HIV integrase strand transfer (IC<sub>50</sub> = 0.005 µM), displaying only a 4-fold shift in activity in the spread assay in the presence of 50% human plasma serum (CIC<sub>95</sub> = 0.021 µM). The corresponding analogue with <i>n</i> = 2 (<b>22c</b>), though only 2-fold less potent than <b>22b</b> in the enzymatic assay, showed a lower activity in the high serum cell based assay (CIC<sub>95</sub> = 0.125 vs 0.021 µM). Surprisingly, the corresponding analogue for <i>n</i> = 0 (<b>22a</b>) was 9-fold less potent than <b>22b</b> in the strand transfer assay and not active up to 1 µM in both the cell based assays.</div><div class="NLM_p">Further studies on the effects of different alkylation patterns on the sulfamide nitrogen were performed. Internal cyclization of the sulfamide as in <b>23b</b>,<b>c</b> provided compounds equipotent with the corresponding open derivatives <b>22b</b>,<b>c</b>. Replacement of the two methyls of <b>22b</b> with cycloalkyls as in <b>24b</b> and <b>25b</b> lowered activity in the cell based assay (50% NHS). Activity could be restored to previous levels by introduction of the more polar morpholine (<b>26b</b>), obtaining a compound that is essentially equipotent with <b>22b</b> in the cell based assays. This observation prompted us to further increase polarity by introducing a protonable nitrogen in the sulfamide moiety; the change of morpholine into <i>N</i>-methylpiperazine gave an extremely potent compound (<b>27b</b>), and interestingly, it was characterized by a higher stability toward glucuronidation with respect to <b>22b</b> (data not shown).</div><div class="NLM_p">The two enantiomers (<i>S</i>)- and (<i>R</i>)-<b>27b</b> were profiled in vitro and in vivo showing that the (<i>S</i>)-enantiomer was 3-fold more potent than the (<i>R</i>)-enantiomer in the high serum spread assay (CIC<sub>95</sub> = 0.006 µM for (<i>S</i>)-<b>27b</b> vs CIC<sub>95</sub> =<sub></sub> 0.020 µM for (<i>R</i>)-<b>27b</b>). (<i>S</i>)-<b>27b</b> thus proved to be the most active compound in the series.</div><div class="NLM_p">Metabolic stability of (<i>S</i>)-<b>27b</b> in liver microsomes in the presence of both NADPH and UDPGA showed a moderately low turnover (turnover; rat 10, dog 8 (mL/min)/mg P),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> but plasma protein binding was also low, consistent with a positively charged molecule<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (PPB; rat 76, dog 82% bound), and the compound presented a rat and dog PK<a class="ref internalNav" href="#fn1" aria-label="a ">a </a><div class="NLM_fn" id="fn1">a <p class="last">Abbreviations: TFA, trifluoroacetic acid; TMS, tetramethylsilane; DMSO, dimethyl sulfoxide; DMF, dimethylformamide; DCM, dichloromethane; THF, tetrahydrofuran; TEA, triethylamine; HOBt, 1-hydroxybenzotriazole; EDC, <i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide; DIPEA, <i>N</i>,<i>N</i>-diisopropylethylamine; PEG, poly(ethylene glycol); NBS, <i>N</i>-bromosuccinimide; PK, pharmacokinetic; NADPH, nicotinamide adenine dinucleotide phosphate, reduced form; UDPGA, uridine 5′-diphosphoglucuronic acid; PPB, plasma protein binding; HPLC, high-performance liquid chromatography; RP-HPLC, reverse-phase high-performance liquid chromatography; UPLC, ultraperformance liquid chromatography; HRMS, high-resolution mass spectrometry.</p></div>  profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) characterized by high plasma clearance (98 and 23 (mL/min)/kg, respectively, in rat and dog).</div><div class="NLM_p"><b>22b</b> and its two enantiomers ((<i>S</i>)-<b>22b</b> and (<i>R</i>)-<b>22b</b>) were also evaluated in vitro and in vivo in preclinical species; they displayed almost the same potency in the enzymatic and in the cell based assays and similar moderately low human PPB ((<i>S</i>)-<b>22b</b>, 87% bound, (<i>R</i>)-<b>22b</b>, 81% bound). Pharmacokinetic profiles of the two enantiomers (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) showed significant differences; in rat, (<i>R</i>)-<b>22b</b> showed a 1.8 (mL/min)/kg plasma clearance value, while the corresponding value for (<i>S</i>)-<b>22b</b> was almost 8-fold higher (Clp = 14 (mL/min)/kg). Furthermore, oral bioavailability was higher for (<i>R</i>)-<b>22b</b> (<i>F</i> = 63%) than for (<i>S</i>)-<b>22b</b> (<i>F</i> = 49%). Comparison of the dog PK parameters revealed that although the plasma clearance was identical for the two enantiomers, the oral bioavailability was again higher for (<i>R</i>)-<b>22b</b> (<i>F</i> = 42%) than for (<i>S</i>)-<b>22b</b> (<i>F</i> = 16%). Rhesus monkey PK profile of (<i>R</i>)-<b>22b</b> displayed a plasma clearance of 27 (mL/min)/kg and 9% oral bioavailability.</div><div class="NLM_p">The stability of (<i>R</i>)-<b>22b</b> was also investigated in liver microsomes in the presence of NADPH and UDPGA, revealing that the compound was not subject to significant oxidative metabolism and was metabolized mainly by glucuronidation. Despite the low (rat and dog) and moderate (rhesus) plasma clearance in vivo (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), (<i>R</i>)-<b>22b</b> displayed unexpectedly high turnover in liver microsomes in the presence of UDPGA (turnover; rat 81, dog 46, rhesus 84 %/h).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The high plasma protein binding values observed (PPB; rat 99, dog 89, rhesus 86% bound) may partially account for this apparent discrepancy by reducing the in vivo turnover, thus resulting in a low plasma clearance.</div><div class="NLM_p">Further profiling of (<i>R</i>)-<b>22b</b> demonstrated that it does not inhibit human DNA polymerases α, β, and γ (IC<sub>50</sub> > 200 µM), HIV-RNase-H (IC<sub>50</sub> > 25 µM), or HCV polymerase (IC<sub>50</sub> > 50 µM), and when tested for hERG-channel activity, it showed IC<sub>50</sub> = 20 µM. It was not an inhibitor of CyP450 (1A2, 2C19, 2C9, 2D6, and 3A4, IC<sub>50</sub> > 100 µM)).</div><div class="NLM_p">In order to further optimize the pharmacological properties of our inhibitors, we turned our attention to other possible nitrogen functionalizations to improve metabolic stability and maintain the high potency.</div><div class="NLM_p">In other series of HIV-1 integrase inhibitors<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> that had been developed in our company, it had been found that the introduction of a ketoamide functionality had positive effects on activity and pharmacological profile. We thus investigated the ketoamide derivatization in the bicyclic series (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Ketoamides: Effect of Ring Size on Activity<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0009.gif" alt="" id="gr9" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle" char="."> </th><th align="center" valign="middle" char="."> </th><th colspan="2" align="center" valign="middle" char=".">spread CIC<sub>95</sub> (µM)<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a></th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">compd</th><th class="rowsep1" align="center" valign="middle" char="."><i>n</i></th><th class="rowsep1" align="center" valign="middle" char=".">strand transfer IC<sub>50</sub> (µM)<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a></th><th class="rowsep1" align="center" valign="middle" char=".">10% FBS</th><th class="rowsep1" align="center" valign="middle" char=".">50% NHS</th></tr></thead><tbody><tr valign="top"><td align="left"><b>28a</b></td><td align="char" char=".">0</td><td align="char" char=".">0.020</td><td align="char" char=".">>1</td><td align="char" char=".">>1</td></tr><tr valign="top"><td align="left"><b>28b</b></td><td align="char" char=".">1</td><td align="char" char=".">0.007</td><td align="char" char=".">0.038</td><td align="char" char=".">0.040</td></tr><tr valign="top"><td align="left">(<i>R</i>)-<b>28b</b></td><td align="char" char=".">1</td><td align="char" char=".">0.019</td><td align="char" char=".">0.067</td><td align="char" char=".">0.098</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>28b</b></td><td align="char" char=".">1</td><td align="char" char=".">0.012</td><td align="char" char=".">0.033</td><td align="char" char=".">0.043</td></tr><tr valign="top"><td align="left"><b>28c</b></td><td align="char" char=".">2</td><td align="char" char=".">0.013</td><td align="char" char=".">0.094</td><td align="char" char=".">0.063</td></tr><tr valign="top"><td align="left">(<i>R</i>)-<b>28c</b></td><td align="char" char=".">2</td><td align="char" char=".">0.035</td><td align="char" char=".">0.021</td><td align="char" char=".">0.042</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>28c</b></td><td align="char" char=".">2</td><td align="char" char=".">0.012</td><td align="char" char=".">0.010</td><td align="char" char=".">0.013</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Results are the mean of at least three independent experiments.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Assays were performed with recombinant HIV-1 integrase (0.1 µM) preassembled on immobilized oligonucleotides. Inhibitors were added after assembly and washings. For details, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div><div class="footnote" id="tbl5-fn3"><sup>c</sup><p class="last">Cell culture inhibitory concentrations (CIC<sub>95</sub>) are defined as those that inhibited by ≥ 95% the spread of HIV-1 infection in susceptible cell culture MT-4 human T-lymphoid cells. For details, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a> and references therein.</p></div></div></div><div class="NLM_p">As already observed in the amide and sulfonamide series, when <i>n</i> = 0, compound <b>28a</b>, though active in the enzymatic assay (IC<sub>50</sub> = 0.020 µM), displayed no significant activity up to 1 µM in the cell based assays. The enlargement of the saturated ring as in <b>28b</b> (<i>n</i> = 1) and <b>28c</b> (<i>n</i> = 2) resulted in potent inhibitors both of the strand transfer and of the viral spread in cells (spread CIC<sub>95</sub>: <b>28b</b> 0.040 µM and <b>28c</b> 0.063 µM in the presence of 50% NHS). In order to further evaluate the series, the enantiomers of both compounds were tested and, in both cases, they shared the common feature of the (<i>S</i>)-enantiomers (<i>S</i>)-<b>28b</b> and (<i>S</i>)-<b>28c</b>, being about 2-fold more active than the corresponding (<i>R</i>)-enantiomers (<i>R</i>)-<b>28b</b> and (<i>R</i>)-<b>28c</b> in the enzyme assay and in the cell based assay in high serum conditions. Plasma protein binding values for (<i>S</i>)-<b>28c</b> (PPB; rat 94, dog 76, rhesus 88, human 81% bound) were higher in all species tested with respect to (<i>S</i>)-<b>28b</b> (PPB; rat 84, dog 66, human 63% bound).</div><div class="NLM_p">Rat PK profiles of both (<i>S</i>)-<b>28b</b> and (<i>S</i>)-<b>28c</b> were then evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Both compounds proved to be orally bioavailable, and (<i>S</i>)-<b>28c</b> showed a lower plasma clearance with respect to (<i>S</i>)-<b>28b</b> (7 vs 11 (mL/min)/kg). The <i>C</i><sub>max</sub> of (<i>S</i>)-<b>28c</b> was 13-fold higher than that for (<i>S</i>)-<b>28b</b> (25 vs 2 µM). The same behavior was also observed after administration to dog, when (<i>S</i>)-<b>28c</b> showed a 2-fold lower plasma clearance and 10-fold higher <i>C</i><sub>max</sub> than (<i>S</i>)-<b>28b</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetics Data for Ketoamides Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">species</th><th align="center" valign="bottom" char="."><i>F</i> (%)<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></th><th align="center" valign="bottom" char=".">Clp<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a>((mL/min)/kg)</th><th align="center" valign="bottom" char="."><i>T</i><sub>1/2</sub>(h)<a class="ref internalNav" href="#tbl6-fn3" aria-label="c">c</a></th><th align="center" valign="bottom" char=".">AUC<a class="ref internalNav" href="#tbl6-fn4" aria-label="d">d</a>(µM·h)</th><th align="center" valign="bottom" char="."><i>C</i> <sub>max</sub><a class="ref internalNav" href="#tbl6-fn5" aria-label="e">e</a> (µM)</th><th align="center" valign="bottom" char="."><i>V</i><sub>dss</sub><a class="ref internalNav" href="#tbl6-fn6" aria-label="f">f</a> (L/kg)</th></tr></thead><tbody><tr valign="top"><td align="left">(<i>S</i>)-<b>28b</b></td><td align="left">rat<a class="ref internalNav" href="#tbl6-fn7" aria-label="g">g</a></td><td align="char" char=".">47</td><td align="char" char=".">11</td><td align="char" char=".">14</td><td align="char" char=".">2.5</td><td align="char" char=".">2.0</td><td align="char" char=".">3.0</td></tr><tr valign="top"><td align="left"> </td><td align="left">dog<a class="ref internalNav" href="#tbl6-fn8" aria-label="h">h</a></td><td align="char" char=".">39</td><td align="char" char=".">15</td><td align="char" char=".">1.7</td><td align="char" char=".">3.8</td><td align="char" char=".">2.5</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>28c</b><a class="ref internalNav" href="#tbl6-fni" aria-label="i">i</a></td><td align="left">rat<a class="ref internalNav" href="#tbl6-fn9" aria-label="j">j</a></td><td align="char" char=".">64</td><td align="char" char=".">7</td><td align="char" char=".">7.4</td><td align="char" char=".">37</td><td align="char" char=".">27</td><td align="char" char=".">0.7</td></tr><tr valign="top"><td align="left"> </td><td align="left">dog<a class="ref internalNav" href="#tbl6-fn10" aria-label="k">k</a></td><td align="char" char=".">61</td><td align="char" char=".">7.5</td><td align="char" char=".">2.1</td><td align="char" char=".">31</td><td align="char" char=".">25</td><td align="char" char=".">0.9</td></tr><tr valign="top"><td align="left"> </td><td align="left">rhesus<a class="ref internalNav" href="#tbl6-fn11" aria-label="l">l</a></td><td align="char" char=".">31</td><td align="char" char=".">8</td><td align="char" char=".">2.6</td><td align="char" char=".">14</td><td align="char" char=".">10</td><td align="char" char=".">0.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Plasma clearance.</p></div><div class="footnote" id="tbl6-fn3"><sup>c</sup><p class="last">Plasma half-life after iv administration.</p></div><div class="footnote" id="tbl6-fn4"><sup>d</sup><p class="last">Area under the curve after po administration.</p></div><div class="footnote" id="tbl6-fn5"><sup>e</sup><p class="last">After PO administration.</p></div><div class="footnote" id="tbl6-fn6"><sup>f</sup><p class="last">Volume of distribution.</p></div><div class="footnote" id="tbl6-fn7"><sup>g</sup><p class="last">Dose: iv = po, 3 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−40%−40%); po, 1% methylcellulose suspension.</p></div><div class="footnote" id="tbl6-fn8"><sup>h</sup><p class="last">Dose: iv, 1 mg/kg; po, 4 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−40%−40%); po, 1% methylcellulose suspension.</p></div><div class="footnote" id="tbl6-fni"><sup>i</sup><p class="last">Dosed as potassium salt.</p></div><div class="footnote" id="tbl6-fn9"><sup>j</sup><p class="last">Dose: iv, 3 mg/kg; po, 10 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−60%−20%); po, 1% methylcellulose suspension.</p></div><div class="footnote" id="tbl6-fn10"><sup>k</sup><p class="last">Dose: iv, 1 mg/kg; po, 2 mg/kg. Formulation: iv, DMSO/PEG400/H<sub>2</sub>O (20%−60%−20%); po, 1% methylcellulose suspension.</p></div><div class="footnote" id="tbl6-fn11"><sup>l</sup><p class="last">Dose: iv, 2 mg/kg; po, 10 mg/kg. Formulation: iv, DMSO; po, 0.5% methylcellulose suspension.</p></div></div></div><div class="NLM_p">Because of the above results, (<i>S</i>)-<b>28c</b> was further profiled. A PK study in rhesus monkey showed a moderately low plasma clearance (8 (mL/min)/kg), acceptable oral bioavailability (<i>F</i> = 31%), and also in this species a high <i>C</i><sub>max</sub> (10 µM).</div><div class="NLM_p">In rat the compound displayed dose proportionality of plasma exposure after oral administration of the compound (dose: 1, 4, 16, 48 mg/kg) as reported in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat oral administration of (<i>S</i>)-<b>28c</b>, exposure dose proportionality.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Plasma concentration in the three preclinical species studied (rat, dog, rhesus) was monitored after a 10 mg/kg oral administration, revealing that up to 24–30 h after administration, all species tested maintained concentration values that are higher than the CIC<sub>95</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The po dosing of (<i>S</i>)-<b>28c</b> (potassium salt) at 10 mg/kg in three preclinical species.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Metabolic stability of (<i>S</i>)-<b>28c</b> in liver microsomes in the presence of NADPH showed no appreciable turnover in dog and human and only minor oxidative metabolism in rat and rhesus. In the presence of both NADPH and UDPGA the compound exhibited low turnover (turnover; rat 11, dog 4, human 3 (mL/min)/mg P) and was cleared mainly by 5-O-glucuronidation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Likewise, glucuronide formation was observed in human hepatocytes, while no significant disappearance of (<i>S</i>)-<b>28c</b> was detected from three different donors during a 4 h incubation with 10<sup>6</sup> cells/mL.</div><div class="NLM_p last">Selectivity of (<i>S</i>)-<b>28c</b> was demonstrated by testing it for inhibition of human DNA polymerase α, β, and γ (IC<sub>50</sub> > 10 µM), HIV RNaseH (IC<sub>50</sub> > 50 µM), and it was also counterscreened on a panel of 170 enzymes (MDS Pharma Services-Panlabs) to evaluate potential off-target activities, resulting in no significant notable responses. It did not significantly inhibit the main isoforms of CyP450 (3A4, 2D6, 2C19; IC<sub>50</sub> > 100 µM; 2C9, IC<sub>50</sub> = 75 µM), and when tested for hERG-channel activity, it showed IC<sub>50</sub> > 10 µM.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the bicyclic scaffolds was performed as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Treatment of pyrimidinones <b>29a</b>−<b>c</b><a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> or the corresponding <i>O</i>-benzoyl protected <b>30a</b>−<b>c</b> (more easily isolated and purified) with 4-fluorobenzylamine provided benzylamides <b>12a</b>−<b>c</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0012.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Unsubstituted Bicyclic Pyrimidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzoic anhydride, pyridine or THF; (b) 4-fluorobenzylamine, MeOH, 60 °C.</p></p></figure><div class="NLM_p">To obtain the functionalized derivatives shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, the synthetic pathway shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> was followed. Most of the steps could also be performed in one pot or sequentially without isolating the intermediate steps (as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). The <i>O</i>-benzoyl protected pyrimidinones <b>30a</b>−<b>c</b> were brominated with NBS,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the resulting bromides (<b>31a</b>−<b>c</b>) were displaced with the appropriate secondary amine, which provided also O-deprotection (<b>32</b>–<b>37</b>). Treatment with 4-fluorobenzylamine, upon heating in MeOH, afforded amino substituted compounds <b>7b</b>,<b>c, 8</b>–<b>9b, 10b</b>,<b>c, 11b</b>,<b>c</b>. Compounds <b>36a</b>−<b>c</b> and <b>37b</b>, where R<sup>1</sup> (or both R<sup>1</sup> and R<sup>2</sup> as in <b>37b</b>) was a benzyl, gave access to further functionalized compounds by removal of the benzyl group(s) by Pd-catalyzed hydrogenation to <b>38a</b>−<b>c</b> and <b>39b</b> that, when treated with 4-fluorobenzylamine as before, furnished the versatile advanced intermediates <b>40a</b>−<b>c</b> and <b>41b</b>, which allowed the synthesis of the racemic compounds by reductive amination (<b>7a</b>) or functionalization with acyl chlorides or carboxylic acids to give the amide derivatives shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, or with sulfonyl and sulfamoyl chlorides to give the sulfonamide and sulfamide derivatives shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and with methyl chlorooxoacetate, followed by in situ amidation with dimethylamine, to provide ketoamides shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. To facilitate the purification of the advanced intermediates <b>40</b>, <i>N</i>-Boc derivatization can be performed, followed by flash chromatography and Boc deprotection in acidic conditions, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for <b>40b</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0013.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Substituted Bicyclic Pyrimidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>, reflux; (b) R<sup>1</sup>R<sup>2</sup>NH, DMF; (c) 4-fluorobenzylamine, MeOH, 60 °C; (d) H<sub>2</sub> atmospheric pressure, 10% Pd/C, MeOH; (e) appropriate acyl chloride (or sulfonyl chloride or sulfamoyl chloride), base or carboxylic acid, coupling reagent; (f) for <b>40a</b>, to obtain <b>7a</b>, 37% HCHO, NaCNBH<sub>3</sub>, AcONa, MeOH; (g) (1) Boc<sub>2</sub>O, dioxane; (2) 4 M HCl/dioxane.</p></p></figure><div class="NLM_p">The syntheses of the chiral derivatives present in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were performed, as described for the corresponding racemic compounds in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> (step e), by functionalizing the chiral benzylamide intermediates (R)- or (S)-<b>43b</b>,<b>c</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Chiral advanced intermediates <b>43b</b> (<i>n</i> = 1) were obtained by treatment with 4-fluorobenzylamine of the corresponding chiral esters <b>42b</b>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> while <b>43c</b> (<i>n</i> = 2) had been prepared as recently described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The amide derivatives (<i>R</i>)<b>/</b>(<i>S</i>)-<b>17b</b> were obtained by conventional amide coupling with [(dimethylamino)sulfonyl]acetic acid,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the sulfamides (<i>R</i>)/(<i>S</i>)-<b>22b</b> and (<i>R</i>)/(<i>S</i>)-<b>27b</b> were obtained by reaction with the appropriate sulfamoyl chlorides in the presence of TEA. (<i>R</i>)/(<i>S</i>)-<b>28b</b>,<b>c</b> could be obtained by a two-step one-pot procedure by acylating the pyrimidone <i>N</i>-methylamine derivatives (<i>R</i>)/(<i>S</i>)-<b>43b</b>,<b>c</b> with methyl chlorooxoacetate, followed by addition of a THF solution of dimethylamine ((<i>R</i>)/(<i>S</i>)-<b>28b</b>) or alternatively by conventional amide coupling with potassium (dimethylamino)(oxo)acetate ((<i>R</i>)/(<i>S</i>)-<b>28c</b>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0014.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Chiral Pyrimidinone Benzylamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-fluorobenzylamine, MeOH, 65 °C, 3 h. (b) For (<i>R</i>)/(<i>S</i>)-<b>17b</b>: HOBt, EDC, DIPEA, [(dimethylamino)sulfonyl]acetic acid, DMF, room temperature, 24 h. (c) For (<i>R</i>)/(<i>S</i>)-<b>22b</b> and (<i>R</i>)/(<i>S</i>)-<b>27b</b>: appropriate sulfamoyl chloride, DCM, TEA, room temperature, 90 min. (d) For (<i>R</i>)/(<i>S</i>)-<b>28b</b>: (1) methyl chlorooxoacetate, TEA, DCM, room temperature, 50 min; (2) 2 M <i>N</i>,<i>N</i>-dimethylamine/THF, 55 °C, 16 h. (e) For (<i>R</i>)/(<i>S</i>)-<b>28c</b>: potassium (dimethylamino)(oxo)acetate, HOBt, EDC, TEA, DCM, room temperature overnight.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Design and synthesis of bicyclic analogues of <i>N</i>-methylpyrimidinones led to a new class of HIV-1 integrase inhibitors. Prompted by the results of the unsubstituted bicyclic compounds <b>12a</b>−<b>c</b>, which were nanomolar inhibitors of the strand transfer of the integration process, we undertook a wide study on the substitutions on the saturated ring of the bicyclic structures. Amine, amide, sulfonamide, sulfamide, and ketoamide derivatives were evaluated as well as the size of the saturated ring (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). A number of low nanomolar inhibitors of the HIV-1 infection spread in cell culture could be identified and further profiled in vitro and in vivo, leading to the ketoamide (<i>S</i>)-<b>28c</b>, which proved to be a very potent and selective HIV integrase inhibitor and orally biovailable and with good pharmacological profile in preclinical species (rat, dog, rhesus monkey) and was taken into further development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reagents and solvents were obtained from commercial suppliers and were used as obtained without further purification. Flash chromatography purifications were performed on a Biotage system using prepacked silica gel (200–400 mesh) cartridges. Analytical HPLC-MS (X-Terra C<sub>18</sub> column, 4.6 mm × 50 mm, 5 µm) and UPLC−MS (Acquity UPLC BEH C<sub>18</sub> column, 2.1 mm × 50 mm, 1.7 µm) were performed on a Waters Alliance 2795 apparatus equipped with a diode array and a ZQ mass spectrometer (solvent system acetonitrile/water + 0.1% HCOOH). Purity of final compounds was more than 98% by area. Preparative RP-HPLC was performed on a Waters Delta Prep 4000 connected to a dual-wavelength absorbance detector 2487 (gradient of CH<sub>3</sub>CN/H<sub>2</sub>O + 0.1% TFA<a class="ref internalNav" href="#fn1" aria-label="a ">a </a>, flow rate of 20 mL/min), typically using a Waters Symmetry preparative column C<sub>18</sub>, 5 µm, 19 mm × 300 mm. After RP-HPLC, the final compounds were isolated by lyophilization. Enantiomeric excesses were determined by chiral HPLC using a Chiralpak AD column, mobile phase <i>n</i>-hexane/ethanol + 0.2% TFA + 3% methanol, or or <i>n</i>-hexane + isopropanol + 0.2% TFA. Nuclear magnetic resonance spectra (<sup>1</sup>H NMR recorded at 300, 400, or 500 MHz; <sup>13</sup>C NMR recorded at 100 or 75 MHz) were obtained on Bruker AMX spectrometers and are referenced in ppm relative to TMS. Unless otherwise indicated, spectra were acquired at 300 K. Microwave irradiation was performed in a Personal Chemistry (now Biotage) Optimizer.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for the Synthesis of Amines <b>7b</b>−<b>11c</b></h3><div class="NLM_p last">To a solution of bromide <b>31</b><a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> (0.245 mmol) in DMF (0.5 mL) (or MeOH), the appropriate amine (0.75 mmol) was added. The mixture was stirred at room temperature for 1 h. The solvent was removed under reduced pressure, and the crude material was dissolved in methanol (0.5 mL). 4-Fluorobenzylamine (0.084 mL, 0.75 mmol) was added, and the mixture was stirred for 1.5 h at 65 °C. The solvent was removed under reduced pressure, and the product was purified by preparative RP-HPLC and isolated as the trifluoroacetate salt unless otherwise indicated.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (±)-9-(Dimethylamino)-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>7b</b>)</h3><div class="NLM_p last">A solution 2 N in MeOH of dimethylamine was used as amine. Yield: 26%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.51 (s, 1H), 10.69 (s, 1H), 10.59 (t, <i>J</i> = 3.6 Hz, 1H), 7.50–7.40 (m, 2H), 7.22–7.10 (m, 2H), 4.79–4.68 (m, 1H), 4.60–4.38 (m, 2H), 4.13–4.03 (m, 1H), 3.61–3.48 (m, 1H), 2.97 (d, <i>J</i> = 5.1 Hz, 3H), 2.66 (d, <i>J</i> = 5.1 Hz, 3H), 2.34–2.17 (m, 2H), 2.00–1.79 (m, 2H). MS <i>m</i>/<i>z</i>: 361 (M + H)<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (±)-10-(Dimethylamino)-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>7c</b>)</h3><div class="NLM_p last">A solution 2 N in MeOH of dimethylamine was used as amine. Yield: 18%. <sup>1</sup>H NMR (300 MHz, pyridine-<i>d</i><sub>5</sub>) δ 10.01 (bs, 1H), 7.52 (dd, <i>J</i> = 8.6, 5.7 Hz, 2H), 7.13 (t, <i>J</i> = 8.6 Hz, 2H), 5.12–4.91 (m, 1H), 4.79 (dd, <i>J</i> = 14.4, 6.2 Hz, 1H), 4.68 (dd, <i>J</i> = 14.7, 5.9 Hz, 1H), 4.42 (t, <i>J</i> = 11.8 Hz, 1H), 2.95 (bs, 1H), 2.00 (m, 6H), 1.92–1.61 (m, 3H), 1.60–1.10 (m, 3H). MS <i>m</i>/<i>z</i>: 375 (M + H)<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-4-oxo-9-pyrrolidin-1-yl-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>8b</b>)</h3><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.44 (s, 1H), 11.14 (s, 1H), 10.66 (t, <i>J</i> = 6.4 Hz, 1H), 7.47–7.40 (m, 2H), 7.18–7.10 (m, 2H), 4.85–4.74 (m, 1H), 4.55–4.37 (m, 2H), 4.07–4.00 (m, 1H), 3.76–3.65 (m, 1H), 3.65–3.52 (m, 1H), 3.42–3.25 (m, 2H), 3.22–3.15 (m, 1H), 2.37–2.29 (m, 1H), 2.25–2.15 (m, 1H), 2.10–1.76 (m, 6H). MS <i>m</i>/<i>z</i>: 387 (M + H)<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-4-oxo-9-piperidin-1-yl-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>9b</b>)</h3><div class="NLM_p last">Yield: 17%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.32 (s, 1H), 10.45 (t, <i>J</i> = 5.4 Hz, 1H), 10.07 (s, br, 1H), 7.52–7.40 (m, 2H), 7.22–7.11 (m, 2H), 4.83–4.70 (m, 1H), 4.62–4.40 (m, 2H), 4.13–4.02 (m, 1H), 3.60–3.15 (m, 4H), 2.98–2.82 (m, 1H), 2.65–2.50 (m, 1H), 2.44–2.22 (m, 2H), 2.00–1.67 (m, 6H), 1.56–1.37 (m, 1H). MS <i>m</i>/<i>z</i>: 401 (M + H)<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-morpholin-4-yl-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-a]pyrimidine-2-carboxamide (<b>10b</b>)</h3><div class="NLM_p last">Yield: 9%. The trifluoroacetate salt obtained after RP-HPLC was dissolved in 1 N HCl, the solvent was removed under reduced pressure, and the residue was lyophilized from water/acetonitrile to afford <i>N</i>-(4-fluorobenzyl)-3-hydroxy-9-morpholin-4-yl-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide <b>10b</b> as the hydrochloride salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.34 (s, 1H), 10.99 (s, 1H), 10.47 (s, 1H), 7.44 (m, 2H), 7.16 (m, 2H), 4.85 (m, 1H), 4.60–4.40 (m, 3H), 4.10–3.85 (m, 4H), 3.60–3.05 (m, 5H), 2.35–2.15 (m, 2H), 2.03–1.80 (m, 2H). MS <i>m</i>/<i>z</i>: 403 (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-10-morpholin-4-yl-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>10c</b>)</h3><div class="NLM_p last">Yield: 31%.<sup>1</sup>H NMR (300 MHz, pyridine-<i>d</i><sub>5</sub>) δ 10.04 (bs, 1H), 7.52 (dd, <i>J</i> = 8.3, 5.6 Hz, 2H), 7.14 (t, <i>J</i> = 8.7 Hz, 2H), 5.13 (dd, <i>J</i> = 13.2, 6.1 Hz, 1H), 4.81 (dd, <i>J</i> = 14.4, 6.6 Hz, 1H), 4.69 (dd, <i>J</i> = 14.5, 6.5 Hz, 1H), 4.41 (t, <i>J</i> = 12.1 Hz, 1H), 3.77–3.57 (m, 4H), 2.96 (d, <i>J</i> = 5.3 Hz, 1H), 2.42–2.19 (m, 2H), 2.00–1.64 (m, 5H), 1.56–1.23 (m, 3H). MS <i>m</i>/<i>z</i>: 417 (M + H)<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (±)-9-[Benzyl(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>11b</b>)</h3><div class="NLM_p last">Yield: 26%.<sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.64 (s, 0.4H), 12.34 (s, 0.6H), 10.92 (t, <i>J</i> = 6.2 Hz, 0.4H), 10.77 (s, 0.4H), 10.32 (s, 0.6H), 10.17 (t, <i>J</i> = 6.3 Hz, 0.6H), 8.00 (m, 1H), 7.53–7.11 (m, 9H), 4.93–4.82 (m, 0.6H), 4.82–4.73 (m, 0.4H), 4.65–4.49 (m, 2H), 4.45–4.32 (m, 1H), 4.23–4.05 (m, 1.6H), 3.98–3.85 (m, 0.4H), 3.52–3.45 (m, 1H), 2.96 (d, <i>J</i> = 4.8 Hz, 1.8H), 2.89 (d, <i>J</i> = 4.8 Hz, 1.2H), 2.49–1.60 (m, 4H). MS <i>m</i>/<i>z</i>: 438 (M + H)<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (±)-10-[Benzyl(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>11c</b>)</h3><div class="NLM_p last">Yield: 36%. <sup>1</sup>H NMR (400 MHz, pyridine-<i>d</i><sub>5</sub>) δ 9.85 (bs, 1H), 7.51 (dd, <i>J</i> = 8.3, 5.6 Hz, 2H), 7.43–7.25 (m, 5H), 7.10 (t, <i>J</i> = 8.7 Hz, 2H), 5.13 (dd, <i>J</i> = 13.2, 6.1 Hz, 1H), 4.61–4.82 (m, 3H), 3.42–3.11 (m, 3H), 1.98–1.75 (m, 6H), 1.62–1.22 (m, 3H). MS <i>m</i>/<i>z</i>: 451 (M + H)<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (±)-8-(Dimethylamino)-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>7a</b>)</h3><div class="NLM_p last">The title compound was prepared using the following five-step procedure. Step a: A mixture of methyl 3-(benzoyloxy)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxylate <b>30a</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (0.095 g, 88% w/w, 0.26 mmol), NBS (0.061 g, 0.35 mmol), and catalytic dibenzoylperoxide in CCl<sub>4</sub> (1.6 mL) was stirred under reflux for 6 h. The mixture was cooled to room temperature and filtered over silica gel (petroleum ether/ethyl acetate, 65:35) to afford methyl 3-(benzoyloxy)-8-bromo-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxylate <b>31a</b> (MS <i>m</i>/<i>z</i>, 393/395 (M + H)<sup>+</sup>), which was used as such in the next step. Step b: To a stirred solution of the above bromide in anhydrous DMF (0.3 mL) was added <i>N</i>-benzyl-<i>N</i>-methylamine (0.064 mL, 0.5 mmol). The mixture was stirred for 2 h at room temperature and then concentrated to dryness under reduced pressure to provide crude methyl 8-[benzyl(methyl)amino]-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxylate <b>36a</b> (MS <i>m</i>/<i>z</i>, 330 (M + H)<sup>+</sup>), which was used as such in the next step. Step c: A solution of crude as above in methanol (0.9 mL), containing palladium on charcoal (6 mg, 10% w/w), was stirred under hydrogen at atmospheric pressure for 1.5 h. The catalyst was filtered off, and the solution was concentrated to dryness under reduced pressure. Crude methyl 3-hydroxy-8-(methylamino)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxylate <b>38a</b> (MS <i>m</i>/<i>z</i>, 240 (M + H)<sup>+</sup>) was used as such in the next step. Step d: To a solution of the above crude and TEA (0.023 mL, 0.16 mmol) in dry methanol (0.7 mL) was added 4-fluorobenzylamine (0.028 mL, 0.25 mmol). The mixture was stirred and heated to 65 °C overnight. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the crude <i>N</i>-(4-fluorobenzyl)-3-hydroxy-8-(methylamino)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide <b>40a</b> (MS <i>m</i>/<i>z</i>, 333 (M + H)<sup>+</sup>) obtained was used as such. Step e: To a solution of the above crude in methanol (2 mL) were added formaldehyde (37% aqueous solution, 0.03 mL, 0.33 mmol), sodium acetate (0.022 g, 0.27 mmol), and sodium cyanoborohydride (0.014 g, 0.23 mmol). The mixture was stirred for 16 h at room temperature. The mixture was concentrated under reduced pressure, and 8-(dimethylamino)-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide <b>7a</b> was isolated by preparative RP-HPLC as the trifluoroacetate salt. Yield: 5%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA, 340 K) δ 9.03 (bs, 1H), 7.42–7.33 (m, 2H), 7.20–7.09 (m, 2H), 4.96 (t, <i>J</i> = 8.3 Hz, 1H), 4.55 (ddd, <i>J</i><sub></sub> = 6.3, 15.0, 35.9 Hz, 2H), 4.21–4.09 (m, 1H), 4.00–3.89 (m, 1H), 2.96 (s, 6H), 2.72–2.59 (m, 1H), 2.47–2.39 (m, 1H, partially under solvent signal). MS <i>m</i>/<i>z</i>: 347 (M + H)<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(4-Fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>12a</b>)</h3><div class="NLM_p last">To a solution of <b>30a</b> (0.100 g, 88% w/w, 0.28 mmol) in dry methanol (1.0 mL) was added 4-fluorobenzylamine (0.11 g, 0.84 mmol). The mixture was irradiated in a sealed vessel in a microwave apparatus (140 °C, 500 s). After the mixture was cooled, the solvent was removed under reduced pressure and the product was isolated by preparative RP-HPLC (0.070 g, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.74 (bs, 1H), 8.96 (bs, 1H), 7.94–7.89 (m, 2H), 7.66–7.60 (m, 2H), 5.06 (d, <i>J</i> = 6.6 Hz, 2H), 4.56 (t, <i>J</i> = 7.2 Hz, 2H), 3.47 (t, <i>J</i> = 7.9 Hz, 2H), 2.77 (m, partially overlapped by H<sub>2</sub>O). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA) δ 9.41 (t, <i>J</i> = 6.2 Hz, 1H), 7.38–7.31 (m, 2H), 7.19–7.07 (m, 2H), 4.42 (d, <i>J</i> = 6.2 Hz, 2H), 3.98 (t, <i>J</i> = 7.4 Hz, 2H), 2.97 (t, <i>J</i> = 7.8 Hz, 2H), 2.14 (q, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.6, 161.2 (d, <i>J</i> = 242 Hz), 156.3, 153.7, 147.0, 134.8 (d, <i>J</i> = 3 Hz), 129.5 (d, <i>J</i> = 8 Hz), 126.6, 115.0 (d, <i>J</i> = 21 Hz), 46.8, 41.4, 31.1, 19.3. MS <i>m</i>/<i>z</i>: 304 (M + H)<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(4-Fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>12b</b>)</h3><div class="NLM_p last">A solution of <b>29b</b> (0.050 g, 0.22 mmol) and 4-fluorobenzylamine (0.055 g, 0.44 mmol) in methanol (0.5 mL) was stirred and heated to 65 °C for 22 h. After the mixture was cooled, the solvent was removed under reduced pressure and the product was isolated by preparative RP-HPLC. Yield: 45%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.12 (s, 1H), 9.35 (m, 1H), 7.36 (m, 2H), 7.15 (m, 2H), 4.44 (m, 2H), 3.84 (t, <i>J</i> = 6.4 Hz, 2H), 2.80 (t, <i>J</i> = 6.8 Hz, 2H), 1.90–1.73 (m, 4H). MS <i>m</i>/<i>z</i>: 318 (M + H)<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(4-Fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>12c</b>)</h3><div class="NLM_p last"><b>12c</b> was prepared as described for <b>12b</b>. The product was isolated by preparative RP-HPLC (yield 54%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA) δ 9.35 (bs, 1H), 7.36 (dd, <i>J</i> = 8.4, 5.6 Hz, 2H), 7.14 (t, <i>J</i> = 8.9 Hz, 2H), 4.44 (d, <i>J</i> = 6.4 Hz, 2H), 4.33–4.20 (m, 2H), 3.05–2.90 (m, 2H), 1.78–1.62 (m, 6H). MS: <i>m</i>/<i>z</i>: 332 (M + H)<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (±)-2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-<i>N</i>-methyl-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-9-aminium chloride (<b>40b</b>)</h3><div class="NLM_p last">The title compound was prepared using the following five-step procedure. Step a: To a stirred solution of methyl 3-(benzoyloxy)-9-bromo-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxylate <b>31b</b> (5.9 g, 14.43 mmol) in DMF (25 mL) at room temperature were added <i>N</i>-methyl-<i>N</i>-benzylamine (4.03 mL, 30.3 mmol) and TEA (2.21 mL, 16.0 mmol). The mixture was stirred for 75 min, and Et<sub>2</sub>O (900 mL) and 2 M HCl/Et<sub>2</sub>O (23.6 mL) were added. The formed yellow precipitate was filtered off, washed with Et<sub>2</sub>O, and dried under high vacuum to afford a yellow solid (9.3 g). Crude methyl 9-[benzyl(methyl)amino]-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxylate hydrochloride <b>36b</b> was used as such without further purification (MS <i>m</i>/<i>z</i>: 344 (M + H)<sup>+</sup>). Step b: The above crude material was dissolved in MeOH (160 mL), palladium on charcoal (0.980 g, 10% w/w) was added, and the mixture was stirred under a hydrogen atmosphere for 3.5 h. The catalyst was filtered off, and the solution was concentrated to dryness under reduced pressure to afford crude methyl 3-hydroxy-9-(methylamino)-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxylate <b>38b</b> as the hydrochloride salt (6.9 g), which was used as such in the next step without further purification (MS <i>m</i>/<i>z</i>: 254 (M + H)<sup>+</sup>). Step c: An amount of 4.72 g of this crude material was dissolved in MeOH (60 mL). 4-Fluorobenzylamine (1.15 mL, 10 mmol) and TEA (2.78 mL, 20 mmol) were added, and the mixture was stirred at 60 °C for 14 h. The mixture was concentrated to dryness. The residue was triturated with Et<sub>2</sub>O, and the residue was dried under vacuum to afford 6.4 g of crude <i>N</i>-(4-fluorobenzyl)-3-hydroxy-9-(methylamino)-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide <b>40b</b> as a yellow solid, which was used without further purification (MS <i>m</i>/<i>z</i>: 347 (M + H)<sup>+</sup>). Step d: An amount of 5.9 g of this crude material was suspended in a mixture of water (52 mL) and 1,4-dioxane (67 mL). Di-<i>tert</i>-butyl dicarbonate (11.0 g, 50.7 mmol), and NaHCO<sub>3</sub> (4 g, 22.5 mmol) were added, and the mixture was stirred at 62 °C for 3.5 h. After cooling to room temperature, the mixture was partitioned between EtOAc (400 mL) and 0.3 M aqueous HCl (200 mL). The organic phase was separated, and the aqueous phase was extracted with EtOAc (200 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel, using EtOAc/petroleum ether (4:1) as eluent. The pooled product fractions were concentrated to dryness under reduced pressure to afford <i>tert</i>-butyl (2-{[(4-fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-9-yl)methylcarbamate as a light-pink oil (1.67 g, 3.74 mmol, 41% from <b>31b</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.02 (s, 0.6H), 11.86 (s, 0.4H), 8.60 (s, 0.6H), 8.24 (s, 0.4H), 7.40–7.08 (m, 4H), 4.80–4.75 (m, 0.4H), 4.60–4.40 (m, 2.6H), 4.16–7.00 (m, 1H), 3.67–3.45 (m, 1H), 2.93 (s, 1.8H), 2.78 (s, 1.2H), 2.18–1.75 (m, 4H), 1.25 (s, 3.6H), 1.14 (s, 5.4H). MS <i>m</i>/<i>z</i>: 447 (M + H)<sup>+</sup>. Step e: A solution of the above <i>tert</i>-butyl (2-{[(4-fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-9-yl)methylcarbamate (1.62 g, 3.62 mmol) in 4 M HCl/1,4-dioxane (31 mL) was stirred at room temperature for 3 h. The solvents were removed under reduced pressure and the residue was triturated with Et<sub>2</sub>O, filtered, and left under high vacuum to afford <b>40b</b> as the hydrochloride salt as a yellow solid (1.37 g, 99%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.38 (s, 1H), 10.39 (t, <i>J</i> = 6.2 Hz, 1H), 9.90 (s, br, 1H), 9.43 (s, br, 1H), 7.49–7.05 (m, 4H), 4.60–4.43 (m, 3H), 4.06–3.99 (m, 1H), 3.70–3.60 (m, 1H), 2.64 (s, 3H), 2.35–2.25 (m, 1H), 2.20–2.11 (m, 1H), 1.96–1.73 (m, 2H). MS <i>m</i>/<i>z</i>: 347 (M + H)<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-10-(methylamino)-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>40c</b>)</h3><div class="NLM_p last"><b>40c</b> was prepared as described for <b>40b</b>, steps a−c, starting from methyl 10-bromo-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxylate <b>31c</b>. The compound was used as a crude for the next reactions or isolated by RP-HPLC as the trifluoroacetate salt (yield 49%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.33 (s, 1H), 9.52 (s, 1H), 9.22 (bs, 1H), 8.82 (bs, 1H), 7.39 (t, <i>J</i> = 7.12 Hz, 2H), 7.21 (t, <i>J</i> = 8.6 Hz, 2H), 4.94 (dd, <i>J</i> = 14.3, 4.6 Hz, 1H), 4.71 (m, 1H), 4.63–4.51 (m, 2H), 3.50 (dd, partially overlapped by water, 1H), 2.69 (s, 3H), 2.23 (d, <i>J</i> = 12.7 Hz, 1H), 1.97 (d, <i>J</i> = 11.5 Hz, 1H), 1.91–1.80 (m, 2H), 1.70–1.60 (m, 1H), 1.45–1.30 (m, 1H). MS <i>m</i>/<i>z</i>: 361 (M + 1)<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Synthesis of Amides <b>13c</b>, <b>14</b>–<b>17b</b>, <b>18b</b>,<b>c</b></h3><div class="NLM_p last">Compound <b>40b</b> or crude <b>40c</b> (0.052 mmol) was dissolved in DMF (0.5 mL) or DCM (1 mL). DIPEA (0.030 mL, 0.15 mmol), HOBt (0.009 g, 0.068 mmol), EDC (0.038 g, 0.16 mmol), and the appropriate carboxylic acid (0.16 mmol) were added, and the mixture was stirred for 24 h at room temperature. The mixture was diluted with 0.5 mL of DMF and filtered, and the product was isolated by preparative RP-HPLC.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (±)-10-[Acetyl(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>13c</b>)</h3><div class="NLM_p last">Yield: 17% from <b>31c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA) δ 8.13 (bs, 1H), 7.41–7.36 (m, 2H), 7.16 (t, <i>J</i> = 8.8 Hz, 2H), 5.61 (bs, 1H), 5.00 (dd, <i>J</i> = 14.4, 5.4 Hz, 1H), 4.61–4.49 (m, 2H), 3.63–3.50 (m, 1H), 3.05 (bs, 2H), 2.09–1.77 (m, 9H), 1.44–1.29 (m, 1H). MS <i>m</i>/<i>z</i>: 403 (M + H)<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (±)-9-[(Difluoroacetyl)(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>14b</b>)</h3><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.20–11.90 (m, 1H), 8.67 (t, <i>J</i> = 6.0 Hz, 0.7H), 8.57 (t, <i>J</i> = 6.0 Hz, 0.3H), 7.39–7.25 (m, 2H), 7.21–7.10 (m, 2H), 6.92–6.55 (m, 1H), 5.26–5.02 (m, 1H), 4.50 (d, <i>J</i> = 6.0 Hz, 2H), 4.18–4.02 (m, 1H), 3.80–3.59 (m, 1H), 3.02 (s, 2.1H), 2.73 (s, 0.9H), 2.18–1.82 (m, 4H). MS <i>m</i>/<i>z</i>: 425 (M + H)<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-[methyl(1<i>H</i>-pyrazol-1-ylacetyl)amino]-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>15b</b>)</h3><div class="NLM_p last">Yield: 44%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (bs, 1H), 9.07 (t, <i>J</i> = 6.7 Hz, 0.44H), 8.81 (t, <i>J</i> = 6.7 Hz, 0.56H), 7.68 (d, <i>J</i> = 2.0 Hz, 0.44H), 7.56 (d, <i>J</i> = 2.2 Hz, 0.56H), 7.41–7.28 (m, 3H), 7.22–7.06 (m, 2H), 6.28–6.21 (m, 1H), 5.48 (d, <i>J</i> = 16.1 Hz, 0.44H), 5.29–5.10 (m, 2.56H), 4.65–4.51 (m, 2H), 4.20–4.05 (m, 1H), 3.72–3.55 (m, 1H), 3.00 (s, 1.68H), 2.66 (s, 1.32 H), 2.18–1.85 (m, 4H). MS <i>m</i>/<i>z</i>: 455 (M + H)<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-[methyl([1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-ylcarbonyl)amino]-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>16b</b>)</h3><div class="NLM_p last">Yield: 68%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.20–11.5 (m, 1H), 9.60–9.50 (m, 0.6H), 9.45–9.40 (m, 0.6H), 9.35–9.23 (m, 0.8H), 7.56–7.38 (m, 3H), 7.21–7.03 (m, 2H), 5.57–5.50 (m, 0.6H), 5.25–5.15 (m, 0.4H), 4.80–4.60 (m, 2H), 4.15–3.90 (m, 1H), 3.76–3.55 (m, 1H), 2.89 (s, 1.2H), 2.85 (s, 1.8H), 2.23–1.71 (m, 4H). MS <i>m</i>/<i>z</i>: 493 (M + H)<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (±)9-[{[(Dimethylamino)sulfonyl]acetyl}(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>17b</b>)</h3><div class="NLM_p last">Yield: 53%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) mixture of two rotamers in ratio 4/1: δ 12.07 (s, 1H), 8.90 (t, <i>J</i> = 6.3 Hz, 0.8H), 8.53 (t, <i>J</i> = 6.3 Hz, 0.2H), 7.46–7.32 (m, 2H), 7.26–7.13 (m, 2H), 5.56–5.44 (m, 0.8H), 5.24–5.12 (m, 0.2H), 4.64–4.04 (m, 5H), 3.80–3.64 (m, 1H), 3.10 (s, 2.4H), 2.83 (s, 6H), 2.74 (s, 0.6H), 2.19–1.90 (m, 4H). MS <i>m</i>/<i>z</i>: 496 (M + H)<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-9-[{[(Dimethylamino)sulfonyl]acetyl}(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide ((<i>R</i>)-<b>17b</b>)</h3><div class="NLM_p last">(<i>R</i>)-<b>17b</b> was prepared from (<i>R</i>)-<b>43b</b>. [α]<sup>20</sup><sub>D</sub> +89 ± 3 (EtOH), 99.5% ee. Spectral properties are identical to those of the corresponding racemic compound <b>17b</b>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-9-[{[(Dimethylamino)sulfonyl]acetyl}(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide ((<i>S</i>)-<b>17b</b>)</h3><div class="NLM_p last">(<i>S</i>)-<b>17b</b> was prepared from (<i>S</i>)-<b>43b</b>. [α]<sup>20</sup><sub>D</sub> −93 ± 3 (EtOH), 96.7% ee. Spectral properties are identical to those of the corresponding racemic compound <b>17b</b>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-{methyl[(methylsulfonyl)acetyl]amino}-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>18b</b>)</h3><div class="NLM_p last">Yield: 70%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) mixture of two rotamers in ratio 4/1: δ 12.11 (s, 1H), 8.89 (t, <i>J</i> = 6.3 Hz, 0.8H), 8.68 (t, <i>J</i> = 6.3 Hz, 0.2H), 7.45–7.33 (m, 2H), 7.25–7.13 (m, 2H), 5.55–5.43 (m, 0.8H), 5.25–5.15 (m, 0.2H), 4.74–4.44 (m, 4H), 4.22–4.10 (m, 1H), 3.80–3.60 (m, 1H), 3.25 (s, 0.6H), 3.10 (s, 2.4H), 3.08 (s, 2.4H), 2.73 (s, 0.6H), 2.20–1.92 (m, 4H). MS <i>m</i>/<i>z</i>: 467 (M + H)<sup>+</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-10-{methyl[(methylsulfonyl)acetyl]amino}-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>18c</b>)</h3><div class="NLM_p last">To crude <i>N</i>-(4-fluorobenzyl)-3-hydroxy-10-(methylamino)-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide <b>40c</b> (0.33 mmol) in DCM (6 mL) were added DIPEA (0.043 g, 0.33 mmol), HATU (0.152 g, 0.4 mmol), methylsulfonylacetic acid (0.055 g, 0.4 mmol), and TEA (0.121 g, 1.2 mmol), and the mixture was stirred at room temperature. The reaction mixture, diluted with DCM, was washed with 1 M HCl in water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by RP-HPLC. Yield: 14% from <b>31c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) mixture of two rotamers in ratio 4/1: δ 12.78 (bs, 1H), 8.60 (bs, 0.8H), 8.09 (bs, 0.2H), 7.34–7.30 (m, 2H), 7.14 (t, <i>J</i> = 8.8 Hz, 2H), 5.58 (d, <i>J</i> = 8.8 Hz, 0.8H), 5.26 (bs, 0.2H), 4.98 (dd, <i>J</i> = 14.1, 5.2 Hz, 1H), 4.69 (d, <i>J</i> = 14.3 Hz, 1H), 4.56 (dd, <i>J</i> = 14.7, 6.7 Hz, 1H), 4.45 (dd, <i>J</i> = 15.0, 6.2 Hz, 1H), 4.32 (d, <i>J</i> = 14.5 Hz, 1H), 3.53 (t, <i>J</i> = 12.8 Hz, 1H), 3.18 (s, 2.4H), 3.02 (s, 3H), 2.95 (s, 0.6H), 2.15–1.71 (m, 5H), 1.45–1.31 (m, 1H). MS <i>m</i>/<i>z</i>: 481 (M + H)<sup>+</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (±)-8-[Acetyl(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>13a</b>)</h3><div class="NLM_p last">The compound was prepared by reacting a solution of crude <i>N</i>-(4-fluorobenzyl)-3-hydroxy-8-(methylamino)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide <b>40a</b> (prepared as described for <b>7a</b>, step d) in dry DCM (2 mL) with DIPEA (0.062 g, 0.48 mmol), HOBt (0.045 g, 0.33 mmol), EDC (0.064 mg, 0.33 mmol), and acetic acid (0.034 g, 0.56 mmol). The mixture was stirred at room temperature for 16 h and then concentrated. The product was isolated by preparative RP-HPLC. Yield: 2% from <b>30a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA) mixture of two rotamers in ratio 3/1: δ 9.02 (bs, 1H), 7.40–7.32 (m, 2H), 7.18–7.08 (m, 2H), 5.75–5.65 (m, 0.75H), 5.59–5.48 (m, 0.25H), 4.50 (ddd, <i>J</i> = 6.6, 15.0, 24.8 Hz, 2H), 4.19–4.05 (m, 1H), 3.91–3.78 (m, 1H), 2.93 (s, 2.1H), 2.71–2.64 (bs, 0.9H), 2.46–2.35 (m, 1H, partially under solvent signal), 2.20–2.00 (m, 4H). MS <i>m</i>/<i>z</i>: 375 (M + H)<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (±)-9-[Acetyl(methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>13b</b>)</h3><div class="NLM_p last">The compound was prepared starting from <b>31b</b> (0.055 g, 0.138 mmol), according to the procedure described for the synthesis of <b>40b</b> (step c) and then the following step d: Crude <b>40b</b> was dissolved in DCM (2 mL). DIPEA (0.105 g, 0.82 mmol), acetic acid (0.029 g, 0.48 mmol), HOBt (0.081 g, 0.60 mmol), and EDC (0.115 g, 0.60 mmol) were added, and the mixture was stirred for 4 h at room temperature. The solvent was removed under reduced pressure, and the product was isolated by preparative RP-HPLC to afford the title compound (0.020 g, 26%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) mixture of two rotamers in ratio 4/1: δ 12.08 (s, br, 1H), 8.72 (t, <i>J</i> = 6.4 Hz, 0.8H), 8.49 (t, <i>J</i> = 6.4 Hz, 0.2H), 7.38–7.30 (m, 2H), 7.21–7.11 (m, 2H), 5.23–5.18 (m, 0.8H), 5.02–4.954 (m, 0.2H), 4.58 (d, <i>J</i> = 6.4 Hz, 2H), 4.10–4.01 (m, 1H), 3.74–3.49 (m, 1H), 2.92 (s, 2.4H), 2.60 (s, 0.6H), 2.09 (s, 0.6H), 2.02 (s, 2.4H), 2.01–1.84 (m, 4H). MS <i>m</i>/<i>z</i>: 389 (M + H)<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (±)-9-({[(Dimethylamino)sulfonyl]acetyl}amino)-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>19b</b>)</h3><div class="NLM_p last"><b>19b</b> was prepared from <b>31b</b> as described as for <b>13b</b>, using dibenzylamine in the first step. Yield: 8% from <b>31b</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1H), 9.08 (t, <i>J</i> = 6.2 Hz, 1H), 8.84 (d, <i>J</i> = 7.8 Hz, 1H), 7.42–7.33 (m, 2H), 7.22–7.13 (m, 2H), 4.92–4.81 (m, 1H), 4.60–4.40 (m, 2H), 4.31 (d, <i>J</i> = 13.8 Hz, 1H), 4.13 (d, <i>J</i> = 13.8 Hz, 1H), 4.12–4.02 (m, 1H), 3.90–3.80 (m, 1H), 3.11 (s, 3H), 2.18–1.87 (m, 3H), 1.75–1.55 (m, 1H). MS <i>m</i>/<i>z</i>: 453 (M + H)<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> General Procedure for the Synthesis of Sulfonamides <b>20</b>, <b>21</b>, <b>22b</b>,<b>c</b>, <b>24</b>–<b>27</b></h3><div class="NLM_p last"><b>40b</b> (or <b>40c</b>) (0.14 mmol) was suspended in DCM (4 mL). TEA (0.3 mL, 2.15 mmol) and the appropriate sulfonyl (or sulfamoyl) chloride (1.86 mmol) were added, and the mixture was stirred at room temperature for 90 min. The solvent was removed under reduced pressure, and the product was isolated by preparative RP-HPLC.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-[methyl(methylsulfonyl)amino]-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>20b</b>)</h3><div class="NLM_p last">Yield: 39%. Prior to RP-HPLC, the residue was suspended in a mixture of 1 M NaOH and MeOH (1:1, 20 mL), stirred at room temperature for 16 h, and neutralized with 1 N aqueous HCl. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s, 1H), 8.87 (t, <i>J</i> = 6.4 Hz, 1H), 7.36–7.28 (m, 2H), 7.20–7.12 (m, 2H), 4.97–4.88 (m, 1H), 4.57–4.42 (m, 2H), 4.01–3.94 (m, 1H), 3.74–3.65 (m, 1H), 3.09 (s, 3H), 2.71 (s, 3H), 2.10–1.92 (m, 4H). MS <i>m</i>/<i>z</i>: 425 (M + H)<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (±)<i>-N</i>-(4-Fluorobenzyl)-3-hydroxy-10-[methyl(methylsulfonyl)amino]-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>20c</b>)</h3><div class="NLM_p last"><b>20c</b> was treated with NaOH prior to RP-HPLC, as described for <b>20b</b>. Yield: 8% from <b>31c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.13 (bs, 1H), 8.68 (t, <i>J</i> = 6.0 Hz, 1H), 7.35 (dd, <i>J</i> = 8.6, 5.7 Hz, 2H), 7.16 (t, <i>J</i> = 8.9 Hz, 2H), 4.99 (d, <i>J</i> = 8.8 Hz, 2H), 4.88 (dd, <i>J</i> = 14.0, 5.5 Hz, 1H), 4.59–4.47 (m, 2H), 3.58–3.48 (m, partially hidden under water), 3.03 (s, 1H), 2.94 (s, 3H), 2.11–1.78 (m, 5H), 1.38–1.22 (m, 1H). MS <i>m</i>/<i>z</i>: 439 (M + H)<sup>+</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-{methyl[(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)sulfonyl]amino}-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>21b</b>)</h3><div class="NLM_p last">Yield: 29%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA) δ 9.04 (t, <i>J</i> = 6.0 Hz, 1H), 7.42–7.35 (m, 2H), 7.20–7.11 (m, 2H), 5.17 (t, <i>J</i> = 8.8 Hz, 1H), 4.60 (dd, <i>J</i> = 7.2, 15.0 Hz, 1H), 4.44 (dd, <i>J</i> = 5.6, 15.0 Hz, 1H), 4.10–4.02 (m, 1H), 3.67 (s, 3H), 3.60–3.49 (m, 1H), 2.37 (s, 3H), 2.31 (s, 3H), 2.16 (s, 3H), 2.12–1.92 (m, 4H). MS <i>m</i>/<i>z</i>: 519 (M + H)<sup>+</sup>.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (±)-9-[[(Dimethylamino)sulfonyl](methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>22b</b>)</h3><div class="NLM_p last">Yield: 32%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 11.95 (s, 1H), 9.13 (m, 1H), 7.38 (m, 2H), 7.04 (m, 2H), 4.98 (m, 1H), 4.56 (m, 2H), 4.36 (m, 1H), 3.62 (m, 1H), 2.84 (s, 6H), 2.57 (s, 3H), 2.38–1.85 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.53, 162.55, 160.11, 157.74, 145.76 144.11, 132.70, 128.89, 128.81, 124.82, 114.60, 114.39, 58.06, 42.93, 41.53, 37.00, 29.03, 23.89, 20.09. MS <i>m</i>/<i>z</i>: 454 (M + H)<sup>+</sup>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>)-9-[[(Dimethylamino)sulfonyl](methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide ((<i>S</i>)-<b>22b</b>)</h3><div class="NLM_p last">(<i>S</i>)-<b>22b</b> was prepared from (<i>S</i>)-<b>43b</b> as already described for <b>22b</b>. Yield: 37%. [α]<sup>20</sup><sub>D</sub> +33 ± 3 (EtOH), 97% ee. Spectral properties are identical to those of the corresponding racemic compound <b>22b</b>.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>R</i>)-9-[[(Dimethylamino)sulfonyl](methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide ((<i>R</i>)-<b>22b</b>)</h3><div class="NLM_p last">(<i>R</i>)-<b>22b</b> was prepared from (<i>R</i>)-<b>43b</b> as already described for <b>22b</b>. The pooled product fractions, lyophilized after RP-HPLC purification, afforded the title compound as a fluffy white material (90.7% ee). The compound was dissolved in ethanol and left standing at room temperature for 3 days. The supernatant was taken off and concentrated to dryness under reduced pressure. The residue was redissolved in ethanol, and the solution was left standing at room temperature for 1 day. The supernatant was taken off and concentrated under reduced pressure and the residue lyophilized from water/acetonitrile to afford the title product with an enantiomeric excess of 99.4% (ee determined by chiral HPLC Chiralpak AD, mobile phase <i>n</i>-hexane/isopropanol + 0.2% TFA). Yield: 61%. [α]<sup>20</sup><sub>D</sub> −33 ± 2 (EtOH). Spectral properties are identical to those of the corresponding racemic compound <b>22b</b>.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (±)-10-[[(Dimethylamino)sulfonyl](methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>22c</b>)</h3><div class="NLM_p last">Yield: 10% from <b>31c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.78 (bs, 1H), 8.85 (t, <i>J</i> = 5.8 Hz, 1H), 7.38 (dd, <i>J</i> = 8.4, 5.6 Hz, 2H), 7.18 (t, <i>J</i> = 8.9 Hz, 2H), 4.96–4.85 (m, 2H), 4.61–4.48 (m, 2H), 3.49 (dd, <i>J</i> = 13.8, 11.6 Hz, 1H), 2.81 (s, 3H), 2.71(s, 6H), 2.18–2.08 (m, 1H), 2.03–1.79 (m, 4H), 1.41–1.28 (m, 1H). MS <i>m</i>/<i>z</i>: 468 (M + H)<sup>+</sup>.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-[methyl(pyrrolidin-1-ylsulfonyl)amino]-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>24b</b>)</h3><div class="NLM_p last">The appropriate sulfamoyl chloride was prepared according to the literature.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Yield: 27%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.64 (s, 1H), 9.15 (t, <i>J</i> = 6.3, 1H), 7.40–7.27 (m, 2H), 7.20–7.10 (m, 2H), 4.95–4.82 (m, 1H), 4.50–4.40 (m, 2H), 4.10–4.05 (m, 1H), 3.62–3.48 (m, 1H), 3.30–3.11 (m, 4H), 2.53 (s, 3H), 2.15–1.91 (m, 4H), 1.90–1.79 (m, 4H). MS <i>m</i>/<i>z</i>: 480 (M + H)<sup>+</sup>.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-[methyl(piperidin-1-ylsulfonyl)amino]-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>25b</b>)</h3><div class="NLM_p last">The appropriate sulfamoyl chloride was prepared according to the literature.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Yield: 26%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.64 (bs, 1H), 9.09 (t, <i>J</i> = 6.4 Hz, 1H), 7.41–7.30 (m, 2H), 7.21–7.11 (m, 2H), 4.90–4.78 (m, 1H), 4.61–4.42 (m, 2H), 4.12–3.98 (m, 1H), 3.65–3.48 (m, 1H), 3.15–3.04 (m, 4H), 2.53 (s, 3H), 2.19–1.95 (m, 4H), 1.62–1.41 (m, 6H). MS <i>m</i>/<i>z</i>: 494 (M + H)<sup>+</sup>.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-[methyl(morpholin-4-ylsulfonyl)amino]-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>26b</b>)</h3><div class="NLM_p last">The appropriate sulfamoyl chloride was prepared according to the literature.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Yield: 43%. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>CN) δ 11.90 (bs, 1H), 9.13 (bs, 1H), 7.51–7.35 (m, 2H), 7.21–7.10 (m, 2H), 5.00–4.88 (m, 1H), 4.65–4.50 (m, 2H), 4.28–4.12 (m, 1H), 3.81–3.69 (m, 4H), 3.69–3.55 (m, 1H), 3.26–3.13 (m, 4H), 2.65 (s, 3H), 2.32–1.92 (m, 4H). MS <i>m</i>/<i>z</i>: 496 (M + H)<sup>+</sup>.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-{methyl[(4-methylpiperazin-1-yl)sulfonyl]amino}-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>27b</b>)</h3><div class="NLM_p last">The appropriate sulfamoyl chloride was prepared according to the literature.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Yield: 33%. Isolated as the trifluoroacetate salt after RP-HPLC. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>CN) δ 11.67 (bs, 1H), 9.73 (bs, 1H), 8.96 (t, <i>J</i> = 6.3 Hz, 1H), 7.41–7.29 (m, 2H), 7.21–7.10 (m, 2H), 4.93–4.80 (m, 1H), 4.61–4.40 (m, 2H), 4.12–4.00 (m, 1H), 3.81–3.36 (m, 5H), 3.21–2.97 (m, 4H), 2.84 (s, 3H), 2.59 (s, 3H), 2.19–1.91 (m, 4H). MS <i>m</i>/<i>z</i>: 510 (M + H)<sup>+</sup>.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-{methyl[(4-methylpiperazin-1-yl)sulfonyl]amino}-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide ((<i>S</i>)-<b>27b</b>)</h3><div class="NLM_p last">(<i>S</i>)-<b>27b</b> was prepared from (<i>S</i>)-<b>42b</b> as described for <b>27b</b>. Yield: 11%. [α]<sup>20</sup><sub>D</sub> +22 ± 3 (EtOH), 93% ee. Spectral properties are identical to those of the corresponding racemic compound <b>27b</b>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>R</i>)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-{methyl[(4-methylpiperazin-1-yl)sulfonyl]amino}-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-2-carboxamide ((<i>R</i>)-<b>27b</b>)</h3><div class="NLM_p last">(<i>R</i>)-<b>27b</b> was prepared from (<i>R</i>)-<b>42b</b> as described for <b>27b</b>. Yield: 33%. [α]<sup>20</sup><sub>D</sub> −23 ± 3 (EtOH), 98% ee. Spectral properties are identical to those of the corresponding racemic compound <b>27b</b>.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (±)-8-[[(Dimethylamino)sulfonyl](methyl)amino]-<i>N</i>-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide (<b>22a</b>)</h3><div class="NLM_p last">The compound was prepared by reacting a solution of crude <i>N</i>-(4-fluorobenzyl)-3-hydroxy-8-(methylamino)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidine-2-carboxamide <b>40a</b> (prepared as described for <b>7a</b> step d) in dry DCM (0.5 mL) and TEA (0.04 mL, 0.29 mmol). <i>N,N-</i>Dimethylsulfamoyl chloride (0.031 mL, 0.29 mmol) was added. The mixture was stirred at room temperature for 16 h, then diluted with DCM and washed with 1 N HCl and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The product was isolated by preparative RP-HPLC. Yield: 2% from <b>30a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.42 (bs, 1H), 8.78 (t, <i>J</i> = 6.3 Hz, 1H), 7.42–7.35 (m, 2H), 7.23–7.15 (m, 2H), 5.27 (t, <i>J</i> = 9.1 Hz, 1H), 4.51 (ddd, <i>J</i> = 6.3, 4.8, 6.8 Hz, 2H), 4.13–4.05 (m, 1H), 3.88–3.72 (m, 1H, partially hidden under the signal of water), 2.78 (s, 6H), 2.73 (s, 3H), 2.48–2.38 (m, 1H), 2.35–2.23 (m, 1H). MS <i>m</i>/<i>z</i>: 440 (M + H)<sup>+</sup>.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-9-(6-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl)-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i> ]pyrimidine-2-carboxamide (<b>23b</b>)</h3><div class="NLM_p last"><b>23b</b> was prepared from <b>31b</b> as described below for <b>23c</b>. Yield: 30%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (bs, 1H), 9.14 (t, <i>J</i> = 6.2 Hz, 1H), 7.45–7.32 (m, 2H), 7.25–7.12 (m, 2H), 4.87–4.78 (m, 1H), 4.61–4.42 (m, 2H), 4.12–3.96 (m, 1H), 3.70–3.47 (m, 2H), 3.31–3.22 (m, 1H), 3.18–3.12 (m, 2H), 2.68 (s, 3H), 2.12–1.86 (m, 5H), 1.48–1.35 (m, 1H). MS <i>m</i>/<i>z</i>: 466 (M + H)<sup>+</sup>.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (±)-<i>N</i>-(4-Fluorobenzyl)-3-hydroxy-10-(6-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl)-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide (<b>23c</b>)</h3><div class="NLM_p last">To a solution of methyl 3-(benzoyloxy)-10-bromo-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxylate <b>31c</b> (0.100 g, 0.238 mmol) in DMF (5 mL) were added 2-methyl-1,2,6-thiadiazinane 1,1-dioxide (0.178 g, 1.19 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (0.387 g, 1.19 mmol), and the mixture was stirred at 0 °C for 20 min. The solvent was removed under reduced pressure and to crude methyl 3-hydroxy-10-(6-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl)-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxylate dissolved in methanol (4 mL) was added 4-fluorobenzylamine (0.127 g, 0.952 mmol). The mixture was stirred at reflux overnight. The solvent was removed under reduced pressure, and the product was purified by preparative RP-HPLC. Yield: 6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub> + 2% TFA) δ 9.02 (bs, 1H), 7.39 (dd, <i>J</i> = 8.4, 5.7 Hz, 2H), 7.18 (t, <i>J</i> = 8.9 Hz, 2H), 4.80 (d, <i>J</i> = 8.6 Hz, 1H), 4.68 (dd, <i>J</i> = 14.0, 6.1 Hz, 1H), 4.58–4.44 (m, 2H), 3.77 (t, <i>J</i> = 12.2 Hz, 1H), 3.55–3.47 (m, 2H), 3.43–3.29 (m, 2H), 2.70 (s, 3H), 2.07–1.90 (m, 2H), 1.91–1.62 (m, 5H), 1.39–1.49 (m, 1H). MS <i>m</i>/<i>z</i>: 480 (M + H)<sup>+</sup>.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> General Procedure for the Synthesis of Ketoamides <b>28</b></h3><div id="sec5_46_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Method A</h4><div class="NLM_p last">To a stirred 0.1 M solution of crude <b>40a</b> or <b>40b</b>,<b>c</b> in DCM were added TEA (or DIPEA) (6 equiv) and methyl chlorooxoacetate (6 equiv). The mixture was stirred at room temperature for 2 h, the solvent was removed under reduced pressure, and the residue was dissolved in a solution of 2 M dimethylamine in THF (6 equiv). The mixture was stirred at 57 <i>°</i>C overnight. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the product was isolated by preparative RP-HPLC.</div></div><div id="sec5_46_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Method B</h4><div class="NLM_p last">To a stirred 0.1 M solution of <b>40a</b>−<b>c</b> in DCM were added TEA (3 equiv), potassium (dimethylamino)(oxo)acetate (2 equiv), EDC (2.2 equiv), and HOBt (2.2 equiv). The mixture was stirred at room temperature overnight. The solvent was removed under reduced pressure, and the residue was partitioned between ethyl acetate and 1 M aqueous HCl. The aqueous phase was extracted with ethyl acetate, and the combined organic phases were dried over sodium sulfate, filtered, and concentrated to dryness under vacuum. The product was isolated by preparative RP-HPLC.</div></div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (±)-<i>N</i>-(2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-<i>a</i>]pyrimidin-8-yl)-<i>N</i>,<i>N</i>′,<i>N</i>′-trimethylethanediamide (<b>28a</b>)</h3><div class="NLM_p last"><b>28a</b> was prepared from crude <b>40a</b> (method A) (yield 2% from <b>30a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) mixture of rotamers 1:1: δ 12.57 (s, 0.5H), 12.48 (s, 0.5H), 9.17 (m, 0.5H), 9.01 (m, 0.5H), 7.37–7.29 (m, 2H), 7.21–7.13 (m, 2H), 5.53 (m, 0.5H), 5.18 (m, 0.5H), 4.61–4.34 (m, 2H), 4.18–4.04 (m, 1H), 3.96–3.86 (m, 0.5H), 3.81–3.71 (m, 0.5H), 2.97 (s, 1.5H), 2.91 (s, 1.5H), 2.87–2.78 (m, 6H), 2.57–2.54 (m, partially overlapped by solvent signal), 2.37–2.16 (m, 1.5H). MS <i>m</i>/<i>z</i>: 432 (M + H)<sup>+</sup>.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (±)-<i>N</i><sup>1</sup>-(2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-9-yl)-<i>N</i><sup>1</sup><i>,N</i><sup>2</sup><i>,N</i><sup>2</sup>-trimethylethanediamide (<b>28b</b>)</h3><div class="NLM_p last"><b>28b</b> was prepared from <b>40b</b> (method A). Yield: 39%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) mixture of rotamers 4:1, δ 12.05 (s, 0.2H), 11.89 (s, 0.8H), 9.21 (m, 0.8H), 8.74 (m, 0.2H), 7.40–7.28 (m, 2H), 7.20–7.10 (m, 2H), 5.17 (m, 0.8H), 4.63–4.35 (m, 2.2H), 4.13–4.00 (m, 1H), 3.65–3.53 (m, partially overlapped by water signal), 2.95–2.75 (m, 9H), 2.15–1.80 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.87, 167.73, 165.92, 165.46, 164.51, 164.30, 162.42, 160.01, 157.50, 157.41, 146.27, 146.18, 145.76, 145.49, 134.44, 129.43, 129.35, 129.08, 129.00, 125.17, 125.05, 115.07, 114.85, 57.47, 53.60, 43.14, 41.37, 36.49, 35.95, 32.92, 32.64, 32.36, 28.19, 23.88, 22.12, 19.67, 19.35. MS <i>m</i>/<i>z</i>: 446 (M + H)<sup>+</sup>.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>R</i>)-<i>N</i><sup>1</sup>-((9<i>R</i>)2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-9-yl)-<i>N</i><sup>1</sup>,<i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>-trimethylethanediamide ((<i>R</i>)-<b>28b</b>)</h3><div class="NLM_p last">(<i>R</i>)-<b>28b</b> was prepared from (<i>R</i>)-<b>43b</b>. To a solution of (<i>R</i>)-<b>43b</b> (0.115 g, 0.313 mmol) in MeOH (0.5 mL) were added 4-fluorobenzylamine (0.079 g, 0.63 mmol) and TEA (0.041 g, 0.41 mmol). The mixture was stirred and heated to 65 °C for 3 h. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the residue was dissolved in DCM (4 mL). TEA (0.126 g, 1.25 mmol) and methyl chlorooxoacetate (0.133 g, 1.25 mmol) were added, and the mixture was left stirring at room temperature for 50 min. The solvent was removed under reduced pressure, and the residue was dissolved in a 2 M solution of <i>N</i>,<i>N</i>-dimethylamine in THF (6.0 mL, 12.0 mmol). The mixture was stirred and heated at 55 °C for 16 h. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the product was purified by preparative RP-HPLC. After lyophilization of the pooled product fractions, the title compound was obtained as a fluffy white powder (0.079 g, yield 52%, 94% ee). The compound was dissolved in ethyl acetate/heptane (3:2.5 mixture) and left standing at room temperature for 4 days. The supernatant was taken off from the formed precipitate and concentrated under reduced pressure, and the residue was lyophilized from water/acetonitrile to afford enantiopure title product (100% ee, determined by chiral HPLC Chiralpak AS, mobile phase <i>n</i>-hexane/isopropanol + 0.2% TFA). [α]<sup>20</sup><sub>D</sub> +39 ± 2 (EtOH). Spectral properties are identical to those of the corresponding racemic compound <b>28b.</b></div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>)-<i>N</i><sup>1</sup>-((9<i>S</i>)2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-9-yl)-<i>N</i><sup>1</sup>,<i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>-trimethylethanediamide ((<i>S</i>)-<b>28b</b>)</h3><div class="NLM_p last">(<i>S</i>)-<b>28b</b> was prepared from (<i>S</i>)-<b>43b</b>, as described above for (<i>R</i>)-<b>28b</b>. The compound obtained after RP-HPLC (93% ee) was dissolved in ethanol, and the precipitate formed was filtered off. The filtrate was concentrated to dryness under vacuum and the residue was redissolved in ethanol. The solution was left standing at room temperature for 1 day. The supernatant was taken off, concentrated under reduced pressure, and lyophilized from water/acetonitrile to afford the title compound(99.6% ee, determined by chiral HPLC Chiralpak AS, mobile phase <i>n</i>-hexane/isopropanol + 0.2% TFA). [α]<sup>20</sup><sub>D</sub> −40 ± 2 (EtOH). Spectral properties are identical to those of the corresponding racemic compound <b>28b.</b></div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (±)-<i>N</i>-(2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepin-10-yl)-<i>N</i>,<i>N</i>′,<i>N</i>′-trimethylethanediamide (<b>28c</b>)</h3><div class="NLM_p last"><b>28c</b> was prepared from <b>40c</b> (method B). Yield: 10%. Spectral properties are identical to those of the corresponding enantiomer (<i>S</i>)-<b>28c</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> MS <i>m</i>/<i>z</i>: 460 (M + H)<sup>+</sup>.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>R</i>)-<i>N</i>-(2-{[(4-Fluorobenzyl)amino]carbonyl}-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-<i>a</i>]azepin-10-yl)-<i>N</i>,<i>N</i>′,<i>N</i>′-trimethylethanediamide ((<i>R</i>)-<b>28c</b>)</h3><div class="NLM_p last">Spectral properties are identical to those of the corresponding enantiomer (<i>S</i>)-<b>28c</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> [α]<sup>20</sup><sub>D</sub> +72 ± 2 (CHCl<sub>3</sub>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/jm701164t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and analytical data for the intermediates <b>30a</b>, <b>30c</b>,  <b>31c</b>, and [(dimethylamino)sulfonyl]acetic acid; HPLC, UPLC, and high-resolution mass measurements (HRMS) data for final compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701164t/suppl_file/jm701164t-file002.pdf">jm701164t-file002.pdf (1.3 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701164t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ester Muraglia</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4c293f38293e1321393e2d2b20252d0c21293e2f27622f2321"><span class="__cf_email__" data-cfemail="f39680879681ac9e868192949f9a92b39e96819098dd909c9e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olaf Kinzel</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Gardelli</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benedetta Crescenzi</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Donghi</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Ferrara</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuela Nizi</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Orvieto</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Pescatore</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph Laufer</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Odalys Gonzalez-Paz</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annalise Di Marco</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Fiore</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith Monteagudo</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimiliano Fonsi</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Felock</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Summa</span> - <span class="hlFld-Affiliation affiliation">IRBM Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Rome, Italy, and Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully thank Steve Young and Daria Hazuda for useful discussion. We also thank Vincenzo Pucci for HRMS analysis, Maria Verdirame, Francesca Naimo, and Anna Alfieri for bioanalytical work and plasma protein binding data, Silvia Pesci for NMR analysis, Marina Taliani for microsomal stability studies, and Isabella Marcucci for assistance with CYP inhibition studies. This work was supported in part by a grant from the MIUR.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Emerging anti-HIV drugs</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1517%2F14728214.10.2.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=15934866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=241-273&author=E.+De+Clercq&title=Emerging+anti-HIV+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging anti-HIV drugs</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-274</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There are now exactly 20 anti-HIV drugs licenced (approved) for clin. use, and > 30 anti-HIV compds. under (pre)clin. development.  The licenced anti-HIV drugs fall into five categories: nucleoside reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine); nucleotide reverse transcriptase inhibitors (NtRTIs: tenofovir disproxil fumarate); non-nucleoside reverse transcriptase inhibitors (NNRTIs: nevirapine, delavirdine and efavirenz); protease inhibitors (PIs: saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, lopinavir, atazanavir and fosamprenavir); and fusion inhibitors (FIs: enfuvirtide).  The compds. that are currently under clin. (Phase I, II or III) or preclin. investigation are either targeted at the same specific viral proteins as the licenced compds. (i.e., reverse transcriptase [NRTIs: PSI-5004, (-)-dOTC, DPC-817, elvucitabine, alovudine, MIV-210, amdoxovir, DOT; NNRTIs: thiocarboxanilide, UC-781, capravirine, dapivirine, etravirine, rilpivirine], protease [PIs: tipranavir, TMC-114]) or other specific viral proteins (i.e., gp120: cyanovirin N; attachment inhibitors: Als, such as BMS-488043; integrase: L-870,812, PDPV-165; capsid proteins: PA-457, α-HCG); or cellular proteins (CD4 down-modulators: CADAs; CXCR4 antagonists: AMD-070, CS-3955; CCR5 antagonists: TAK-220, SCH-D, AK-602, UK-427857).  Combination therapy is likely to remain the gold std. for the treatment of AIDS so as to maximize potency, minimize toxicity and diminish the risk for resistance development.  Ideally, pill burden should be reduced to once-daily dosing so as to optimize the patient's compliance and reduce the treatment costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxT0HJuG64arVg90H21EOLACvtfcHk0ljYbkkl7sV1DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D&md5=8b3186fe7585205c72c9bb25c6493382</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.2.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.2.241%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DEmerging%2520anti-HIV%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D241%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">New approaches toward anti-HIV chemotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040158k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1297-1313&author=E.+De+Clercq&title=New+approaches+toward+anti-HIV+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm040158k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040158k%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DNew%2520approaches%2520toward%2520anti-HIV%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1297%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="note"><p class="first last">Recent reviews on HIV-1 protease inhibitors:</p></div><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condra, J. H.</span><span> </span><span class="NLM_article-title">Clinically effective HIV-1 protease inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=261-272&author=J.+P.+Vaccaauthor=J.+H.+Condra&title=Clinically+effective+HIV-1+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DCondra%26aufirst%3DJ.%2BH.%26atitle%3DClinically%2520effective%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1997%26volume%3D2%26spage%3D261%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lebon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledecq, M.</span><span> </span><span class="NLM_article-title">Approaches to the design of effective HIV-1 protease inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=10702619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslOju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=455-477&author=F.+Lebonauthor=M.+Ledecq&title=Approaches+to+the+design+of+effective+HIV-1+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to the design of effective HIV-1 protease inhibitors</span></div><div class="casAuthors">Lebon, F.; Ledecq, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">455-477</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 174 refs.  Recently, western countries have recorded a decrease in the death rate imputed to AIDS.  This success has been largely attributed to the presence on the market of chemotherapies that inhibit the infectivity of the predominant causative agent, the HIV-1 virus, by targeting essential viral enzymes.  One of these is the protease (HIV-1 PR) whose activity is a prerequisite for viral replication.  Two main sites have been identified as potential targets for the inhibition of HIV-1 PR, the active site and the interface, the latter being largely responsible for the stabilization of the enzyme dimeric structure.  The compds. that have reached clin. application so far target the active site of HIV-1 PR.  These mols. act as transition state analogs and result from modifications of the peptidic scaffold into peptidomimetics.  In order to improve their bioavailability, systematic biol. screening and de novo design have been used to suggest new non-peptide inhibitors combining both antiviral potency and favorable pharmacokinetic properties.  In parallel, compds. targeting other potential sites of inhibition have been tested.  Peptides and peptidomimetics based on the terminal sequence of the enzyme, a site which is proposed to be less susceptible to mutations, have been shown to lead to HIV-1 PR inactivation.  Cupric ion was described to bind a sequence on the protease surface, which includes cysteine and histidine residues, leading to the inhibition of the enzyme.  In the future, these non-active site inhibitors could provide an alternative in anti-HIV drug combination strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJUIPwMy52abVg90H21EOLACvtfcHk0liiQdKwHIhI6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslOju7g%253D&md5=5fd57fe306714a39a94832b6b6b149e3</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DF.%26aulast%3DLedecq%26aufirst%3DM.%26atitle%3DApproaches%2520to%2520the%2520design%2520of%2520effective%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D455%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="note"><p class="first last">Recent reviews on HIV-1 reverse transcriptase inhibitors:</p></div><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hogberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, I.</span><span> </span><span class="NLM_article-title">HIV-1 non-nucleoside reverse transcriptase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1189</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1517%2F13543776.10.8.1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1189-1199&author=M.+Hogbergauthor=I.+Morrison&title=HIV-1+non-nucleoside+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 non-nucleoside reverse transcriptase inhibitors</span></div><div class="casAuthors">Hogberg, Marita; Morrison, Iain</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1189-1199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 81 refs.  Two classes of anti-HIV drugs are currently marketed which target the HIV-1 reverse transcriptase (RT).  The first explored class was the nucleoside RT inhibitors (NRTIs), such as AZT, ddI, ddC, 3TC, D4T and abacavir, whereas the more recently launched class are the non-nucleoside RT inhibitors (NNRTI) currently comprising nevirapine (Viramune, Boehringer Ingelheim), delavirdine (Rescriptor, Pharmacia and Upjohn) and efavirenz (Sustiva, Dupont Pharmaceuticals).  The NNRTI class is in rapid development to find more clin. useful inhibitors, esp. against inhibitor-induced mutant RT enzymes.  This article covers development in the area of HIV-1 NNRTI from 1997 through early 2000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAqqXk7Wlu7Vg90H21EOLACvtfcHk0liiQdKwHIhI6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu78%253D&md5=172ca0b4d5ef2baa01223d8e9e6bc100</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.8.1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.8.1189%26sid%3Dliteratum%253Aachs%26aulast%3DHogberg%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DI.%26atitle%3DHIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2000%26volume%3D10%26spage%3D1189%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jonckheere, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The HIV-1 reverse transcription (RT) process as target for RT inhibitors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C129%3A%3AAID-MED2%3E3.0.CO%3B2-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=10723025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=129-154&author=H.+Jonckheereauthor=J.+Anneauthor=E.+De+Clercq&title=The+HIV-1+reverse+transcription+%28RT%29+process+as+target+for+RT+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The HIV-1 reverse transcription (RT) process as target for RT inhibitors</span></div><div class="casAuthors">Jonckheere, Heidi; Anne, Jozef; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-154</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 159 refs.  Since the Human Immunodeficiency Virus Type 1 (HIV-1) was identified as the etiol. agent of the Acquired Immune Deficiency Syndrome (AIDS), the HIV-1 reverse transcriptase (RT) has been the subject of intensive study.  The reverse transcription entails the transition of the single-stranded viral RNA into double-stranded proviral DNA, which is then integrated into the host chromosome.  Therefore, the HIV-1 reverse transcriptase plays a pivotal role in the life cycle of the virus and is consequently an interesting target for anti-HIV drug therapy.  In the first section, we describe the complex process of reverse transcription and the different activities involved in this process.  We then highlight the structure-function relation of the HIV-1 reverse transcriptase, which is of great importance for a better understanding of resistance development, a major problem in anti-AIDS therapies.  Finally, we summarize the mechanisms of HIV resistance toward various RT inhibitors and the implications thereof for the current anti-HIV drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhZ0q1oTzLrVg90H21EOLACvtfcHk0lhaJ5PhI-_mZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVeisLk%253D&md5=9cb8fcc59e71376492d44a2ebf2e69a8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C129%3A%3AAID-MED2%3E3.0.CO%3B2-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200003%252920%253A2%253C129%253A%253AAID-MED2%253E3.0.CO%253B2-A%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DH.%26aulast%3DAnne%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520HIV-1%2520reverse%2520transcription%2520%2528RT%2529%2520process%2520as%2520target%2520for%2520RT%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D129%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">De Clerck, E.</span><span> </span><span class="NLM_article-title">Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1016%2FS0014-827X%2898%2900103-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=10321027" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=26&author=E.+De+Clerck&title=Perspectives+of+non-nucleoside+reverse+transcriptase+inhibitors+%28NNRTIs%29+in+the+therapy+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2898%2900103-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252898%252900103-7%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClerck%26aufirst%3DE.%26atitle%3DPerspectives%2520of%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520%2528NNRTIs%2529%2520in%2520the%2520therapy%2520of%2520HIV-1%2520infection%26jtitle%3DFarmaco%26date%3D1999%26volume%3D54%26spage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Williams, I. G.</span><span> </span><span class="NLM_article-title">Enfuvirtide (Fuzeon): the first fusion inhibitor</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=14712892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=890-897&author=I.+G.+Williams&title=Enfuvirtide+%28Fuzeon%29%3A+the+first+fusion+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Enfuvirtide (Fuzeon): the first fusion inhibitor</span></div><div class="casAuthors">Williams, I. G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">890-897</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  With the no. of people living with HIV infection increasing and the problems of drug resistance and long-term toxicity assocd. with current antiretroviral agents continuing, there is a growing need for new therapy options.  Enfuvirtide is the first fusion inhibitor, a new class of drug, to be licensed for the treatment of HIV infection and is a welcome addn. to the arsenal of antiretrovirals.  This paper, which is the result of a multidisciplinary discussion meeting, reviews current practice in treating HIV infection, the clin. data available on enfuvirtide and discusses its introduction into clin. practice.  Data available to date indicate that enfuvirtide is appropriate for use in patients who have previously taken nucleoside reverse transcriptase inhibitor (NRTI), non-NRTI and protease inhibitor contg. regimens and are either intolerant of them or have experienced virol. failure.  Enfuvirtide should ideally be used while the patient still has other active drug options available to them to combine with enfuvirtide in an effective therapy regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhh-V4eohSi7Vg90H21EOLACvtfcHk0lhaJ5PhI-_mZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlKgtg%253D%253D&md5=d9019607cdf3eac15e3d01ec7a55413d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DI.%2BG.%26atitle%3DEnfuvirtide%2520%2528Fuzeon%2529%253A%2520the%2520first%2520fusion%2520inhibitor%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2003%26volume%3D57%26spage%3D890%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mocroft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiesi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargalianos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Arminio, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yust, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruun, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, J. D.</span><span> </span><span class="NLM_article-title">Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=1725-1730&author=A.+Mocroftauthor=S.+Vellaauthor=T.+L.+Benfieldauthor=A.+Chiesiauthor=V.+Millerauthor=P.+Gargalianosauthor=M.+A.+d%E2%80%99Arminioauthor=I.+Yustauthor=J.+N.+Bruunauthor=A.+N.+Phillipsauthor=J.+D.+Lundgren&title=Changing+patterns+of+mortality+across+Europe+in+patients+infected+with+HIV-1.+EuroSIDA+Study+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMocroft%26aufirst%3DA.%26aulast%3DVella%26aufirst%3DS.%26aulast%3DBenfield%26aufirst%3DT.%2BL.%26aulast%3DChiesi%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DV.%26aulast%3DGargalianos%26aufirst%3DP.%26aulast%3Dd%25E2%2580%2599Arminio%26aufirst%3DM.%2BA.%26aulast%3DYust%26aufirst%3DI.%26aulast%3DBruun%26aufirst%3DJ.%2BN.%26aulast%3DPhillips%26aufirst%3DA.%2BN.%26aulast%3DLundgren%26aufirst%3DJ.%2BD.%26atitle%3DChanging%2520patterns%2520of%2520mortality%2520across%2520Europe%2520in%2520patients%2520infected%2520with%2520HIV-1.%2520EuroSIDA%2520Study%2520Group%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D1725%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Palella, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveless, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satten, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmberg, S. D.</span><span> </span><span class="NLM_article-title">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1056%2FNEJM199803263381301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=9516219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=853-860&author=F.+J.+Palellaauthor=K.+M.+Delaneyauthor=A.+C.+Moormanauthor=M.+O.+Lovelessauthor=J.+Fuhrerauthor=G.+A.+Sattenauthor=D.+J.+Aschmanauthor=S.+D.+Holmberg&title=Declining+morbidity+and+mortality+among+patients+with+advanced+human+immunodeficiency+virus+infection.+HIV+Outpatient+Study+Investigators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</span></div><div class="casAuthors">Palella F J Jr; Delaney K M; Moorman A C; Loveless M O; Fuhrer J; Satten G A; Aschman D J; Holmberg S D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">853-60</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  National surveillance data show recent, marked reductions in morbidity and mortality associated with the acquired immunodeficiency syndrome (AIDS).  To evaluate these declines, we analyzed data on 1255 patients, each of whom had at least one CD4+ count below 100 cells per cubic millimeter, who were seen at nine clinics specializing in the treatment of human immunodeficiency virus (HIV) infection in eight U.S. cities from January 1994 through June 1997.  RESULTS:  Mortality among the patients declined from 29.4 per 100 person-years in the first quarter of 1995 to 8.8 per 100 in the second quarter of 1997.  There were reductions in mortality regardless of sex, race, age, and risk factors for transmission of HIV.  The incidence of any of three major opportunistic infections (Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, and cytomegalovirus retinitis) declined from 21.9 per 100 person-years in 1994 to 3.7 per 100 person-years by mid-1997.  In a failure-rate model, increases in the intensity of antiretroviral therapy (classified as none, monotherapy, combination therapy without a protease inhibitor, and combination therapy with a protease inhibitor) were associated with stepwise reductions in morbidity and mortality.  Combination antiretroviral therapy was associated with the most benefit; the inclusion of protease inhibitors in such regimens conferred additional benefit.  Patients with private insurance were more often prescribed protease inhibitors and had lower mortality rates than those insured by Medicare or Medicaid.  CONCLUSIONS:  The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6uVwzPlrzo4IRAdBLKY41fW6udTcc2ebsKw24a03XpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D&md5=63bd6978cc957517f4bcfae251adc3ef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803263381301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803263381301%26sid%3Dliteratum%253Aachs%26aulast%3DPalella%26aufirst%3DF.%2BJ.%26aulast%3DDelaney%26aufirst%3DK.%2BM.%26aulast%3DMoorman%26aufirst%3DA.%2BC.%26aulast%3DLoveless%26aufirst%3DM.%2BO.%26aulast%3DFuhrer%26aufirst%3DJ.%26aulast%3DSatten%26aufirst%3DG.%2BA.%26aulast%3DAschman%26aufirst%3DD.%2BJ.%26aulast%3DHolmberg%26aufirst%3DS.%2BD.%26atitle%3DDeclining%2520morbidity%2520and%2520mortality%2520among%2520patients%2520with%2520advanced%2520human%2520immunodeficiency%2520virus%2520infection.%2520HIV%2520Outpatient%2520Study%2520Investigators%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D853%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=11727305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVKktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=402-410&author=S.+D.+Young&title=Inhibition+of+HIV-1+integrase+by+small+molecules%3A+the+potential+for+a+new+class+of+AIDS+chemotherapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics</span></div><div class="casAuthors">Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-410</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  HIV-1 integrase, one of three constitutive viral enzymes required for replication, is an attractive target for chemotherapeutic intervention in the treatment of AIDS.  Unlike the retroviral reverse transcriptase and protease enzymes, successful drug candidates based on the inhibition of integrase have yet to emerge despite the multitude of labs. working on the problem.  In vitro inhibition of integrase in the lab. has not always led to antiviral activity in cell culture.  Indeed, most compds. found from broad screening efforts have fallen into this category.  Only recently have compds. that inhibit enzymic function as well as exhibiting an antiviral effect as a result been discovered.  The reasons why certain structural classes of compds. fail to have antiviral activity are only beginning to be understood.  In the last two years a new class of compds. has emerged that do produce potent inhibition of viral growth in cell culture.  Further work in this area may yet produce clin. useful antiviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnA06YtuzfyLVg90H21EOLACvtfcHk0lhI0dLciEI87g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVKktbw%253D&md5=c713eded33ecdee563df0825ce625fd8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DInhibition%2520of%2520HIV-1%2520integrase%2520by%2520small%2520molecules%253A%2520the%2520potential%2520for%2520a%2520new%2520class%2520of%2520AIDS%2520chemotherapeutics%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D402%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">Reviews on biology of HIV-1 integrase:</p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Esposito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craigie, R.</span><span> </span><span class="NLM_article-title">HIV integrase structure and function</span> <span class="citation_source-journal">Adv. Virus Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=319-333&author=D.+Espositoauthor=R.+Craigie&title=HIV+integrase+structure+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DCraigie%26aufirst%3DR.%26atitle%3DHIV%2520integrase%2520structure%2520and%2520function%26jtitle%3DAdv.%2520Virus%2520Res.%26date%3D1999%26volume%3D52%26spage%3D319%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Asante-Appiah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalka, A. M.</span><span> </span><span class="NLM_article-title">HIV-1 integrase: structural organization, conformational changes, and catalysis</span> <span class="citation_source-journal">Adv. Virus Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=351-369&author=E.+Asante-Appiahauthor=A.+M.+Skalka&title=HIV-1+integrase%3A+structural+organization%2C+conformational+changes%2C+and+catalysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DSkalka%26aufirst%3DA.%2BM.%26atitle%3DHIV-1%2520integrase%253A%2520structural%2520organization%252C%2520conformational%2520changes%252C%2520and%2520catalysis%26jtitle%3DAdv.%2520Virus%2520Res.%26date%3D1999%26volume%3D52%26spage%3D351%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span> </span><span class="NLM_article-title">Integrase inhibitors to treat HIV/AIDS</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1038%2Fnrd1660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=15729361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=236-248&author=Y.+Pommierauthor=A.+A.+Johnsonauthor=C.+Marchand&title=Integrase+inhibitors+to+treat+HIV%2FAIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Integrase inhibitors to treat HIV/Aids</span></div><div class="casAuthors">Pommier, Yves; Johnson, Allison A.; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">236-248</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HIV integrase is a rational target for treating HIV infection and preventing AIDS.  It took approx. 12 years to develop clin. usable inhibitors of integrase, and Phase I clin. trials of integrase inhibitors have just begun.  This review focuses on the mol. basis and rationale for developing integrase inhibitors.  The main classes of lead compds. are also described, as well as the concept of interfacial inhibitors of protein-nucleic-acid interactions that might apply to the clin. used strand-transfer inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNsYgtGiwZwrVg90H21EOLACvtfcHk0lhI0dLciEI87g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslSns70%253D&md5=3432f5d60165401adc118eb752c461a3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd1660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1660%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DA.%2BA.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DIntegrase%2520inhibitors%2520to%2520treat%2520HIV%252FAIDS%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D236%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Discovery, Synthesis and Optimization of a New Series of Selective HIV Integrase Inhibitors Leading to MK-0518 Currently in Phase III Clinical Trial for Treatment of HIV/AIDS</span>.  <span class="citation_source-book">Abstracts of Papers</span>, <span class="NLM_conf-name">232nd National Meeting of the American Chemical Society</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">Sep 10–14, 2006</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=V.+Summa&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDiscovery%252C%2520Synthesis%2520and%2520Optimization%2520of%2520a%2520New%2520Series%2520of%2520Selective%2520HIV%2520Integrase%2520Inhibitors%2520Leading%2520to%2520MK-0518%2520Currently%2520in%2520Phase%2520III%2520Clinical%2520Trial%2520for%2520Treatment%2520of%2520HIV%252FAIDS%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span> </span><span class="NLM_article-title">4,5-Dihydroxypyrimidine carboxamides and <i>N</i>-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6649</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060854f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6646-6649&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=C.+Gardelliauthor=E.+Muragliaauthor=M.+Rowleyauthor=O.+G.+Pazauthor=R.+Lauferauthor=E.+Monteagudoauthor=P.+Pace&title=4%2C5-Dihydroxypyrimidine+carboxamides+and+N-alkyl-5-hydroxypyrimidinone+carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+profiles+in+preclinical+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm060854f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060854f%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DPaz%26aufirst%3DO.%2BG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26atitle%3D4%252C5-Dihydroxypyrimidine%2520carboxamides%2520and%2520N-alkyl-5-hydroxypyrimidinone%2520carboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520profiles%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6646%26epage%3D6649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=350-353&author=A.+Petrocchiauthor=U.+Kochauthor=V.+G.+Matassaauthor=B.+Paciniauthor=K.+A.+Stillmockauthor=V.+Summa&title=From+dihydroxypyrimidine+carboxylic+acids+to+carboxamide+HIV-1+integrase+inhibitors%3A+SAR+around+the+amide+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DFrom%2520dihydroxypyrimidine%2520carboxylic%2520acids%2520to%2520carboxamide%2520HIV-1%2520integrase%2520inhibitors%253A%2520SAR%2520around%2520the%2520amide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D350%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Francesco, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2225</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070027u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2225-2239&author=P.+Paceauthor=M.+E.+Di+Francescoauthor=C.+Gardelliauthor=S.+Harperauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=A.+Petrocchiauthor=M.+Pomaauthor=M.+Rowleyauthor=R.+Scarpelliauthor=R.+Lauferauthor=P.+O.+Gonzalezauthor=E.+Monteagudoauthor=F.+Bonelliauthor=D.+Hazudaauthor=K.+A.+Stillmockauthor=V.+Summa&title=Dihydroxypyrimidine-4-carboxamides+as+novel+potent+and+selective+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm070027u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070027u%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DPoma%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DP.%2BO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDihydroxypyrimidine-4-carboxamides%2520as%2520novel%2520potent%2520and%2520selective%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2225%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P. Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J., Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025553u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=453-456&author=L.+Zhuangauthor=J.+S.+Waiauthor=M.+W.+Embreyauthor=T.+E.+Fisherauthor=M.+S.+Egbertsonauthor=L.+S.+Payneauthor=J.+P.+Jr.+Guareauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=A.+L.+Wolfeauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=G.+Moyerauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=Y.+M.+Leonardauthor=J.+J.%2C+Jr.+Lynchauthor=S.+R.+Michelsonauthor=S.+D.+Young&title=Design+and+synthesis+of+8-hydroxy-%5B1%2C6%5Dnaphthyridines+as+novel+inhibitors+of+HIV-1+integrase+in+vitro+and+in+infected+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells</span></div><div class="casAuthors">Zhuang, Linghang; Wai, John S.; Embrey, Mark W.; Fisher, Thorsten E.; Egbertson, Melissa S.; Payne, Linda S.; Guare, James P., Jr.; Vacca, Joseph P.; Hazuda, Daria J.; Felock, Peter J.; Wolfe, Abigail L.; Stillmock, Kara A.; Witmer, Marc V.; Moyer, Gregory; Schleif, William A.; Gabryelski, Lori J.; Leonard, Yvonne M.; Lynch, Joseph J., Jr.; Michelson, Stuart R.; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Naphthyridine I inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 μM.  I does not exhibit cytotoxicity in cell culture at ≤12.5 μM and shows a good pharmacokinetic profile when dosed orally to rats.  The antiviral activity of I and its effect on integration were confirmed using viruses with specific integrase mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOoGGcZHiJMLVg90H21EOLACvtfcHk0ljOCkbCWcdbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D&md5=486db25666b872e6ae3613cf49c458f2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm025553u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025553u%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%2BJr.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%252C%2BJr.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%25208-hydroxy-%255B1%252C6%255Dnaphthyridines%2520as%2520novel%2520inhibitors%2520of%2520HIV-1%2520integrase%2520in%2520vitro%2520and%2520in%2520infected%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D453%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span> </span><span class="NLM_article-title">Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">7005</span><span class="NLM_x">–</span> <span class="NLM_lpage">7011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=9261430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=7005-7011&author=D.+J.+Hazudaauthor=P.+J.+Felockauthor=J.+C.+Hastingsauthor=B.+Pramanikauthor=A.+L.+Wolfe&title=Differential+divalent+cation+requirements+uncouple+the+assembly+and+catalytic+reactions+of+human+immunodeficiency+virus+type+1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Differential divalent cation requirements uncoupled the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Felock, Peter J.; Hastings, Jeffrey C.; Pramanik, Bernali; Wolfe, Abigail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7005-7011</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Previous in vitro analyses have shown that the human immunodeficiency virus type 1 (HIV-1) integrase uses either manganese or magnesium to assemble as a stable complex on the donor substrate and to catalyze strand transfer.  We now demonstrate that subsequent to assembly, catalysis of both 3' end processing and strand transfer requires a divalent cation cofactor and that the divalent cation requirements for assembly and catalysis can be functionally distinguished based on the ability to utilize calcium and cobalt, resp.  The different divalent cation requirements manifest by these processes are exploited to uncouple assembly and catalysis, thus staging the reaction.  Staged 3' end processing and strand transfer assays are then used in conjunction with exonuclease III protection anal. to investigate the effects of integrase inhibitors on each step in the reaction.  Anal. of a series of related inhibitors demonstrates that these types of compds. affect assembly and not either catalytic process, therefore reconciling the apparent disparate results obtained for such inhibitors in assays using isolated pre-integration complexes.  These studies provide evidence for a distinct role of the divalent cation cofactor in assembly and catalysis and have implications for both the identification and characterization of integrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZfMUmmKmUirVg90H21EOLACvtfcHk0liFqN76oI_OQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D&md5=c5ce1c183540f6d4262e660181d59d6e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26atitle%3DDifferential%2520divalent%2520cation%2520requirements%2520uncouple%2520the%2520assembly%2520and%2520catalytic%2520reactions%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D7005%26epage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blahy, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlabach, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condra, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vastag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span> </span><span class="NLM_article-title">L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">4096</span><span class="NLM_x">–</span> <span class="NLM_lpage">4100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=4096-4100&author=J.+P.+Vaccaauthor=B.+D.+Dorseyauthor=W.+A.+Schleifauthor=R.+B.+Levinauthor=S.+L.+McDanielauthor=P.+L.+Darkeauthor=J.+Zugayauthor=J.+C.+Quinteroauthor=O.+M.+Blahyauthor=E.+Rothauthor=V.+V.+Sardanaauthor=A.+J.+Schlabachauthor=P.+I.+Grahamauthor=J.+H.+Condraauthor=L.+Gotlibauthor=M.+K.+Hollowayauthor=J.+Linauthor=I.+Chenauthor=K.+Vastagauthor=D.+Ostovicauthor=P.+S.+Andersonauthor=E.+A.+Eminiauthor=J.+R.+Huff&title=L-735%2C524%3A+an+orally+bioavailable+human+immunodeficiency+virus+type+1+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DLevin%26aufirst%3DR.%2BB.%26aulast%3DMcDaniel%26aufirst%3DS.%2BL.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DZugay%26aufirst%3DJ.%26aulast%3DQuintero%26aufirst%3DJ.%2BC.%26aulast%3DBlahy%26aufirst%3DO.%2BM.%26aulast%3DRoth%26aufirst%3DE.%26aulast%3DSardana%26aufirst%3DV.%2BV.%26aulast%3DSchlabach%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DP.%2BI.%26aulast%3DCondra%26aufirst%3DJ.%2BH.%26aulast%3DGotlib%26aufirst%3DL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DVastag%26aufirst%3DK.%26aulast%3DOstovic%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26atitle%3DL-735%252C524%253A%2520an%2520orally%2520bioavailable%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D4096%26epage%3D4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdirame, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable <i>N</i>-methyl pyrimidones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704705" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4953-4975&author=C.+Gardelliauthor=E.+Niziauthor=E.+Muragliaauthor=B.+Crescenziauthor=M.+Ferraraauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=M.+Pomaauthor=M.+Rico+Ferreiraauthor=R.+Scarpelliauthor=C.+F.+Homnickauthor=N.+Ikemotoauthor=A.+Alfieriauthor=M.+Verdirameauthor=F.+Bonelliauthor=O.+Gonzalez+Pazauthor=M.+Talianiauthor=E.+Monteagudoauthor=S.+Pesciauthor=L.+Lauferauthor=P.+Felockauthor=K.+A.+Stillmockauthor=D.+Hazudaauthor=M.+Rowleyauthor=V.+Summa&title=Discovery+and+synthesis+of+HIV+integrase+inhibitors%3A+development+of+potent+and+orally+bioavailable+N-methyl+pyrimidones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0704705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704705%26sid%3Dliteratum%253Aachs%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DPoma%26aufirst%3DM.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DIkemoto%26aufirst%3DN.%26aulast%3DAlfieri%26aufirst%3DA.%26aulast%3DVerdirame%26aufirst%3DM.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DL.%26aulast%3DFelock%26aufirst%3DP.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520HIV%2520integrase%2520inhibitors%253A%2520development%2520of%2520potent%2520and%2520orally%2520bioavailable%2520N-methyl%2520pyrimidones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4953%26epage%3D4975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span> </span><span class="NLM_article-title">Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7084</span><span class="NLM_x">–</span> <span class="NLM_lpage">7088</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050549e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7084-7088&author=M.+L.+Barrecaauthor=S.+Ferroauthor=A.+Raoauthor=L.+De+Lucaauthor=M.+Zappalaauthor=A.+M.+Monforteauthor=Z.+Debyserauthor=M.+Witvrouwauthor=A.+Chimirri&title=Pharmacophore-based+design+of+HIV-1+integrase+strand-transfer+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm050549e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050549e%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DZappala%26aufirst%3DM.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DChimirri%26aufirst%3DA.%26atitle%3DPharmacophore-based%2520design%2520of%2520HIV-1%2520integrase%2520strand-transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7084%26epage%3D7088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">A large variety of compounds (especially anionic) are reported to have high affinity for HSA (human serum albumin), which accounts for 60% of human serum proteins. This binding limits the amount of drug available and reduces the effective concentration of drug at the cellular target. See the following:</p></div><span class="NLM_contrib-group">Sheppard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidanze, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BaMaung, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedrow, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantei, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker-Garcia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniewski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span> </span><span class="NLM_article-title">Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3832</span><span class="NLM_x">–</span> <span class="NLM_lpage">3849</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3832-3849&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=S.+D.+Fidanzeauthor=N.+Y.+BaMaungauthor=S.+A.+Ericksonauthor=D.+M.+Barnesauthor=J.+S.+Tedrowauthor=L.+Kolaczkowskiauthor=A.+Vasudevanauthor=D.+C.+Parkauthor=G.+T.+Wangauthor=W.+J.+Sandersauthor=R.+A.+Manteiauthor=F.+Palazzoauthor=L.+Tucker-Garciaauthor=P.+Louauthor=Q.+Zhangauthor=C.+H.+Parkauthor=K.+H.+Kimauthor=A.+Petrosauthor=E.+Olejniczakauthor=D.+Nettesheimauthor=P.+Hajdukauthor=J.+Henkinauthor=R.+Lesniewskiauthor=S.+K.+Davidsenauthor=R.+L.+Bell&title=Discovery+and+optimization+of+anthranilic+acid+sulfonamides+as+inhibitors+of+methionine+aminopeptidase-2%3A+a+structural+basis+for+the+reduction+of+albumin+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0601001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601001%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DBarnes%26aufirst%3DD.%2BM.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DKolaczkowski%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DSanders%26aufirst%3DW.%2BJ.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DTucker-Garcia%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DPetros%26aufirst%3DA.%26aulast%3DOlejniczak%26aufirst%3DE.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DHajduk%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DBell%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520anthranilic%2520acid%2520sulfonamides%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%253A%2520a%2520structural%2520basis%2520for%2520the%2520reduction%2520of%2520albumin%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3832%26epage%3D3849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><div class="note"><p class="first last">Protein binding measurements were performed by ultrafiltration with Amicon Centrifree YM-30, after incubation at 37 °C for 1 h. The filtrate was analyzed by HPLC−MS−MS, operating in multiple reaction monitoring (MRM).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+binding+measurements+were+performed+by+ultrafiltration+with+Amicon+Centrifree+YM-30%2C+after+incubation+at+37+%C2%B0C+for+1+h.+The+filtrate+was+analyzed+by+HPLC%E2%88%92MS%E2%88%92MS%2C+operating+in+multiple+reaction+monitoring+%28MRM%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">Single-point measurement after 1 h. Experimental conditions: 2 µM compound, 1 mg/mL microsomes. The degradation of the compound in the presence of UDPGA (or NADPH) was measured by LC/MS/MS after 1 h of incubation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Single-point+measurement+after+1+h.+Experimental+conditions%3A+2+%C2%B5M+compound%2C+1+mg%2FmL+microsomes.+The+degradation+of+the+compound+in+the+presence+of+UDPGA+%28or+NADPH%29+was+measured+by+LC%2FMS%2FMS+after+1+h+of+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">Multiple-points measurement during 1 h. Experimental conditions: 1 µM compound, 1 mg/mL microsomes. The degradation of the compound in the presence of UDPGA and NADPH was measured by LC/MS/MS during 1 h of incubation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Multiple-points+measurement+during+1+h.+Experimental+conditions%3A+1+%C2%B5M+compound%2C+1+mg%2FmL+microsomes.+The+degradation+of+the+compound+in+the+presence+of+UDPGA+and+NADPH+was+measured+by+LC%2FMS%2FMS+during+1+h+of+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">A positive charge on a molecule is reported to often disrupt the high-affinity interaction with HSA (human serum albumin). See ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+positive+charge+on+a+molecule+is+reported+to+often+disrupt+the+high-affinity+interaction+with+HSA+%28human+serum+albumin%29.+See+ref+20."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">Single-point measurement after 1 h. Experimental conditions: 2 µM compound, 0.3 mg/mL microsomes. The degradation of the compound in the presence of UDPGA was measured by LC/MS/MS after 1 h of incubation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Single-point+measurement+after+1+h.+Experimental+conditions%3A+2+%C2%B5M+compound%2C+0.3+mg%2FmL+microsomes.+The+degradation+of+the+compound+in+the+presence+of+UDPGA+was+measured+by+LC%2FMS%2FMS+after+1+h+of+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2900</span><span class="NLM_x">–</span> <span class="NLM_lpage">2904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2900-2904&author=J.+P.+Guareauthor=J.+S.+Waiauthor=R.+P.+Gomezauthor=N.+J.+Anthonyauthor=S.+M.+Jollyauthor=A.+R.+Cortesauthor=J.+P.+Vaccaauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=W.+A.+Schleifauthor=G.+Moyerauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=D.+J.+Hazudaauthor=S.+D.+Young&title=A+series+of+5-aminosubstituted+4-fluorobenzyl-8-hydroxy-%5B1%2C6%5Dnaphthyridine-7-carboxamide+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DCortes%26aufirst%3DA.%2BR.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520series%2520of%25205-aminosubstituted%25204-fluorobenzyl-8-hydroxy-%255B1%252C6%255Dnaphthyridine-7-carboxamide%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2900%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motzel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tussey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casimiro, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiver, J. W.</span><span> </span><span class="NLM_article-title">Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=528-532&author=D.+J.+Hazudaauthor=S.+D.+Youngauthor=J.+P.+Guareauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=L.+Handtauthor=S.+L.+Motzelauthor=H.+J.+Kleinauthor=G.+Dornadulaauthor=R.+M.+Danovichauthor=M.+V.+Witmerauthor=K.+A.+Wilsonauthor=L.+Tusseyauthor=W.+A.+Schleifauthor=L.+S.+Gabryelskiauthor=L.+Jinauthor=M.+D.+Millerauthor=D.+R.+Casimiroauthor=E.+A.+Eminiauthor=J.+W.+Shiver&title=Integrase+inhibitors+and+cellular+immunity+suppress+retroviral+replication+in+rhesus+macaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHandt%26aufirst%3DL.%26aulast%3DMotzel%26aufirst%3DS.%2BL.%26aulast%3DKlein%26aufirst%3DH.%2BJ.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DDanovich%26aufirst%3DR.%2BM.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DWilson%26aufirst%3DK.%2BA.%26aulast%3DTussey%26aufirst%3DL.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DCasimiro%26aufirst%3DD.%2BR.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DShiver%26aufirst%3DJ.%2BW.%26atitle%3DIntegrase%2520inhibitors%2520and%2520cellular%2520immunity%2520suppress%2520retroviral%2520replication%2520in%2520rhesus%2520macaques%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D528%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Monteagudo, E.</span><div class="note"><p class="first last">Unpublished results.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Monteagudo%2C+E.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMonteagudo%26aufirst%3DE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M. D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6552</span><span class="NLM_x">–</span> <span class="NLM_lpage">6555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=6552-6555&author=O.+Kinzelauthor=E.+Monteagudoauthor=E.+Muragliaauthor=F.+Orvietoauthor=G.+Pescatoreauthor=M.+D.+R.+Rico+Ferreiraauthor=M.+Rowleyauthor=V.+Summa&title=The+synthesis+of+tetrahydropyridopyrimidones+as+a+new+scaffold+for+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%2BD.%2BR.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DThe%2520synthesis%2520of%2520tetrahydropyridopyrimidones%2520as%2520a%2520new%2520scaffold%2520for%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D6552%26epage%3D6555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Synthesis of an hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide derivative useful as HIV integrase inhibitor</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8379</span><span class="NLM_x">–</span> <span class="NLM_lpage">8382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=8379-8382&author=M.+Ferraraauthor=B.+Crescenziauthor=M.+Donghiauthor=E.+Muragliaauthor=E.+Niziauthor=S.+Pesciauthor=V.+Summaauthor=C.+Gardelli&title=Synthesis+of+an+hexahydropyrimido%5B1%2C2-a%5Dazepine-2-carboxamide+derivative+useful+as+HIV+integrase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520an%2520hexahydropyrimido%255B1%252C2-a%255Dazepine-2-carboxamide%2520derivative%2520useful%2520as%2520HIV%2520integrase%2520inhibitor%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D8379%26epage%3D8382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">Synthesis described in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Synthesis+described+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Katritzky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachwal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macomber, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. P.</span><span> </span><span class="NLM_article-title">Preparation of 6-, 7- and 8-membered sultams by Friedel−Crafts cyclization of ω-phenylalkanesulfamoyl chlorides</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=463-467&author=A.+R.+Katritzkyauthor=J.+Wuauthor=S.+Rachwalauthor=B.+Rachwalauthor=D.+W.+Macomberauthor=T.+P.+Smith&title=Preparation+of+6-%2C+7-+and+8-membered+sultams+by+Friedel%E2%88%92Crafts+cyclization+of+%CF%89-phenylalkanesulfamoyl+chlorides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRachwal%26aufirst%3DS.%26aulast%3DRachwal%26aufirst%3DB.%26aulast%3DMacomber%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DT.%2BP.%26atitle%3DPreparation%2520of%25206-%252C%25207-%2520and%25208-membered%2520sultams%2520by%2520Friedel%25E2%2588%2592Crafts%2520cyclization%2520of%2520%25CF%2589-phenylalkanesulfamoyl%2520chlorides%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2006%26volume%3D24%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Allie
Y. Chen, Rebecca N. Adamek, Benjamin L. Dick, Cy V. Credille, Christine N. Morrison, <span class="NLM_string-name hlFld-ContribAuthor">Seth M. Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Metalloenzymes for Therapeutic Intervention. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1323-1455. <a href="https://doi.org/10.1021/acs.chemrev.8b00201" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00201%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTargeting%252BMetalloenzymes%252Bfor%252BTherapeutic%252BIntervention%26aulast%3DChen%26aufirst%3DAllie%2BY.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29032018%26date%3D07092018%26volume%3D119%26issue%3D2%26spage%3D1323%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Horrick  Sharma</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Cheng</span>, and <span class="hlFld-ContribAuthor ">John K.  Buolamwini</span>  . </span><span class="cited-content_cbyCitation_article-title">Homology Model-Guided 3D-QSAR Studies of HIV-1 Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (2)
                                     , 515-544. <a href="https://doi.org/10.1021/ci200485a" title="DOI URL">https://doi.org/10.1021/ci200485a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200485a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200485a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHomology%252BModel-Guided%252B3D-QSAR%252BStudies%252Bof%252BHIV-1%252BIntegrase%252BInhibitors%26aulast%3DSharma%26aufirst%3DHorrick%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D12102011%26date%3D07022012%26date%3D27022012%26date%3D18012012%26volume%3D52%26issue%3D2%26spage%3D515%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Shao</span>, <span class="hlFld-ContribAuthor ">Leihong  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Fan</span>, and <span class="hlFld-ContribAuthor ">Yiyu  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Consensus Ranking Approach to Understanding the Underlying Mechanism With QSAR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2010,</strong> <em>50 </em>
                                    (11)
                                     , 1941-1948. <a href="https://doi.org/10.1021/ci100305g" title="DOI URL">https://doi.org/10.1021/ci100305g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100305g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100305g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DConsensus%252BRanking%252BApproach%252Bto%252BUnderstanding%252Bthe%252BUnderlying%252BMechanism%252BWith%252BQSAR%26aulast%3DShao%26aufirst%3DLi%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D9%252008%25202010%26date%3D04112010%26date%3D22112010%26volume%3D50%26issue%3D11%26spage%3D1941%26epage%3D1948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rojita  Sharma</span>, <span class="hlFld-ContribAuthor ">Paul G.  Bulger</span>, <span class="hlFld-ContribAuthor ">Michael  McNevin</span>, <span class="hlFld-ContribAuthor ">Peter G.  Dormer</span>, <span class="hlFld-ContribAuthor ">Richard G.  Ball</span>, <span class="hlFld-ContribAuthor ">Eric  Streckfuss</span>, <span class="hlFld-ContribAuthor ">James F.  Cuff</span>, <span class="hlFld-ContribAuthor ">Jingjun  Yin</span> and <span class="hlFld-ContribAuthor ">Cheng-yi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A Cascade Approach to Cyclic Aminonitrones: Reaction Discovery, Mechanism, and Scope. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2009,</strong> <em>11 </em>
                                    (15)
                                     , 3194-3197. <a href="https://doi.org/10.1021/ol9010147" title="DOI URL">https://doi.org/10.1021/ol9010147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol9010147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol9010147%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BCascade%252BApproach%252Bto%252BCyclic%252BAminonitrones%25253A%252BReaction%252BDiscovery%25252C%252BMechanism%25252C%252Band%252BScope%26aulast%3DSharma%26aufirst%3DRojita%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D10%252005%25202009%26date%3D02072009%26date%3D06082009%26volume%3D11%26issue%3D15%26spage%3D3194%26epage%3D3197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Li  Zhong</span>, <span class="hlFld-ContribAuthor ">Brenda  Pipik</span>, <span class="hlFld-ContribAuthor ">Jaemoon  Lee</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Kohmura</span>, <span class="hlFld-ContribAuthor ">Shigemitsu  Okada</span>, <span class="hlFld-ContribAuthor ">Kazunobu  Igawa</span>, <span class="hlFld-ContribAuthor ">Chie  Kadowaki</span>, <span class="hlFld-ContribAuthor ">Akihiro  Takezawa</span>, <span class="hlFld-ContribAuthor ">Shinji  Kato</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Anthony O.  King</span>, <span class="hlFld-ContribAuthor ">Robert A.  Reamer</span>, <span class="hlFld-ContribAuthor ">Donald R.  Gauthier, Jr.</span> and <span class="hlFld-ContribAuthor ">David  Askin</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Synthesis of a HIV Integrase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2008,</strong> <em>12 </em>
                                    (6)
                                     , 1245-1252. <a href="https://doi.org/10.1021/op800153y" title="DOI URL">https://doi.org/10.1021/op800153y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op800153y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop800153y%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPractical%252BSynthesis%252Bof%252Ba%252BHIV%252BIntegrase%252BInhibitor%26aulast%3DZhong%26aufirst%3DYong-Li%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D21%252011%25202008%26date%3D29%252010%25202008%26date%3D27%252006%25202008%26volume%3D12%26issue%3D6%26spage%3D1245%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gunther  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in 1,2,4-triazolo[1,5-a]pyrimidine chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-101. <a href="https://doi.org/10.1016/bs.aihch.2018.10.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252Badvances%252Bin%252B1%25252C2%25252C4-triazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bchemistry%26aulast%3DFischer%26aufirst%3DGunther%26date%3D2019%26spage%3D1%26epage%3D101%26pub%3DElsevier%26date%3D2019%26volume%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luana Janaína  de Campos</span>, <span class="hlFld-ContribAuthor ">Eduardo Borges  de Melo</span>. </span><span class="cited-content_cbyCitation_article-title">A QSAR study of integrase strand transfer inhibitors based on a large set of pyrimidine, pyrimidone, and pyridopyrazine carboxamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1141 </em>, 252-260. <a href="https://doi.org/10.1016/j.molstruc.2017.03.103" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.03.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.03.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.03.103%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DA%252BQSAR%252Bstudy%252Bof%252Bintegrase%252Bstrand%252Btransfer%252Binhibitors%252Bbased%252Bon%252Ba%252Blarge%252Bset%252Bof%252Bpyrimidine%25252C%252Bpyrimidone%25252C%252Band%252Bpyridopyrazine%252Bcarboxamide%252Bderivatives%26aulast%3Dde%2BCampos%26aufirst%3DLuana%2BJana%25C3%25ADna%26date%3D2017%26volume%3D1141%26spage%3D252%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulo A.  Machicao</span>, <span class="hlFld-ContribAuthor ">Scott R.  Burt</span>, <span class="hlFld-ContribAuthor ">Ryan K.  Christensen</span>, <span class="hlFld-ContribAuthor ">Nathan B.  Lohner</span>, <span class="hlFld-ContribAuthor ">J.D.  Singleton</span>, <span class="hlFld-ContribAuthor ">Matt A.  Peterson</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient microwave assisted synthesis of N′-aryl/(alkyl)-substituted N-(4-hydroxy-6-phenylpyrimidin-2-yl)guanidines: Scope and limitations. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (24)
                                     , 2318-2321. <a href="https://doi.org/10.1016/j.tetlet.2017.03.063" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.03.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.03.063%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bmicrowave%252Bassisted%252Bsynthesis%252Bof%252BN%2525E2%252580%2525B2-aryl%25252F%252528alkyl%252529-substituted%252BN-%2525284-hydroxy-6-phenylpyrimidin-2-yl%252529guanidines%25253A%252BScope%252Band%252Blimitations%26aulast%3DMachicao%26aufirst%3DPaulo%2BA.%26date%3D2017%26volume%3D58%26issue%3D24%26spage%3D2318%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imran  Khan</span>, <span class="hlFld-ContribAuthor ">Mushtaq A.  Tantray</span>, <span class="hlFld-ContribAuthor ">Hinna  Hamid</span>, <span class="hlFld-ContribAuthor ">Mohammad Sarwar  Alam</span>, <span class="hlFld-ContribAuthor ">Abul  Kalam</span>, <span class="hlFld-ContribAuthor ">Firasat  Hussain</span>, <span class="hlFld-ContribAuthor ">Abhijeet  Dhulap</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrimidin-4-one-1,2,3-triazole conjugates as glycogen synthase kinase-3β inhibitors with anti-depressant activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2016,</strong> <em>68 </em>, 41-55. <a href="https://doi.org/10.1016/j.bioorg.2016.07.007" title="DOI URL">https://doi.org/10.1016/j.bioorg.2016.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2016.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2016.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpyrimidin-4-one-1%25252C2%25252C3-triazole%252Bconjugates%252Bas%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitors%252Bwith%252Banti-depressant%252Bactivity%26aulast%3DKhan%26aufirst%3DImran%26date%3D2016%26volume%3D68%26spage%3D41%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loïc  Pantaine</span>, <span class="hlFld-ContribAuthor ">François  Richard</span>, <span class="hlFld-ContribAuthor ">Jérôme  Marrot</span>, <span class="hlFld-ContribAuthor ">Xavier  Moreau</span>, <span class="hlFld-ContribAuthor ">Vincent  Coeffard</span>, <span class="hlFld-ContribAuthor ">Christine  Greck</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Unsymmetrical Sulfamides
              via
              a Lossen-Like Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (12)
                                     , 2012-2016. <a href="https://doi.org/10.1002/adsc.201501139" title="DOI URL">https://doi.org/10.1002/adsc.201501139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201501139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201501139%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEfficient%252BSynthesis%252Bof%252BUnsymmetrical%252BSulfamides%252Bvia%252Ba%252BLossen-Like%252BRearrangement%26aulast%3DPantaine%26aufirst%3DLo%25C3%25AFc%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D12%26spage%3D2012%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan-Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Ya-Qin  Liu</span>, <span class="hlFld-ContribAuthor ">Xu-Sheng  Shao</span>, <span class="hlFld-ContribAuthor ">Zhi-Ping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Zhong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and insecticidal evaluation of tetrahydroimidazo[1,2- a ]pyridin-5(1 H )-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2016,</strong> <em>27 </em>
                                    (1)
                                     , 7-10. <a href="https://doi.org/10.1016/j.cclet.2015.10.002" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DSynthesis%252Band%252Binsecticidal%252Bevaluation%252Bof%252Btetrahydroimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridin-5%2525281%252BH%252B%252529-one%252Bderivatives%26aulast%3DLiu%26aufirst%3DXuan-Qi%26date%3D2016%26volume%3D27%26issue%3D1%26spage%3D7%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Shouyi  Xuan</span>, <span class="hlFld-ContribAuthor ">Yue  Feng</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting HIV-1 integrase with strand transfer inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (4)
                                     , 435-449. <a href="https://doi.org/10.1016/j.drudis.2014.12.001" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTargeting%252BHIV-1%252Bintegrase%252Bwith%252Bstrand%252Btransfer%252Binhibitors%26aulast%3DLi%26aufirst%3DYang%26date%3D2015%26volume%3D20%26issue%3D4%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongliang  Liu</span>, <span class="hlFld-ContribAuthor ">Kun  Wan</span>, <span class="hlFld-ContribAuthor ">Zengxue  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Fast, Microwave-Promoted One-Pot Synthesis of Bicyclic Pyrimidones from Baylis-Hillman Adducts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2015,</strong> <em>39 </em>
                                    (2)
                                     , 63-66. <a href="https://doi.org/10.3184/174751915X14199645231447" title="DOI URL">https://doi.org/10.3184/174751915X14199645231447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751915X14199645231447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751915X14199645231447%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DFast%25252C%252BMicrowave-Promoted%252BOne-Pot%252BSynthesis%252Bof%252BBicyclic%252BPyrimidones%252Bfrom%252BBaylis-Hillman%252BAdducts%26aulast%3DLiu%26aufirst%3DYongliang%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D2%26spage%3D63%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anahita  Ardakani</span>, <span class="hlFld-ContribAuthor ">Jahan B  Ghasemi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel inhibitors of HIV-1 integrase using pharmacophore-based virtual screening combined with molecular docking strategies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (11)
                                     , 5545-5556. <a href="https://doi.org/10.1007/s00044-013-0545-0" title="DOI URL">https://doi.org/10.1007/s00044-013-0545-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0545-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0545-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIdentification%252Bof%252Bnovel%252Binhibitors%252Bof%252BHIV-1%252Bintegrase%252Busing%252Bpharmacophore-based%252Bvirtual%252Bscreening%252Bcombined%252Bwith%252Bmolecular%252Bdocking%252Bstrategies%26aulast%3DArdakani%26aufirst%3DAnahita%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D11%26spage%3D5545%26epage%3D5556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuebing  Chen</span>, <span class="hlFld-ContribAuthor ">Dandan  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Wang</span>, <span class="hlFld-ContribAuthor ">Shengjiao  Yan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade reaction synthesis of multisubstituted bicyclic pyridone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (44)
                                     , 9224-9236. <a href="https://doi.org/10.1016/j.tet.2013.08.052" title="DOI URL">https://doi.org/10.1016/j.tet.2013.08.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.08.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.08.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCascade%252Breaction%252Bsynthesis%252Bof%252Bmultisubstituted%252Bbicyclic%252Bpyridone%252Bderivatives%26aulast%3DChen%26aufirst%3DXuebing%26date%3D2013%26volume%3D69%26issue%3D44%26spage%3D9224%26epage%3D9236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Ruji  Wang</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Hua  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Domino Synthesis of 4-Oxopyrimido[1,2-
              a
              ]indole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2013,</strong> <em>355 </em>
                                    (14-15)
                                     , 2928-2935. <a href="https://doi.org/10.1002/adsc.201300475" title="DOI URL">https://doi.org/10.1002/adsc.201300475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300475%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCopper-Catalyzed%252BDomino%252BSynthesis%252Bof%252B4-Oxopyrimido%25255B1%25252C2-%252Ba%252B%25255Dindole%252BDerivatives%26aulast%3DWang%26aufirst%3DYuyuan%26date%3D2013%26date%3D2013%26volume%3D355%26issue%3D14-15%26spage%3D2928%26epage%3D2935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anwar  Rayan</span>, <span class="hlFld-ContribAuthor ">Mizied  Falah</span>, <span class="hlFld-ContribAuthor ">Jamal  Raiyn</span>, <span class="hlFld-ContribAuthor ">Beny  Da'adoosh</span>, <span class="hlFld-ContribAuthor ">Sleman  Kadan</span>, <span class="hlFld-ContribAuthor ">Hilal  Zaid</span>, <span class="hlFld-ContribAuthor ">Amiram  Goldblum</span>. </span><span class="cited-content_cbyCitation_article-title">Indexing molecules for their hERG liability. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>65 </em>, 304-314. <a href="https://doi.org/10.1016/j.ejmech.2013.04.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.04.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.04.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndexing%252Bmolecules%252Bfor%252Btheir%252BhERG%252Bliability%26aulast%3DRayan%26aufirst%3DAnwar%26date%3D2013%26volume%3D65%26spage%3D304%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sihem  Hessainia</span>, <span class="hlFld-ContribAuthor ">Malika  Berredjem</span>, <span class="hlFld-ContribAuthor ">Souad  Ouarna</span>, <span class="hlFld-ContribAuthor ">Zinelaabidine  Cheraiet</span>, <span class="hlFld-ContribAuthor ">Nour-Eddine  Aouf</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Modified Sulfamides and Cyclosulfamides Containing Phosphonate Moieties. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2013,</strong> <em>188 </em>
                                    (6)
                                     , 719-725. <a href="https://doi.org/10.1080/10426507.2012.700356" title="DOI URL">https://doi.org/10.1080/10426507.2012.700356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2012.700356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2012.700356%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DEfficient%252BSynthesis%252Bof%252BModified%252BSulfamides%252Band%252BCyclosulfamides%252BContaining%252BPhosphonate%252BMoieties%26aulast%3DHessainia%26aufirst%3DSihem%26date%3D2013%26date%3D2013%26volume%3D188%26issue%3D6%26spage%3D719%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter K.  Quashie</span>, <span class="hlFld-ContribAuthor ">Thibault  Mesplède</span>, <span class="hlFld-ContribAuthor ">Mark A.  Wainberg</span>. </span><span class="cited-content_cbyCitation_article-title">HIV Drug Resistance and the Advent of Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Infectious Disease Reports</span><span> <strong>2013,</strong> <em>15 </em>
                                    (1)
                                     , 85-100. <a href="https://doi.org/10.1007/s11908-012-0305-1" title="DOI URL">https://doi.org/10.1007/s11908-012-0305-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11908-012-0305-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11908-012-0305-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Infectious%2520Disease%2520Reports%26atitle%3DHIV%252BDrug%252BResistance%252Band%252Bthe%252BAdvent%252Bof%252BIntegrase%252BInhibitors%26aulast%3DQuashie%26aufirst%3DPeter%2BK.%26date%3D2013%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D85%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Kasthuraiah  Maddali</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Mathieu  Métifiot</span>, <span class="hlFld-ContribAuthor ">Barry C.  Johnson</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7309-7313. <a href="https://doi.org/10.1016/j.bmcl.2012.10.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D6%25252C7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7309%26epage%3D7313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter K  Quashie</span>, <span class="hlFld-ContribAuthor ">Richard D  Sloan</span>, <span class="hlFld-ContribAuthor ">Mark A  Wainberg</span>. </span><span class="cited-content_cbyCitation_article-title">Novel therapeutic strategies targeting HIV integrase. </span><span class="cited-content_cbyCitation_journal-name">BMC Medicine</span><span> <strong>2012,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1741-7015-10-34" title="DOI URL">https://doi.org/10.1186/1741-7015-10-34</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1741-7015-10-34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1741-7015-10-34%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Medicine%26atitle%3DNovel%252Btherapeutic%252Bstrategies%252Btargeting%252BHIV%252Bintegrase%26aulast%3DQuashie%26aufirst%3DPeter%2BK%26date%3D2012%26date%3D2012%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Kasthuraiah  Maddali</span>, <span class="hlFld-ContribAuthor ">Mathieu  Metifiot</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">B. Christie  Vu</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Hydroxy-1H-pyrrolopyridine-trione Containing HIV-1 Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2012,</strong> <em>79 </em>
                                    (2)
                                     , 157-165. <a href="https://doi.org/10.1111/j.1747-0285.2011.01270.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2011.01270.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2011.01270.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2011.01270.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DBicyclic%252BHydroxy-1H-pyrrolopyridine-trione%252BContaining%252BHIV-1%252BIntegrase%252BInhibitors%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2012%26date%3D2011%26volume%3D79%26issue%3D2%26spage%3D157%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Wainberg</span>. </span><span class="cited-content_cbyCitation_article-title">The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Scientifica</span><span> <strong>2012,</strong> <em>2012 </em>, 1-28. <a href="https://doi.org/10.6064/2012/238278" title="DOI URL">https://doi.org/10.6064/2012/238278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.6064/2012/238278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.6064%2F2012%2F238278%26sid%3Dliteratum%253Aachs%26jtitle%3DScientifica%26atitle%3DThe%252BNeed%252Bfor%252BDevelopment%252Bof%252BNew%252BHIV-1%252BReverse%252BTranscriptase%252Band%252BIntegrase%252BInhibitors%252Bin%252Bthe%252BAftermath%252Bof%252BAntiviral%252BDrug%252BResistance%26aulast%3DWainberg%26aufirst%3DMark%2BA.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  Serrao</span>, <span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Jinxia  Deng</span>, <span class="hlFld-ContribAuthor ">Srinivas  Odde</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Techniques in Design of HIV-1 Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 389-413. <a href="https://doi.org/10.1002/9781118015377.ch26" title="DOI URL">https://doi.org/10.1002/9781118015377.ch26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118015377.ch26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118015377.ch26%26sid%3Dliteratum%253Aachs%26atitle%3DComputer-Aided%252BTechniques%252Bin%252BDesign%252Bof%252BHIV-1%252BIntegrase%252BInhibitors%26aulast%3DSerrao%26aufirst%3DErik%26date%3D2011%26date%3D2011%26spage%3D389%26epage%3D413%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DHIV-1%252BIntegrase%26aulast%3DNeamati%26aufirst%3DNouri%26date%3D2011%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas N.  Telvekar</span>, <span class="hlFld-ContribAuthor ">Kavitkumar N.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Development and Docking Studies of the HIV-1 Integrase Inhibitors Derived from N-methylpyrimidones, Dihydroxypyrimidines, and Bicyclic Pyrimidinones. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2011,</strong> <em>78 </em>
                                    (1)
                                     , 150-160. <a href="https://doi.org/10.1111/j.1747-0285.2011.01130.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2011.01130.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2011.01130.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2011.01130.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DPharmacophore%252BDevelopment%252Band%252BDocking%252BStudies%252Bof%252Bthe%252BHIV-1%252BIntegrase%252BInhibitors%252BDerived%252Bfrom%252BN-methylpyrimidones%25252C%252BDihydroxypyrimidines%25252C%252Band%252BBicyclic%252BPyrimidinones%26aulast%3DTelvekar%26aufirst%3DVikas%2BN.%26date%3D2011%26date%3D2011%26volume%3D78%26issue%3D1%26spage%3D150%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnout R. D.  Voet</span>, <span class="hlFld-ContribAuthor ">Marc  De Maeyer</span>, <span class="hlFld-ContribAuthor ">Frauke  Christ</span>, <span class="hlFld-ContribAuthor ">Zeger  Debyser</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Integration beyond Strand Transfer: Development of Second-Generation HIV Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 51-71. <a href="https://doi.org/10.1002/9783527635955.ch3" title="DOI URL">https://doi.org/10.1002/9783527635955.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527635955.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527635955.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BIntegration%252Bbeyond%252BStrand%252BTransfer%25253A%252BDevelopment%252Bof%252BSecond-Generation%252BHIV%252BIntegrase%252BInhibitors%26aulast%3DVoet%26aufirst%3DArnout%2BR.%2BD.%26date%3D2011%26date%3D2011%26spage%3D51%26epage%3D71%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DAntiviral%252BDrug%252BStrategies%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2011%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Kasthuraiah  Maddali</span>, <span class="hlFld-ContribAuthor ">Mathieu  Metifiot</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">B.  Christie Vu</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (10)
                                     , 2986-2990. <a href="https://doi.org/10.1016/j.bmcl.2011.03.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Btricyclic%252Bhydroxy-1H-pyrrolopyridine-trione%252Bcontaining%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2986%26epage%3D2990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kavya  Ramkumar</span>, <span class="hlFld-ContribAuthor ">Erik  Serrao</span>, <span class="hlFld-ContribAuthor ">Srinivas  Odde</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 integrase inhibitors: 2007-2008 update. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2010,</strong> <em>30 </em>
                                    (6)
                                     , 890-954. <a href="https://doi.org/10.1002/med.20194" title="DOI URL">https://doi.org/10.1002/med.20194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20194%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHIV-1%252Bintegrase%252Binhibitors%25253A%252B2007-2008%252Bupdate%26aulast%3DRamkumar%26aufirst%3DKavya%26date%3D2010%26date%3D2010%26volume%3D30%26issue%3D6%26spage%3D890%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian A.  Johns</span>. </span><span class="cited-content_cbyCitation_article-title">HIV
              Integrase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 75-106. <a href="https://doi.org/10.1002/0471266949.bmc225" title="DOI URL">https://doi.org/10.1002/0471266949.bmc225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc225%26sid%3Dliteratum%253Aachs%26atitle%3DHIV%252BIntegrase%26aulast%3DJohns%26aufirst%3DBrian%2BA.%26date%3D2010%26date%3D2010%26spage%3D75%26epage%3D106%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Cristina  Gardelli</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-pyrrolidinyl-N-methyl pyrimidones as potent and orally bioavailable HIV integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (17)
                                     , 5031-5034. <a href="https://doi.org/10.1016/j.bmcl.2010.07.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.07.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.07.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-pyrrolidinyl-N-methyl%252Bpyrimidones%252Bas%252Bpotent%252Band%252Borally%252Bbioavailable%252BHIV%252Bintegrase%252Binhibitors%26aulast%3DFerrara%26aufirst%3DMarco%26date%3D2010%26volume%3D20%26issue%3D17%26spage%3D5031%26epage%3D5034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Marc C.  Nicklaus</span>. </span><span class="cited-content_cbyCitation_article-title">Tautomerism and Magnesium Chelation of HIV-1 Integrase Inhibitors: A Theoretical Study. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (7)
                                     , 1053-1066. <a href="https://doi.org/10.1002/cmdc.201000039" title="DOI URL">https://doi.org/10.1002/cmdc.201000039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201000039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201000039%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTautomerism%252Band%252BMagnesium%252BChelation%252Bof%252BHIV-1%252BIntegrase%252BInhibitors%25253A%252BA%252BTheoretical%252BStudy%26aulast%3DLiao%26aufirst%3DChenzhong%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D7%26spage%3D1053%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuangxing  Guo</span>, <span class="hlFld-ContribAuthor ">Liming  Dong</span>, <span class="hlFld-ContribAuthor ">Susan  Kephart</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of sulfamides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (21)
                                     , 2909-2913. <a href="https://doi.org/10.1016/j.tetlet.2010.03.106" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.03.106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.03.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.03.106%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Bsulfamides%26aulast%3DGuo%26aufirst%3DChuangxing%26date%3D2010%26volume%3D51%26issue%3D21%26spage%3D2909%26epage%3D2913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Ramajayam</span>, <span class="hlFld-ContribAuthor ">Nilesh B.  Mahera</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>, <span class="hlFld-ContribAuthor ">Mange Ram  Yadav</span>, <span class="hlFld-ContribAuthor ">Rajani  Giridhar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HIV-1 Integrase Activitiy of Cyano Pyrimidinones. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2009,</strong> <em>342 </em>
                                    (12)
                                     , 710-715. <a href="https://doi.org/10.1002/ardp.200900066" title="DOI URL">https://doi.org/10.1002/ardp.200900066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.200900066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.200900066%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BAnti-HIV-1%252BIntegrase%252BActivitiy%252Bof%252BCyano%252BPyrimidinones%26aulast%3DRamajayam%26aufirst%3DR.%26date%3D2009%26volume%3D342%26issue%3D12%26spage%3D710%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnout RD  Voet</span>, <span class="hlFld-ContribAuthor ">Marc De  Maeyer</span>, <span class="hlFld-ContribAuthor ">Zeger  Debyser</span>, <span class="hlFld-ContribAuthor ">Frauke  Christ</span>. </span><span class="cited-content_cbyCitation_article-title">In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2009,</strong> <em>1 </em>
                                    (7)
                                     , 1259-1274. <a href="https://doi.org/10.4155/fmc.09.86" title="DOI URL">https://doi.org/10.4155/fmc.09.86</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.09.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.09.86%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bsearch%252Bof%252Bsecond-generation%252BHIV%252Bintegrase%252Binhibitors%25253A%252Btargeting%252Bintegration%252Bbeyond%252Bstrand%252Btransfer%26aulast%3DVoet%26aufirst%3DArnout%2BRD%26date%3D2009%26volume%3D1%26issue%3D7%26spage%3D1259%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessia  Petrocchi</span>, <span class="hlFld-ContribAuthor ">Philip  Jones</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (15)
                                     , 4245-4249. <a href="https://doi.org/10.1016/j.bmcl.2009.05.098" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.098%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DN-%2525284-Fluorobenzyl%252529-3-hydroxy-9%25252C9-dimethyl-4-oxo-6%25252C7%25252C8%25252C9-tetrahydro-4H-pyrazino%25255B1%25252C2-a%25255Dpyrimidine-2-carboxamides%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DPetrocchi%26aufirst%3DAlessia%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4245%26epage%3D4249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica  Donghi</span>, <span class="hlFld-ContribAuthor ">Olaf D.  Kinzel</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—A new class of HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (7)
                                     , 1930-1934. <a href="https://doi.org/10.1016/j.bmcl.2009.02.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3-Hydroxy-4-oxo-4H-pyrido%25255B1%25252C2-a%25255Dpyrimidine-2-carboxylates%2525E2%252580%252594A%252Bnew%252Bclass%252Bof%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DDonghi%26aufirst%3DMonica%26date%3D2009%26volume%3D19%26issue%3D7%26spage%3D1930%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralph  Laufer</span>, <span class="hlFld-ContribAuthor ">Odalys Gonzalez  Paz</span>, <span class="hlFld-ContribAuthor ">Annalise  Di Marco</span>, <span class="hlFld-ContribAuthor ">Fabio  Bonelli</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Prediction of Human Clearance Guiding the Development of Raltegravir (MK-0518, Isentress) and Related HIV Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2009,</strong> <em>37 </em>
                                    (4)
                                     , 873-883. <a href="https://doi.org/10.1124/dmd.108.023804" title="DOI URL">https://doi.org/10.1124/dmd.108.023804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.108.023804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.108.023804%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DQuantitative%252BPrediction%252Bof%252BHuman%252BClearance%252BGuiding%252Bthe%252BDevelopment%252Bof%252BRaltegravir%252B%252528MK-0518%25252C%252BIsentress%252529%252Band%252BRelated%252BHIV%252BIntegrase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DRalph%26date%3D2009%26date%3D2009%26volume%3D37%26issue%3D4%26spage%3D873%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amelia  Manlove</span>, <span class="hlFld-ContribAuthor ">Michael P.  Groziak</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.2: Six-Membered Ring Systems: Diazines and Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 375-414. <a href="https://doi.org/10.1016/S0959-6380(09)70040-6" title="DOI URL">https://doi.org/10.1016/S0959-6380(09)70040-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(09)70040-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2809%2970040-6%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.2%25253A%252BSix-Membered%252BRing%252BSystems%25253A%252BDiazines%252Band%252BBenzo%252BDerivatives%26aulast%3DManlove%26aufirst%3DAmelia%26date%3D2009%26spage%3D375%26epage%3D414%26pub%3DElsevier%26date%3D2009%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Peter P.  Molesworth</span>, <span class="hlFld-ContribAuthor ">John H.  Ryan</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 7: Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 491-530. <a href="https://doi.org/10.1016/S0959-6380(09)70044-3" title="DOI URL">https://doi.org/10.1016/S0959-6380(09)70044-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(09)70044-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2809%2970044-3%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B7%25253A%252BSeven-Membered%252BRings%26aulast%3DSmith%26aufirst%3DJason%2BA.%26date%3D2009%26spage%3D491%26epage%3D530%26pub%3DElsevier%26date%3D2009%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria del Rosario Rico  Ferreira</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Cecere</span>, <span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Routes to HIV-integrase inhibitors: efficient synthesis of bicyclic pyrimidones by ring expansion or amination at a benzylic position. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2009,</strong> <em>50 </em>
                                    (2)
                                     , 148-151. <a href="https://doi.org/10.1016/j.tetlet.2008.10.119" title="DOI URL">https://doi.org/10.1016/j.tetlet.2008.10.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2008.10.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2008.10.119%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRoutes%252Bto%252BHIV-integrase%252Binhibitors%25253A%252Befficient%252Bsynthesis%252Bof%252Bbicyclic%252Bpyrimidones%252Bby%252Bring%252Bexpansion%252Bor%252Bamination%252Bat%252Ba%252Bbenzylic%252Bposition%26aulast%3DFerreira%26aufirst%3DMaria%2Bdel%2BRosario%2BRico%26date%3D2009%26volume%3D50%26issue%3D2%26spage%3D148%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olaf D.  Kinzel</span>, <span class="hlFld-ContribAuthor ">Richard G.  Ball</span>, <span class="hlFld-ContribAuthor ">Monica  Donghi</span>, <span class="hlFld-ContribAuthor ">Courtney K.  Maguire</span>, <span class="hlFld-ContribAuthor ">Ester  Muraglia</span>, <span class="hlFld-ContribAuthor ">Silvia  Pesci</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—fast access to a heterocyclic scaffold for HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2008,</strong> <em>49 </em>
                                    (46)
                                     , 6556-6558. <a href="https://doi.org/10.1016/j.tetlet.2008.09.010" title="DOI URL">https://doi.org/10.1016/j.tetlet.2008.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2008.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2008.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3D3-Hydroxy-4-oxo-4H-pyrido%25255B1%25252C2-a%25255Dpyrimidine-2-carboxylates%2525E2%252580%252594fast%252Baccess%252Bto%252Ba%252Bheterocyclic%252Bscaffold%252Bfor%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DKinzel%26aufirst%3DOlaf%2BD.%26date%3D2008%26volume%3D49%26issue%3D46%26spage%3D6556%26epage%3D6558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Stéphane A.H.  Spieser</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (14)
                                     , 3865-3869. <a href="https://doi.org/10.1016/j.bmcl.2008.06.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.06.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.06.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Hydroxy-5-pyrrolinone-3-carboxamide%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DPace%26aufirst%3DPaola%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D3865%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0015.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Evolution from dihydroxypyrimidine to <i>N</i>-methylpyrimidinones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Strategic approach from <i>N</i>-methylpyrimidinones to bicyclic pyrimidinones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat oral administration of (<i>S</i>)-<b>28c</b>, exposure dose proportionality.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The po dosing of (<i>S</i>)-<b>28c</b> (potassium salt) at 10 mg/kg in three preclinical species.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0012.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Unsubstituted Bicyclic Pyrimidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzoic anhydride, pyridine or THF; (b) 4-fluorobenzylamine, MeOH, 60 °C.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0013.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Substituted Bicyclic Pyrimidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>, reflux; (b) R<sup>1</sup>R<sup>2</sup>NH, DMF; (c) 4-fluorobenzylamine, MeOH, 60 °C; (d) H<sub>2</sub> atmospheric pressure, 10% Pd/C, MeOH; (e) appropriate acyl chloride (or sulfonyl chloride or sulfamoyl chloride), base or carboxylic acid, coupling reagent; (f) for <b>40a</b>, to obtain <b>7a</b>, 37% HCHO, NaCNBH<sub>3</sub>, AcONa, MeOH; (g) (1) Boc<sub>2</sub>O, dioxane; (2) 4 M HCl/dioxane.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/medium/jm-2007-01164t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0014.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Chiral Pyrimidinone Benzylamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701164t/production/images/large/jm-2007-01164t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701164t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-fluorobenzylamine, MeOH, 65 °C, 3 h. (b) For (<i>R</i>)/(<i>S</i>)-<b>17b</b>: HOBt, EDC, DIPEA, [(dimethylamino)sulfonyl]acetic acid, DMF, room temperature, 24 h. (c) For (<i>R</i>)/(<i>S</i>)-<b>22b</b> and (<i>R</i>)/(<i>S</i>)-<b>27b</b>: appropriate sulfamoyl chloride, DCM, TEA, room temperature, 90 min. (d) For (<i>R</i>)/(<i>S</i>)-<b>28b</b>: (1) methyl chlorooxoacetate, TEA, DCM, room temperature, 50 min; (2) 2 M <i>N</i>,<i>N</i>-dimethylamine/THF, 55 °C, 16 h. (e) For (<i>R</i>)/(<i>S</i>)-<b>28c</b>: potassium (dimethylamino)(oxo)acetate, HOBt, EDC, TEA, DCM, room temperature overnight.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Emerging anti-HIV drugs</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1517%2F14728214.10.2.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=15934866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=241-273&author=E.+De+Clercq&title=Emerging+anti-HIV+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging anti-HIV drugs</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-274</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There are now exactly 20 anti-HIV drugs licenced (approved) for clin. use, and > 30 anti-HIV compds. under (pre)clin. development.  The licenced anti-HIV drugs fall into five categories: nucleoside reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine); nucleotide reverse transcriptase inhibitors (NtRTIs: tenofovir disproxil fumarate); non-nucleoside reverse transcriptase inhibitors (NNRTIs: nevirapine, delavirdine and efavirenz); protease inhibitors (PIs: saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, lopinavir, atazanavir and fosamprenavir); and fusion inhibitors (FIs: enfuvirtide).  The compds. that are currently under clin. (Phase I, II or III) or preclin. investigation are either targeted at the same specific viral proteins as the licenced compds. (i.e., reverse transcriptase [NRTIs: PSI-5004, (-)-dOTC, DPC-817, elvucitabine, alovudine, MIV-210, amdoxovir, DOT; NNRTIs: thiocarboxanilide, UC-781, capravirine, dapivirine, etravirine, rilpivirine], protease [PIs: tipranavir, TMC-114]) or other specific viral proteins (i.e., gp120: cyanovirin N; attachment inhibitors: Als, such as BMS-488043; integrase: L-870,812, PDPV-165; capsid proteins: PA-457, α-HCG); or cellular proteins (CD4 down-modulators: CADAs; CXCR4 antagonists: AMD-070, CS-3955; CCR5 antagonists: TAK-220, SCH-D, AK-602, UK-427857).  Combination therapy is likely to remain the gold std. for the treatment of AIDS so as to maximize potency, minimize toxicity and diminish the risk for resistance development.  Ideally, pill burden should be reduced to once-daily dosing so as to optimize the patient's compliance and reduce the treatment costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxT0HJuG64arVg90H21EOLACvtfcHk0lhzAfGtqSPauA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D&md5=8b3186fe7585205c72c9bb25c6493382</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.2.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.2.241%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DEmerging%2520anti-HIV%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D241%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">New approaches toward anti-HIV chemotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040158k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1297-1313&author=E.+De+Clercq&title=New+approaches+toward+anti-HIV+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm040158k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040158k%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DNew%2520approaches%2520toward%2520anti-HIV%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1297%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="note"><p class="first last">Recent reviews on HIV-1 protease inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condra, J. H.</span><span> </span><span class="NLM_article-title">Clinically effective HIV-1 protease inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=261-272&author=J.+P.+Vaccaauthor=J.+H.+Condra&title=Clinically+effective+HIV-1+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DCondra%26aufirst%3DJ.%2BH.%26atitle%3DClinically%2520effective%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1997%26volume%3D2%26spage%3D261%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lebon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledecq, M.</span><span> </span><span class="NLM_article-title">Approaches to the design of effective HIV-1 protease inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=10702619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslOju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=455-477&author=F.+Lebonauthor=M.+Ledecq&title=Approaches+to+the+design+of+effective+HIV-1+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to the design of effective HIV-1 protease inhibitors</span></div><div class="casAuthors">Lebon, F.; Ledecq, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">455-477</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 174 refs.  Recently, western countries have recorded a decrease in the death rate imputed to AIDS.  This success has been largely attributed to the presence on the market of chemotherapies that inhibit the infectivity of the predominant causative agent, the HIV-1 virus, by targeting essential viral enzymes.  One of these is the protease (HIV-1 PR) whose activity is a prerequisite for viral replication.  Two main sites have been identified as potential targets for the inhibition of HIV-1 PR, the active site and the interface, the latter being largely responsible for the stabilization of the enzyme dimeric structure.  The compds. that have reached clin. application so far target the active site of HIV-1 PR.  These mols. act as transition state analogs and result from modifications of the peptidic scaffold into peptidomimetics.  In order to improve their bioavailability, systematic biol. screening and de novo design have been used to suggest new non-peptide inhibitors combining both antiviral potency and favorable pharmacokinetic properties.  In parallel, compds. targeting other potential sites of inhibition have been tested.  Peptides and peptidomimetics based on the terminal sequence of the enzyme, a site which is proposed to be less susceptible to mutations, have been shown to lead to HIV-1 PR inactivation.  Cupric ion was described to bind a sequence on the protease surface, which includes cysteine and histidine residues, leading to the inhibition of the enzyme.  In the future, these non-active site inhibitors could provide an alternative in anti-HIV drug combination strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJUIPwMy52abVg90H21EOLACvtfcHk0lhzAfGtqSPauA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslOju7g%253D&md5=5fd57fe306714a39a94832b6b6b149e3</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DF.%26aulast%3DLedecq%26aufirst%3DM.%26atitle%3DApproaches%2520to%2520the%2520design%2520of%2520effective%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D455%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="note"><p class="first last">Recent reviews on HIV-1 reverse transcriptase inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hogberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, I.</span><span> </span><span class="NLM_article-title">HIV-1 non-nucleoside reverse transcriptase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1189</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1517%2F13543776.10.8.1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1189-1199&author=M.+Hogbergauthor=I.+Morrison&title=HIV-1+non-nucleoside+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 non-nucleoside reverse transcriptase inhibitors</span></div><div class="casAuthors">Hogberg, Marita; Morrison, Iain</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1189-1199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 81 refs.  Two classes of anti-HIV drugs are currently marketed which target the HIV-1 reverse transcriptase (RT).  The first explored class was the nucleoside RT inhibitors (NRTIs), such as AZT, ddI, ddC, 3TC, D4T and abacavir, whereas the more recently launched class are the non-nucleoside RT inhibitors (NNRTI) currently comprising nevirapine (Viramune, Boehringer Ingelheim), delavirdine (Rescriptor, Pharmacia and Upjohn) and efavirenz (Sustiva, Dupont Pharmaceuticals).  The NNRTI class is in rapid development to find more clin. useful inhibitors, esp. against inhibitor-induced mutant RT enzymes.  This article covers development in the area of HIV-1 NNRTI from 1997 through early 2000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAqqXk7Wlu7Vg90H21EOLACvtfcHk0lhfoGDvXsxY7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu78%253D&md5=172ca0b4d5ef2baa01223d8e9e6bc100</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.8.1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.8.1189%26sid%3Dliteratum%253Aachs%26aulast%3DHogberg%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DI.%26atitle%3DHIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2000%26volume%3D10%26spage%3D1189%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jonckheere, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The HIV-1 reverse transcription (RT) process as target for RT inhibitors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C129%3A%3AAID-MED2%3E3.0.CO%3B2-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=10723025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=129-154&author=H.+Jonckheereauthor=J.+Anneauthor=E.+De+Clercq&title=The+HIV-1+reverse+transcription+%28RT%29+process+as+target+for+RT+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The HIV-1 reverse transcription (RT) process as target for RT inhibitors</span></div><div class="casAuthors">Jonckheere, Heidi; Anne, Jozef; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-154</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 159 refs.  Since the Human Immunodeficiency Virus Type 1 (HIV-1) was identified as the etiol. agent of the Acquired Immune Deficiency Syndrome (AIDS), the HIV-1 reverse transcriptase (RT) has been the subject of intensive study.  The reverse transcription entails the transition of the single-stranded viral RNA into double-stranded proviral DNA, which is then integrated into the host chromosome.  Therefore, the HIV-1 reverse transcriptase plays a pivotal role in the life cycle of the virus and is consequently an interesting target for anti-HIV drug therapy.  In the first section, we describe the complex process of reverse transcription and the different activities involved in this process.  We then highlight the structure-function relation of the HIV-1 reverse transcriptase, which is of great importance for a better understanding of resistance development, a major problem in anti-AIDS therapies.  Finally, we summarize the mechanisms of HIV resistance toward various RT inhibitors and the implications thereof for the current anti-HIV drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhZ0q1oTzLrVg90H21EOLACvtfcHk0lhfoGDvXsxY7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVeisLk%253D&md5=9cb8fcc59e71376492d44a2ebf2e69a8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C129%3A%3AAID-MED2%3E3.0.CO%3B2-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200003%252920%253A2%253C129%253A%253AAID-MED2%253E3.0.CO%253B2-A%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DH.%26aulast%3DAnne%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520HIV-1%2520reverse%2520transcription%2520%2528RT%2529%2520process%2520as%2520target%2520for%2520RT%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D129%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">De Clerck, E.</span><span> </span><span class="NLM_article-title">Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1016%2FS0014-827X%2898%2900103-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=10321027" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=26&author=E.+De+Clerck&title=Perspectives+of+non-nucleoside+reverse+transcriptase+inhibitors+%28NNRTIs%29+in+the+therapy+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2898%2900103-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252898%252900103-7%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClerck%26aufirst%3DE.%26atitle%3DPerspectives%2520of%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520%2528NNRTIs%2529%2520in%2520the%2520therapy%2520of%2520HIV-1%2520infection%26jtitle%3DFarmaco%26date%3D1999%26volume%3D54%26spage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Williams, I. G.</span><span> </span><span class="NLM_article-title">Enfuvirtide (Fuzeon): the first fusion inhibitor</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=14712892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=890-897&author=I.+G.+Williams&title=Enfuvirtide+%28Fuzeon%29%3A+the+first+fusion+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Enfuvirtide (Fuzeon): the first fusion inhibitor</span></div><div class="casAuthors">Williams, I. G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">890-897</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  With the no. of people living with HIV infection increasing and the problems of drug resistance and long-term toxicity assocd. with current antiretroviral agents continuing, there is a growing need for new therapy options.  Enfuvirtide is the first fusion inhibitor, a new class of drug, to be licensed for the treatment of HIV infection and is a welcome addn. to the arsenal of antiretrovirals.  This paper, which is the result of a multidisciplinary discussion meeting, reviews current practice in treating HIV infection, the clin. data available on enfuvirtide and discusses its introduction into clin. practice.  Data available to date indicate that enfuvirtide is appropriate for use in patients who have previously taken nucleoside reverse transcriptase inhibitor (NRTI), non-NRTI and protease inhibitor contg. regimens and are either intolerant of them or have experienced virol. failure.  Enfuvirtide should ideally be used while the patient still has other active drug options available to them to combine with enfuvirtide in an effective therapy regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhh-V4eohSi7Vg90H21EOLACvtfcHk0lhfoGDvXsxY7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlKgtg%253D%253D&md5=d9019607cdf3eac15e3d01ec7a55413d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DI.%2BG.%26atitle%3DEnfuvirtide%2520%2528Fuzeon%2529%253A%2520the%2520first%2520fusion%2520inhibitor%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2003%26volume%3D57%26spage%3D890%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mocroft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiesi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargalianos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Arminio, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yust, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruun, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, J. D.</span><span> </span><span class="NLM_article-title">Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=1725-1730&author=A.+Mocroftauthor=S.+Vellaauthor=T.+L.+Benfieldauthor=A.+Chiesiauthor=V.+Millerauthor=P.+Gargalianosauthor=M.+A.+d%E2%80%99Arminioauthor=I.+Yustauthor=J.+N.+Bruunauthor=A.+N.+Phillipsauthor=J.+D.+Lundgren&title=Changing+patterns+of+mortality+across+Europe+in+patients+infected+with+HIV-1.+EuroSIDA+Study+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMocroft%26aufirst%3DA.%26aulast%3DVella%26aufirst%3DS.%26aulast%3DBenfield%26aufirst%3DT.%2BL.%26aulast%3DChiesi%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DV.%26aulast%3DGargalianos%26aufirst%3DP.%26aulast%3Dd%25E2%2580%2599Arminio%26aufirst%3DM.%2BA.%26aulast%3DYust%26aufirst%3DI.%26aulast%3DBruun%26aufirst%3DJ.%2BN.%26aulast%3DPhillips%26aufirst%3DA.%2BN.%26aulast%3DLundgren%26aufirst%3DJ.%2BD.%26atitle%3DChanging%2520patterns%2520of%2520mortality%2520across%2520Europe%2520in%2520patients%2520infected%2520with%2520HIV-1.%2520EuroSIDA%2520Study%2520Group%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D1725%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Palella, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveless, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satten, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmberg, S. D.</span><span> </span><span class="NLM_article-title">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1056%2FNEJM199803263381301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=9516219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=853-860&author=F.+J.+Palellaauthor=K.+M.+Delaneyauthor=A.+C.+Moormanauthor=M.+O.+Lovelessauthor=J.+Fuhrerauthor=G.+A.+Sattenauthor=D.+J.+Aschmanauthor=S.+D.+Holmberg&title=Declining+morbidity+and+mortality+among+patients+with+advanced+human+immunodeficiency+virus+infection.+HIV+Outpatient+Study+Investigators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</span></div><div class="casAuthors">Palella F J Jr; Delaney K M; Moorman A C; Loveless M O; Fuhrer J; Satten G A; Aschman D J; Holmberg S D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">853-60</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  National surveillance data show recent, marked reductions in morbidity and mortality associated with the acquired immunodeficiency syndrome (AIDS).  To evaluate these declines, we analyzed data on 1255 patients, each of whom had at least one CD4+ count below 100 cells per cubic millimeter, who were seen at nine clinics specializing in the treatment of human immunodeficiency virus (HIV) infection in eight U.S. cities from January 1994 through June 1997.  RESULTS:  Mortality among the patients declined from 29.4 per 100 person-years in the first quarter of 1995 to 8.8 per 100 in the second quarter of 1997.  There were reductions in mortality regardless of sex, race, age, and risk factors for transmission of HIV.  The incidence of any of three major opportunistic infections (Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, and cytomegalovirus retinitis) declined from 21.9 per 100 person-years in 1994 to 3.7 per 100 person-years by mid-1997.  In a failure-rate model, increases in the intensity of antiretroviral therapy (classified as none, monotherapy, combination therapy without a protease inhibitor, and combination therapy with a protease inhibitor) were associated with stepwise reductions in morbidity and mortality.  Combination antiretroviral therapy was associated with the most benefit; the inclusion of protease inhibitors in such regimens conferred additional benefit.  Patients with private insurance were more often prescribed protease inhibitors and had lower mortality rates than those insured by Medicare or Medicaid.  CONCLUSIONS:  The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6uVwzPlrzo4IRAdBLKY41fW6udTcc2eZB45WXkCYhLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D&md5=63bd6978cc957517f4bcfae251adc3ef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803263381301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803263381301%26sid%3Dliteratum%253Aachs%26aulast%3DPalella%26aufirst%3DF.%2BJ.%26aulast%3DDelaney%26aufirst%3DK.%2BM.%26aulast%3DMoorman%26aufirst%3DA.%2BC.%26aulast%3DLoveless%26aufirst%3DM.%2BO.%26aulast%3DFuhrer%26aufirst%3DJ.%26aulast%3DSatten%26aufirst%3DG.%2BA.%26aulast%3DAschman%26aufirst%3DD.%2BJ.%26aulast%3DHolmberg%26aufirst%3DS.%2BD.%26atitle%3DDeclining%2520morbidity%2520and%2520mortality%2520among%2520patients%2520with%2520advanced%2520human%2520immunodeficiency%2520virus%2520infection.%2520HIV%2520Outpatient%2520Study%2520Investigators%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D853%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=11727305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVKktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=402-410&author=S.+D.+Young&title=Inhibition+of+HIV-1+integrase+by+small+molecules%3A+the+potential+for+a+new+class+of+AIDS+chemotherapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics</span></div><div class="casAuthors">Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-410</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  HIV-1 integrase, one of three constitutive viral enzymes required for replication, is an attractive target for chemotherapeutic intervention in the treatment of AIDS.  Unlike the retroviral reverse transcriptase and protease enzymes, successful drug candidates based on the inhibition of integrase have yet to emerge despite the multitude of labs. working on the problem.  In vitro inhibition of integrase in the lab. has not always led to antiviral activity in cell culture.  Indeed, most compds. found from broad screening efforts have fallen into this category.  Only recently have compds. that inhibit enzymic function as well as exhibiting an antiviral effect as a result been discovered.  The reasons why certain structural classes of compds. fail to have antiviral activity are only beginning to be understood.  In the last two years a new class of compds. has emerged that do produce potent inhibition of viral growth in cell culture.  Further work in this area may yet produce clin. useful antiviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnA06YtuzfyLVg90H21EOLACvtfcHk0li_YSdZEjwHDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVKktbw%253D&md5=c713eded33ecdee563df0825ce625fd8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DInhibition%2520of%2520HIV-1%2520integrase%2520by%2520small%2520molecules%253A%2520the%2520potential%2520for%2520a%2520new%2520class%2520of%2520AIDS%2520chemotherapeutics%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D402%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">Reviews on biology of HIV-1 integrase:</p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Esposito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craigie, R.</span><span> </span><span class="NLM_article-title">HIV integrase structure and function</span> <span class="citation_source-journal">Adv. Virus Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=319-333&author=D.+Espositoauthor=R.+Craigie&title=HIV+integrase+structure+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DCraigie%26aufirst%3DR.%26atitle%3DHIV%2520integrase%2520structure%2520and%2520function%26jtitle%3DAdv.%2520Virus%2520Res.%26date%3D1999%26volume%3D52%26spage%3D319%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Asante-Appiah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalka, A. M.</span><span> </span><span class="NLM_article-title">HIV-1 integrase: structural organization, conformational changes, and catalysis</span> <span class="citation_source-journal">Adv. Virus Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=351-369&author=E.+Asante-Appiahauthor=A.+M.+Skalka&title=HIV-1+integrase%3A+structural+organization%2C+conformational+changes%2C+and+catalysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DSkalka%26aufirst%3DA.%2BM.%26atitle%3DHIV-1%2520integrase%253A%2520structural%2520organization%252C%2520conformational%2520changes%252C%2520and%2520catalysis%26jtitle%3DAdv.%2520Virus%2520Res.%26date%3D1999%26volume%3D52%26spage%3D351%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span> </span><span class="NLM_article-title">Integrase inhibitors to treat HIV/AIDS</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701164t&amp;key=10.1038%2Fnrd1660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=15729361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=236-248&author=Y.+Pommierauthor=A.+A.+Johnsonauthor=C.+Marchand&title=Integrase+inhibitors+to+treat+HIV%2FAIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Integrase inhibitors to treat HIV/Aids</span></div><div class="casAuthors">Pommier, Yves; Johnson, Allison A.; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">236-248</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HIV integrase is a rational target for treating HIV infection and preventing AIDS.  It took approx. 12 years to develop clin. usable inhibitors of integrase, and Phase I clin. trials of integrase inhibitors have just begun.  This review focuses on the mol. basis and rationale for developing integrase inhibitors.  The main classes of lead compds. are also described, as well as the concept of interfacial inhibitors of protein-nucleic-acid interactions that might apply to the clin. used strand-transfer inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNsYgtGiwZwrVg90H21EOLACvtfcHk0liTrVHv6CqzPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslSns70%253D&md5=3432f5d60165401adc118eb752c461a3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd1660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1660%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DA.%2BA.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DIntegrase%2520inhibitors%2520to%2520treat%2520HIV%252FAIDS%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D236%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Discovery, Synthesis and Optimization of a New Series of Selective HIV Integrase Inhibitors Leading to MK-0518 Currently in Phase III Clinical Trial for Treatment of HIV/AIDS</span>.  <span class="citation_source-book">Abstracts of Papers</span>, <span class="NLM_conf-name">232nd National Meeting of the American Chemical Society</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">Sep 10–14, 2006</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=V.+Summa&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDiscovery%252C%2520Synthesis%2520and%2520Optimization%2520of%2520a%2520New%2520Series%2520of%2520Selective%2520HIV%2520Integrase%2520Inhibitors%2520Leading%2520to%2520MK-0518%2520Currently%2520in%2520Phase%2520III%2520Clinical%2520Trial%2520for%2520Treatment%2520of%2520HIV%252FAIDS%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span> </span><span class="NLM_article-title">4,5-Dihydroxypyrimidine carboxamides and <i>N</i>-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6649</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060854f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6646-6649&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=C.+Gardelliauthor=E.+Muragliaauthor=M.+Rowleyauthor=O.+G.+Pazauthor=R.+Lauferauthor=E.+Monteagudoauthor=P.+Pace&title=4%2C5-Dihydroxypyrimidine+carboxamides+and+N-alkyl-5-hydroxypyrimidinone+carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+profiles+in+preclinical+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm060854f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060854f%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DPaz%26aufirst%3DO.%2BG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26atitle%3D4%252C5-Dihydroxypyrimidine%2520carboxamides%2520and%2520N-alkyl-5-hydroxypyrimidinone%2520carboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520profiles%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6646%26epage%3D6649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=350-353&author=A.+Petrocchiauthor=U.+Kochauthor=V.+G.+Matassaauthor=B.+Paciniauthor=K.+A.+Stillmockauthor=V.+Summa&title=From+dihydroxypyrimidine+carboxylic+acids+to+carboxamide+HIV-1+integrase+inhibitors%3A+SAR+around+the+amide+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DFrom%2520dihydroxypyrimidine%2520carboxylic%2520acids%2520to%2520carboxamide%2520HIV-1%2520integrase%2520inhibitors%253A%2520SAR%2520around%2520the%2520amide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D350%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Francesco, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2225</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070027u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2225-2239&author=P.+Paceauthor=M.+E.+Di+Francescoauthor=C.+Gardelliauthor=S.+Harperauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=A.+Petrocchiauthor=M.+Pomaauthor=M.+Rowleyauthor=R.+Scarpelliauthor=R.+Lauferauthor=P.+O.+Gonzalezauthor=E.+Monteagudoauthor=F.+Bonelliauthor=D.+Hazudaauthor=K.+A.+Stillmockauthor=V.+Summa&title=Dihydroxypyrimidine-4-carboxamides+as+novel+potent+and+selective+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm070027u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070027u%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DPoma%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DP.%2BO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDihydroxypyrimidine-4-carboxamides%2520as%2520novel%2520potent%2520and%2520selective%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2225%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P. Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J., Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025553u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=453-456&author=L.+Zhuangauthor=J.+S.+Waiauthor=M.+W.+Embreyauthor=T.+E.+Fisherauthor=M.+S.+Egbertsonauthor=L.+S.+Payneauthor=J.+P.+Jr.+Guareauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=A.+L.+Wolfeauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=G.+Moyerauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=Y.+M.+Leonardauthor=J.+J.%2C+Jr.+Lynchauthor=S.+R.+Michelsonauthor=S.+D.+Young&title=Design+and+synthesis+of+8-hydroxy-%5B1%2C6%5Dnaphthyridines+as+novel+inhibitors+of+HIV-1+integrase+in+vitro+and+in+infected+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells</span></div><div class="casAuthors">Zhuang, Linghang; Wai, John S.; Embrey, Mark W.; Fisher, Thorsten E.; Egbertson, Melissa S.; Payne, Linda S.; Guare, James P., Jr.; Vacca, Joseph P.; Hazuda, Daria J.; Felock, Peter J.; Wolfe, Abigail L.; Stillmock, Kara A.; Witmer, Marc V.; Moyer, Gregory; Schleif, William A.; Gabryelski, Lori J.; Leonard, Yvonne M.; Lynch, Joseph J., Jr.; Michelson, Stuart R.; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Naphthyridine I inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 μM.  I does not exhibit cytotoxicity in cell culture at ≤12.5 μM and shows a good pharmacokinetic profile when dosed orally to rats.  The antiviral activity of I and its effect on integration were confirmed using viruses with specific integrase mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOoGGcZHiJMLVg90H21EOLACvtfcHk0lgsd4PvDzTCqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D&md5=486db25666b872e6ae3613cf49c458f2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm025553u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025553u%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%2BJr.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%252C%2BJr.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%25208-hydroxy-%255B1%252C6%255Dnaphthyridines%2520as%2520novel%2520inhibitors%2520of%2520HIV-1%2520integrase%2520in%2520vitro%2520and%2520in%2520infected%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D453%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span> </span><span class="NLM_article-title">Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">7005</span><span class="NLM_x">–</span> <span class="NLM_lpage">7011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701164t&amp;key=9261430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701164t&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=7005-7011&author=D.+J.+Hazudaauthor=P.+J.+Felockauthor=J.+C.+Hastingsauthor=B.+Pramanikauthor=A.+L.+Wolfe&title=Differential+divalent+cation+requirements+uncouple+the+assembly+and+catalytic+reactions+of+human+immunodeficiency+virus+type+1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Differential divalent cation requirements uncoupled the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Felock, Peter J.; Hastings, Jeffrey C.; Pramanik, Bernali; Wolfe, Abigail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7005-7011</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Previous in vitro analyses have shown that the human immunodeficiency virus type 1 (HIV-1) integrase uses either manganese or magnesium to assemble as a stable complex on the donor substrate and to catalyze strand transfer.  We now demonstrate that subsequent to assembly, catalysis of both 3' end processing and strand transfer requires a divalent cation cofactor and that the divalent cation requirements for assembly and catalysis can be functionally distinguished based on the ability to utilize calcium and cobalt, resp.  The different divalent cation requirements manifest by these processes are exploited to uncouple assembly and catalysis, thus staging the reaction.  Staged 3' end processing and strand transfer assays are then used in conjunction with exonuclease III protection anal. to investigate the effects of integrase inhibitors on each step in the reaction.  Anal. of a series of related inhibitors demonstrates that these types of compds. affect assembly and not either catalytic process, therefore reconciling the apparent disparate results obtained for such inhibitors in assays using isolated pre-integration complexes.  These studies provide evidence for a distinct role of the divalent cation cofactor in assembly and catalysis and have implications for both the identification and characterization of integrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZfMUmmKmUirVg90H21EOLACvtfcHk0lgsd4PvDzTCqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D&md5=c5ce1c183540f6d4262e660181d59d6e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26atitle%3DDifferential%2520divalent%2520cation%2520requirements%2520uncouple%2520the%2520assembly%2520and%2520catalytic%2520reactions%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D7005%26epage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blahy, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlabach, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condra, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vastag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span> </span><span class="NLM_article-title">L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">4096</span><span class="NLM_x">–</span> <span class="NLM_lpage">4100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=4096-4100&author=J.+P.+Vaccaauthor=B.+D.+Dorseyauthor=W.+A.+Schleifauthor=R.+B.+Levinauthor=S.+L.+McDanielauthor=P.+L.+Darkeauthor=J.+Zugayauthor=J.+C.+Quinteroauthor=O.+M.+Blahyauthor=E.+Rothauthor=V.+V.+Sardanaauthor=A.+J.+Schlabachauthor=P.+I.+Grahamauthor=J.+H.+Condraauthor=L.+Gotlibauthor=M.+K.+Hollowayauthor=J.+Linauthor=I.+Chenauthor=K.+Vastagauthor=D.+Ostovicauthor=P.+S.+Andersonauthor=E.+A.+Eminiauthor=J.+R.+Huff&title=L-735%2C524%3A+an+orally+bioavailable+human+immunodeficiency+virus+type+1+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DLevin%26aufirst%3DR.%2BB.%26aulast%3DMcDaniel%26aufirst%3DS.%2BL.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DZugay%26aufirst%3DJ.%26aulast%3DQuintero%26aufirst%3DJ.%2BC.%26aulast%3DBlahy%26aufirst%3DO.%2BM.%26aulast%3DRoth%26aufirst%3DE.%26aulast%3DSardana%26aufirst%3DV.%2BV.%26aulast%3DSchlabach%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DP.%2BI.%26aulast%3DCondra%26aufirst%3DJ.%2BH.%26aulast%3DGotlib%26aufirst%3DL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DVastag%26aufirst%3DK.%26aulast%3DOstovic%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26atitle%3DL-735%252C524%253A%2520an%2520orally%2520bioavailable%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D4096%26epage%3D4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdirame, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable <i>N</i>-methyl pyrimidones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704705" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4953-4975&author=C.+Gardelliauthor=E.+Niziauthor=E.+Muragliaauthor=B.+Crescenziauthor=M.+Ferraraauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=M.+Pomaauthor=M.+Rico+Ferreiraauthor=R.+Scarpelliauthor=C.+F.+Homnickauthor=N.+Ikemotoauthor=A.+Alfieriauthor=M.+Verdirameauthor=F.+Bonelliauthor=O.+Gonzalez+Pazauthor=M.+Talianiauthor=E.+Monteagudoauthor=S.+Pesciauthor=L.+Lauferauthor=P.+Felockauthor=K.+A.+Stillmockauthor=D.+Hazudaauthor=M.+Rowleyauthor=V.+Summa&title=Discovery+and+synthesis+of+HIV+integrase+inhibitors%3A+development+of+potent+and+orally+bioavailable+N-methyl+pyrimidones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0704705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704705%26sid%3Dliteratum%253Aachs%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DPoma%26aufirst%3DM.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DIkemoto%26aufirst%3DN.%26aulast%3DAlfieri%26aufirst%3DA.%26aulast%3DVerdirame%26aufirst%3DM.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DL.%26aulast%3DFelock%26aufirst%3DP.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520HIV%2520integrase%2520inhibitors%253A%2520development%2520of%2520potent%2520and%2520orally%2520bioavailable%2520N-methyl%2520pyrimidones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4953%26epage%3D4975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span> </span><span class="NLM_article-title">Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7084</span><span class="NLM_x">–</span> <span class="NLM_lpage">7088</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050549e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7084-7088&author=M.+L.+Barrecaauthor=S.+Ferroauthor=A.+Raoauthor=L.+De+Lucaauthor=M.+Zappalaauthor=A.+M.+Monforteauthor=Z.+Debyserauthor=M.+Witvrouwauthor=A.+Chimirri&title=Pharmacophore-based+design+of+HIV-1+integrase+strand-transfer+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm050549e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050549e%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DZappala%26aufirst%3DM.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DChimirri%26aufirst%3DA.%26atitle%3DPharmacophore-based%2520design%2520of%2520HIV-1%2520integrase%2520strand-transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7084%26epage%3D7088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">A large variety of compounds (especially anionic) are reported to have high affinity for HSA (human serum albumin), which accounts for 60% of human serum proteins. This binding limits the amount of drug available and reduces the effective concentration of drug at the cellular target. See the following:</p></div><span class="NLM_contrib-group">Sheppard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidanze, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BaMaung, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedrow, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantei, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker-Garcia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniewski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span> </span><span class="NLM_article-title">Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3832</span><span class="NLM_x">–</span> <span class="NLM_lpage">3849</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3832-3849&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=S.+D.+Fidanzeauthor=N.+Y.+BaMaungauthor=S.+A.+Ericksonauthor=D.+M.+Barnesauthor=J.+S.+Tedrowauthor=L.+Kolaczkowskiauthor=A.+Vasudevanauthor=D.+C.+Parkauthor=G.+T.+Wangauthor=W.+J.+Sandersauthor=R.+A.+Manteiauthor=F.+Palazzoauthor=L.+Tucker-Garciaauthor=P.+Louauthor=Q.+Zhangauthor=C.+H.+Parkauthor=K.+H.+Kimauthor=A.+Petrosauthor=E.+Olejniczakauthor=D.+Nettesheimauthor=P.+Hajdukauthor=J.+Henkinauthor=R.+Lesniewskiauthor=S.+K.+Davidsenauthor=R.+L.+Bell&title=Discovery+and+optimization+of+anthranilic+acid+sulfonamides+as+inhibitors+of+methionine+aminopeptidase-2%3A+a+structural+basis+for+the+reduction+of+albumin+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0601001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601001%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DBarnes%26aufirst%3DD.%2BM.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DKolaczkowski%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DSanders%26aufirst%3DW.%2BJ.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DTucker-Garcia%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DPetros%26aufirst%3DA.%26aulast%3DOlejniczak%26aufirst%3DE.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DHajduk%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DBell%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520anthranilic%2520acid%2520sulfonamides%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%253A%2520a%2520structural%2520basis%2520for%2520the%2520reduction%2520of%2520albumin%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3832%26epage%3D3849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><div class="note"><p class="first last">Protein binding measurements were performed by ultrafiltration with Amicon Centrifree YM-30, after incubation at 37 °C for 1 h. The filtrate was analyzed by HPLC−MS−MS, operating in multiple reaction monitoring (MRM).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+binding+measurements+were+performed+by+ultrafiltration+with+Amicon+Centrifree+YM-30%2C+after+incubation+at+37+%C2%B0C+for+1+h.+The+filtrate+was+analyzed+by+HPLC%E2%88%92MS%E2%88%92MS%2C+operating+in+multiple+reaction+monitoring+%28MRM%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">Single-point measurement after 1 h. Experimental conditions: 2 µM compound, 1 mg/mL microsomes. The degradation of the compound in the presence of UDPGA (or NADPH) was measured by LC/MS/MS after 1 h of incubation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Single-point+measurement+after+1+h.+Experimental+conditions%3A+2+%C2%B5M+compound%2C+1+mg%2FmL+microsomes.+The+degradation+of+the+compound+in+the+presence+of+UDPGA+%28or+NADPH%29+was+measured+by+LC%2FMS%2FMS+after+1+h+of+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">Multiple-points measurement during 1 h. Experimental conditions: 1 µM compound, 1 mg/mL microsomes. The degradation of the compound in the presence of UDPGA and NADPH was measured by LC/MS/MS during 1 h of incubation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Multiple-points+measurement+during+1+h.+Experimental+conditions%3A+1+%C2%B5M+compound%2C+1+mg%2FmL+microsomes.+The+degradation+of+the+compound+in+the+presence+of+UDPGA+and+NADPH+was+measured+by+LC%2FMS%2FMS+during+1+h+of+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">A positive charge on a molecule is reported to often disrupt the high-affinity interaction with HSA (human serum albumin). See ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+positive+charge+on+a+molecule+is+reported+to+often+disrupt+the+high-affinity+interaction+with+HSA+%28human+serum+albumin%29.+See+ref+20."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">Single-point measurement after 1 h. Experimental conditions: 2 µM compound, 0.3 mg/mL microsomes. The degradation of the compound in the presence of UDPGA was measured by LC/MS/MS after 1 h of incubation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Single-point+measurement+after+1+h.+Experimental+conditions%3A+2+%C2%B5M+compound%2C+0.3+mg%2FmL+microsomes.+The+degradation+of+the+compound+in+the+presence+of+UDPGA+was+measured+by+LC%2FMS%2FMS+after+1+h+of+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2900</span><span class="NLM_x">–</span> <span class="NLM_lpage">2904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2900-2904&author=J.+P.+Guareauthor=J.+S.+Waiauthor=R.+P.+Gomezauthor=N.+J.+Anthonyauthor=S.+M.+Jollyauthor=A.+R.+Cortesauthor=J.+P.+Vaccaauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=W.+A.+Schleifauthor=G.+Moyerauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=D.+J.+Hazudaauthor=S.+D.+Young&title=A+series+of+5-aminosubstituted+4-fluorobenzyl-8-hydroxy-%5B1%2C6%5Dnaphthyridine-7-carboxamide+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DCortes%26aufirst%3DA.%2BR.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520series%2520of%25205-aminosubstituted%25204-fluorobenzyl-8-hydroxy-%255B1%252C6%255Dnaphthyridine-7-carboxamide%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2900%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motzel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tussey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casimiro, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiver, J. W.</span><span> </span><span class="NLM_article-title">Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=528-532&author=D.+J.+Hazudaauthor=S.+D.+Youngauthor=J.+P.+Guareauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=L.+Handtauthor=S.+L.+Motzelauthor=H.+J.+Kleinauthor=G.+Dornadulaauthor=R.+M.+Danovichauthor=M.+V.+Witmerauthor=K.+A.+Wilsonauthor=L.+Tusseyauthor=W.+A.+Schleifauthor=L.+S.+Gabryelskiauthor=L.+Jinauthor=M.+D.+Millerauthor=D.+R.+Casimiroauthor=E.+A.+Eminiauthor=J.+W.+Shiver&title=Integrase+inhibitors+and+cellular+immunity+suppress+retroviral+replication+in+rhesus+macaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHandt%26aufirst%3DL.%26aulast%3DMotzel%26aufirst%3DS.%2BL.%26aulast%3DKlein%26aufirst%3DH.%2BJ.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DDanovich%26aufirst%3DR.%2BM.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DWilson%26aufirst%3DK.%2BA.%26aulast%3DTussey%26aufirst%3DL.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DCasimiro%26aufirst%3DD.%2BR.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DShiver%26aufirst%3DJ.%2BW.%26atitle%3DIntegrase%2520inhibitors%2520and%2520cellular%2520immunity%2520suppress%2520retroviral%2520replication%2520in%2520rhesus%2520macaques%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D528%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Monteagudo, E.</span><div class="note"><p class="first last">Unpublished results.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Monteagudo%2C+E.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMonteagudo%26aufirst%3DE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M. D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6552</span><span class="NLM_x">–</span> <span class="NLM_lpage">6555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=6552-6555&author=O.+Kinzelauthor=E.+Monteagudoauthor=E.+Muragliaauthor=F.+Orvietoauthor=G.+Pescatoreauthor=M.+D.+R.+Rico+Ferreiraauthor=M.+Rowleyauthor=V.+Summa&title=The+synthesis+of+tetrahydropyridopyrimidones+as+a+new+scaffold+for+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%2BD.%2BR.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DThe%2520synthesis%2520of%2520tetrahydropyridopyrimidones%2520as%2520a%2520new%2520scaffold%2520for%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D6552%26epage%3D6555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Synthesis of an hexahydropyrimido[1,2-<i>a</i>]azepine-2-carboxamide derivative useful as HIV integrase inhibitor</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8379</span><span class="NLM_x">–</span> <span class="NLM_lpage">8382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=8379-8382&author=M.+Ferraraauthor=B.+Crescenziauthor=M.+Donghiauthor=E.+Muragliaauthor=E.+Niziauthor=S.+Pesciauthor=V.+Summaauthor=C.+Gardelli&title=Synthesis+of+an+hexahydropyrimido%5B1%2C2-a%5Dazepine-2-carboxamide+derivative+useful+as+HIV+integrase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520an%2520hexahydropyrimido%255B1%252C2-a%255Dazepine-2-carboxamide%2520derivative%2520useful%2520as%2520HIV%2520integrase%2520inhibitor%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D8379%26epage%3D8382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">Synthesis described in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Synthesis+described+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Katritzky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachwal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macomber, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. P.</span><span> </span><span class="NLM_article-title">Preparation of 6-, 7- and 8-membered sultams by Friedel−Crafts cyclization of ω-phenylalkanesulfamoyl chlorides</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=463-467&author=A.+R.+Katritzkyauthor=J.+Wuauthor=S.+Rachwalauthor=B.+Rachwalauthor=D.+W.+Macomberauthor=T.+P.+Smith&title=Preparation+of+6-%2C+7-+and+8-membered+sultams+by+Friedel%E2%88%92Crafts+cyclization+of+%CF%89-phenylalkanesulfamoyl+chlorides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRachwal%26aufirst%3DS.%26aulast%3DRachwal%26aufirst%3DB.%26aulast%3DMacomber%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DT.%2BP.%26atitle%3DPreparation%2520of%25206-%252C%25207-%2520and%25208-membered%2520sultams%2520by%2520Friedel%25E2%2588%2592Crafts%2520cyclization%2520of%2520%25CF%2589-phenylalkanesulfamoyl%2520chlorides%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2006%26volume%3D24%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/jm701164t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_44873"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and analytical data for the intermediates <b>30a</b>, <b>30c</b>,  <b>31c</b>, and [(dimethylamino)sulfonyl]acetic acid; HPLC, UPLC, and high-resolution mass measurements (HRMS) data for final compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701164t/suppl_file/jm701164t-file002.pdf">jm701164t-file002.pdf (1.3 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701164t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-4%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm701164t%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701164t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                375KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999c453c9bd96e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
